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ABSTRACT OF DISSERTATION 
 
 
 
 
A MASS SPECTROMETRY-BASED STUDY OF SERUM 
BUTYRYLCHOLINESTERASE INHIBITION FROM PESTICIDE EXPOSURE 
AND ORGANOPHOSPHATE PESTICIDE-INDUCED PROTEOME ALTERATION 
 
Pesticides including organophosphates (OPs) and carbamates (CBs) are widely 
used to control undesirable pests.  These compounds are neurotoxic and inhibit 
hydrolysis of the neurotransmitter acetylcholine by acetylcholinesterase.  Public health 
concerns have increased with the escalating usage of pesticides.  Reliable monitoring 
programs are required to detect and quantify pesticide exposure, as well as to promote 
an understanding of their neurotoxic properties.  In this dissertation, both the 
anticholinergic (Part I) toxicity and neurotoxicity in neuroblastoma cells (Part II) of 
pesticides were explored using mass spectrometry (MS).  The high sensitivity and 
high-throughput of this technique renders it well-suited for proteomics analysis. 
Part I describes the study of butyrylcholinesterase (BChE) inhibition resulting 
from OP and CB exposure.  The main hypothesis of Part I is that the special 
modification of BChE can provide the origin and extent of pesticide exposure.  A novel 
method for detection and quantification of pesticide exposure was designed using a 
proteomics approach and equine BChE (eBChE) as a model system.  The methodology 
featured detection and analysis of phosphorylated or carbamylated peptides at the 
active site serine residue.  The developed technique was successfully applied towards 
the study of human BChE (hBChE) inhibition in vitro and in serum samples.  A 
specially designed affinity column enabled an isolation of BChE from serum.  Enriched 
BChE was subjected to enzymatic digestion by a novel on-bead double digestion 
protocol.  LC/MS/MS was employed to produce a calibration system for the analysis of 
hBChE inhibition, which was then applied towards quantification of the enzyme. 
Part II describes a proteomic study of the neurotoxicity in neuroblastoma cells 
caused from chlorpyrifos (CPF), an organophosphate pesticide.  The concerns of CPF 
exposure to pregnant women, infants and children are increasing due to 
developmentally neurotoxic effects of this chemical.  The main hypothesis of Part II is 
that CPF can cause protein alterations and these altered proteins can be detected using 
proteomics.  Systematic studies at subcellular levels evaluated proteome changes in 
SH-SY5Y cells exposed to CPF.  Two-dimensional gel electrophoresis (2DE) was 
applied with MALDI-TOF-MS to analyze differential protein expression.  Thirty seven 
common unique altered proteins were identified, which play important roles in 
metabolic pathway. 
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GENERAL INTRODUCTION 
 
PESTICIDE BACKGROUND 
 
Pesticides are biologically active by design and intentionally dispersed into the 
environment. They are extensively used in the world to destroy or control undesired pests, 
including insects, weeds, bacteria or other organisms. A prominent group of cholinesterase 
inhibitors includes two different kinds of pesticides, organophosphate (OP) and carbamate 
(CB), which were investigated in this dissertation. The following describes their properties, 
metabolism, and mode of action.  
 
Properties 
Forty one different kinds of OPs are registered for use in the United States. They 
are normally esters, amides, or thiol derivatives of phosphoric, phosphonic, 
phosphorothioic, or phosphonothioic acids. Although there are various structures of OPs, 
they share a common basic structure (R1)(R2)(X)P=(S or O). All OPs contain a central 
phosphorus atom with a double bond to either sulfur or oxygen. R1 and R2 groups are 
usually simple alkyl or aryl groups, both of which may be either bonded directly to the 
phosphorus, or linked via –O–, or –S–. A leaving group X is specific to the individual OP, 
which can be any one of a wide variety of substituted and branched aliphatic, aromatic, or 
heterocyclic groups linked to phosphorus via a bond (usually –O– or –S–). In order to be 
useful, these OP compounds must be reasonably stable at a neutral pH. Many OPs are 
formulated as high concentration in oil, or in a water-miscible solvent, and they are slightly 
soluble in water and have a high oil-water partition coefficient and low vapor pressure. As 
such, OPs are applied either directly or after dispersion in water to reach target organisms. 
All the OPs can be degraded by hydrolysis, yielding water-soluble products that are 
believed to be non-toxic at all practical concentrations. 
More than 50 cabamates are known as N-substituted esters of carbamic acid. Their 
general structure is R1NHC(O)OR2, in which R2 is an aromatic and/or aliphatic moieties. 
Three main classes of CBs are known: (i) carbamate insecticides (R1 is a methyl group); (ii) 
carbamate herbicides (R1 is an aromatic moiety); and (iii) carbamate fungicides (R1 is a 
 2
benzimidazole moiety). Carbamate ester derivatives are crystalline solids of low vapor 
pressure with variable, but usually low, water solubility. They are moderately soluble in 
solvents such as benzene, toluene, xylene, and chloroform. In general, they are poorly 
soluble in nonpolar organic solvents such as petroleum but highly soluble in polar organic 
solvents like ethanol. CBs can be hydrolyzed by alkali. The instability in alkali is of use for 
decontamination and clean-up. 
 
Metabolism 
The metabolic fate of OPs and CBs is basically the same in insects, and animals. 
Animals take in OPs and CBs through the skin, inhalation, or gastrointestinal tract. 
Metabolism of OPs occurs primarily by oxidation, hydrolysis by esterases, and by transfer 
of portions of the molecule to glutathione. Oxidation of OPs may result in more or less 
toxic products. Phosphorothioates generally require oxidative metabolism to produce the 
proximal toxin, which exerts their acute effects. The rates of hydrolysis of OPs by esterases 
mostly are faster in mammals than insects. Therefore, mammals are often more efficient in 
their detoxification processes.  In most cases, the products from the glutathione transferase 
reactions are of low toxicity. Hydrolytic and transferase reaction affect both the thioates 
and their oxons. Numerous conjugation reactions follow primary metabolic processes, and 
elimination of the phosphorus-containing residue may be via the urine and feces. 
CBs are metabolically transformed by a variety of chemical reactions, including 
oxidation and enzymatic hydrolysis by enzyme, into more water soluble molecules with 
increased polar properties. Oxidative products are more or less toxic and are cholinesterase 
inhibitors. CBs are hydrolyzed either spontaneously or by esterases, yielding as final 
products, an amine, carbon dioxide, and an alcohol or phenol. Most mammals have more 
efficiency in hydrolytic enzymes than insects and, therefore, are often more efficient their 
detoxification processes. The conversion to conjugated compounds of the hydroxyl 
products produced from the primary metabolic processes is an important reaction that leads 
to the water-soluble compounds, which can be eliminated via urine and feces.   
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Mode of action 
OPs and CBs exert their acute effects in both insects and mammals by inhibiting 
acetylcholinesterase (AChE) in the nervous system with subsequent accumulation of toxic 
levels of acetylcholine (ACh), which is a neurotransmitter. In many cases, the 
organophosphorylated enzyme is fairly stable, so that recovery from intoxication may be 
very slow. However, the carbamylated enzyme is unstable, and the regeneration of AChE 
is relatively rapid compared with that of a phosphorylated enzyme. Thus, carbamate 
pesticides are less dangerous with regard to human exposure than OPs. The ratio between 
the dose required to cause death and the dose required to produce minimum symptoms of 
poisoning is substantially larger for CBs than for OPs. 
With the introduction of the organophosphate pesticides (OPs) and carbamates 
(CBs) into American agriculture, interest in their chemistry, mode of action, and toxicity 
has increased. Many articles and books have been published concerning the inhibitory 
action of pesticides on AChE. The inhibitory action of OPs and CBs on AChE appears to 
be largely responsible for their toxicity toward invertebrates and vertebrates. The action of 
pesticides may be purely anticholinergic; however, several researchers discovered that 
some of the OPs chlorpyrifos (CPF) for example are more than cholinergic agonist.  
In this dissertation, both the anticholinergic properties (Part I) and neurotoxicity in 
neuroblastoma cells (Part II) of CPF were studied using proteomics approaches and mass 
spectrometry (MS). In the last decade, the sensitivity of MS has improved by several orders 
of magnitude (1). Because of the high sensitivity, selectivity and its high-throughput 
operations, MS has become an increasingly reliable technique for protein identification. 
Two new mass spectrometric techniques, electrospray ionization (ESI) and matrix-assisted 
laser desorption/ionization (MALDI), have dramatically extended protein analysis. These 
two types of mass spectrometry work in different ways and produce different, but 
complementary, information. Both MALDI and LC/MS were applied in this dissertation 
and will be discussed later. 
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PROTEOMICS BACKGROUND 
 
Marc Wilkins and colleagues first mentioned “proteomics” and “proteome” to 
mirror “genomics” and “genome” in the early 1990s. Proteomics is the protein complement 
of the organism’s genome (2). Three developments changed the biological landscape and 
formed the foundation of the new biology. The first was the growth of the gene database, 
expressed sequence tag (EST), and protein sequence databases during the 1990s. The 
genome-sequencing projects yielded complete genomic sequences of bacteria, yeast, 
nematodes, and drosophila, and culminated recently in the complete sequence of the 
human genome in the late 1990s. The second key development was the introduction of 
browser-based bioinformatics tools to extract information from the gene databases. 
Searching an entire genome for specific nucleic acid or protein sequences in seconds is 
possible. The third key development is the oligonucleotide microarray. The array contains 
a series of gene-specific oligonucleotides or cDNA sequences on a slide or a chip.  
Although gene microarrays offer a global view of the expression of many or all 
genes in a cell, it can not predict the levels of the corresponding proteins in a cell. In 
addition, mRNA levels tell us nothing about the functions of the corresponding proteins, 
whose activities and functions are subject to many posttranslational modifications. 
Consequently, many proteins are present in many forms. The detection and differentiation 
between multiple protein isoforms add an analytical challenge of proteomics.  
To address these concerns, scientific researchers recently started to focus on 
elucidating genomic sequence to total protein analysis, giving rise to a new scientific 
discipline called “proteomics” (3, 4). Proteomics requires analytical tools to detect and 
quantify proteins in their different isoforms. Currently two methods, “top-down” and 
“bottom-up”, are performed for proteomics analysis. Both techniques rely on mass 
spectrometry (MS) for the protein analysis. However, only “bottom-up” proteomics is 
described and used in this dissertation.  
 
Bottom-up Proteomics  
A proteomics approach currently drawing the most attention is that of bottom-up 
proteomics. The approach collects protein information from the analysis of peptides 
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generated from proteolytic digests and can be carried out via two basic strategies. The first 
strategy of proteomics approaches (Figure 0-1 A) is known as the peptide mass 
finger-printing scheme by combination of two dimensional gel electrophoresis (2D gel) 
with mass spectrometry. The protein mixture can be resolved by 2D gel in high resolution, 
and proteins can be identified using MS in high sensitivity. A typical protocol of this 
approach begins with 2D gel electrophoresis, where protein mixtures are separated by 
charge (pI) in the first dimension and then separated orthogonally by size (MW) in the 
second dimension. Resolved proteins are visualized by staining proteins with Coomassie 
Blue, SYPRO Ruby, or Silver staining. After analysis of the 2D gel image with software 
e.g. PDQuest (Bio-Rad), proteins of interest are excised and subjected to in-gel digestion. 
The digests are further analyzed to generate mass spectra by MALDI-TOF-MS. The 
experimental peptide masses are then compared to the theoretical ones from the insilico 
digestion of the protein database to identify the protein of interest. 
A second proteomic approach is by peptide fragmentation (Figure 0-1B). The 
approach starts to convert a protein or protein mixture into peptides by protease digestion 
(Figure 0-1 B). Generated peptides are then resolved by different types of chromatography 
columns, and each peptide is subjected to MS/MS analysis to produce unique peptide 
fragmentations. Through electrospray ionization (ESI), peptides in the HPLC effluent are 
directly introduced into the mass analyzer, such as ion trap or triple quadrupole, allowing 
on-line MS/MS analysis. The experimental MS/MS spectrum of each peptide is compared 
with the theoretical MS/MS spectra to elucidate its amino acid sequence using modern 
protein database search algorithms. Thus, the parent protein of interest is identified. 
 
Bottom-up Proteomics Tools 
As described in the previous section, the growth of proteomics is dependent on the 
development of mass spectrometry and the ability to rapidly obtain accurate masses of 
proteins and peptides. A typical proteomics experiment is divided into three main classes: 
protein preparation and analysis, mass spectrometry, and bioinformatics. A variety of 
instrumentation is required to resolve protein/peptide mixtures and introduce them to the 
analyzer for analysis. After an analysis using mass spectrometry, bioinformatics tools are  
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Figure 0-1. Strategies for the analysis of protein mixture using mass spectrometry. (A) 
Protein mixtures can be resolved by 2D gel electrophoresis. The protein of interest is 
picked, digested, and analyzed by mass spectrometry. (B) The entire protein mixture is 
digested, separated by multi-dimensional chromatography, analyzed by tandem MS, and 
identified by database search.   
Protein mixture
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peptides 
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then applied to identify proteins of interest by searching protein databases. This section 
will describe some important tools used in this dissertation. These tools include HPLC, two 
dimensional gel electrophoresis (2DE), MALDI-TOF-MS, ESI, and quadrupole ion trap 
mass analyzer. 
 
High-pressure Liquid Chromatography  
High-pressure liquid chromatography (HPLC) separation/ electrospray ionization 
(ESI) mass spectrometric detection has been an important tool in proteomics since the last 
ten years (5, 6). HPLC performs separation by pumping the mobile phase through a column 
at high pressure to increase the separation performance. Furthermore, the diversity of 
stationary phases and separation modes increases HPLC resolving power. The major 
HPLC separation modes used in peptide separation and the characteristics that dictate 
separation are listed as follows.  
• Reversed phase (RP): hydrophobicity 
• Strong cation exchange: net positive charge 
• Strong anion exchange: net negative charge 
• Affinity: interaction with specific functional groups 
However, RP-HPLC is usually chosen for resolving a mixture of peptides. The stationary 
phase of RP-HPLC is non-polar, and the mobile phase is a polar solvent. A typical 
stationary phase of the reversed phase (RP) chromatography consists of silica based 
packings or the other supports covalently bound with n-alkyl chains. For example, C-8 
signifies an octyl chain and C-18 an octadecyl ligand in the matrix. A typical mobile phase 
is a mixture of water or buffer with polar solvents such as methanol, acetonitrile, or 
tetrahydrofuran. 
The more hydrophobic the matrix, the greater is the tendency of the column to 
retain hydrophobic moieties. There are three competing explanations for retention in 
reverse phase chromatography: the hydrophobic theory, partitioning, and adsorption. 
However, a complete theory of retention mechanism of reversed-phase chromatography 
must include both partitioning and adsorption(7). The theory of Jaroniec (8) treats the 
retention mechanism as a mixture of partitioning and displacement. The partitioning model 
can explain how peptide mixtures can be resolved in RP-HPLC. Based on this theory, an 
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equilibrium exists when peptides partition between the stationary phase and the liquid 
mobile phase. Peptides migrate in and out of the stationary phase along with the mobile 
phase. However, the equilibrium can be shifted toward the mobile phase by increasing the 
organic component of the solvent. Peptides in a mixture are separated based on their 
hydrophobicity using a gradient mobile phase of increasing organic component. 
The separation of a peptide mixture into its individual components takes place in 
the chromatography column. In order to understand the mechanism of retention and 
selectivity and thus be in a position to exercise some control over the chromatography 
system, it is necessary to know the theory of chromatography. Next, the theory of 
chromatography, especially of the hydrodynamics of chromatography will be covered. 
The quality of a separation is measured by the plate count N, which is related to the 
height equivalent to a theoretical plate (HETP). HETP is described by the equation: 
                                                
dL
dh
2σ
=                                                              (0.1) 
Where L is the column length, σ is the standard deviation of a Gaussian distributed 
chromatographic peak. Generally, if HETP is plotted against a linear velocity, a curved 
relationship with a minimum of the HETP will be obtained (Figure 0-2).  Among all the 
equations describing the dependence of the HETP on linear velocity, the van Deemter 
equation (9) is conceptually the simplest. It is assumed that the overall spreading of a peak 
is the result of a number of individual, non-interacting, random processes that, taken 
together, account for the total peak dispersion. Since these contributions are independent of 
each other, HETP is simply described by adding them up: 
                                           Cu
u
BAH ++=                                                         (0.2) 
 Where u is the velocity; A, velocity-independent, is a function of the size and 
distribution of the inter-particle channels and other non-uniformities in the packed bed; B, 
describing the molecular diffusion in the axial direction, is inversely proportional to the 
linear velocity; C, containing all terms related to mass transfer, is directly proportional to 
the linear velocity. 
The A term of the van Deemter equation is expressed as 
                                                        pidA λ=                                                      (0.3) 
 9
 
 
 
 
 
 
Figure 0-2. Relationship between HETP and linear velocity. The curve has a minimum 
and the right-hand branch increases usually practically linearly with the linear velocity.
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Where λi stands for the factor of the packed bed, which is between 1.5 and 2, dp is the 
particle diameter. The A term is proportional to the particle size and can be influenced by 
the column packing technique. 
The B term of the van Deemter equation is described as  
                                                        
u
DB Mγ2=                                                   (0.4) 
The coefficient γ is the obstruction factor, which depends on the amount and the 
nature of the “obstruction” that is in the way of free movement of the molecule. The factor 
γ is usually between 0.5 and 1. DM is the diffusion coefficient in the mobile phase, 
assuming that the diffusion coefficient in the pores is the same as that in the interstitial 
mobile phase. 
Now, let us look at the term of the van Deemter equation that describes all the 
phenomena resulting in an increase in HETP with increasing linear velocity. This term 
includes the mass transfer from the center of the moving mobile phase to the surface of the 
particle (mobile-phase mass transfer), through the stagnant mobile phase in the pores to the 
stationary phase on the internal surface of the packing (mobile-phase mass transfer 
resistance to the stagnant mobile phase), and the interaction kinetics with the stationary 
phase (stationary-phase mass transfer). Although these contribute to the resistance to mass 
transfer, a rough estimation is made for the coefficient on the mass-transfer term in a 
packed bed with porous particles in the practical range as 
                                                  u
D
d
cC
M
p
2
=                                                           (0.5) 
Where the coefficient c is between 0.1 and 0.3 in most practical cases; dp is the 
particle diameter; DM is the diffusion coefficient in the mobile phase. 
The whole van Deemter equation is described as follows, including all the 
coefficients used to estimate the HETP for a normal packed bed of porous particles: 
                                         u
D
d
u
DdH
M
pM
p
2
6
15.1 ++=                                             (0.6) 
The plate count of a column can be estimated using this equation assuming that the 
diffusion coefficient is known. Figure 0-2 shows a curve with a minimum, which means 
that there is an optimum mobile phase velocity at which the column will give the minimum 
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HETP, and consequently, a maximum efficiency. In practice, this usually means that 
reducing the flow rate of a column will increase the efficiency, and thus, the resolution. In 
doing so, however, it also will increase the analysis time. In addition, there is a limit to 
velocity procedure, as reducing the column flow rate so that the mobile phase velocity falls 
below the optimum will result in an increase in the HETP, and thus, a decrease in column 
efficiency. 
It is seen that equation (0.6) is explicit and would permit the design of a column to 
have the particular efficiency required for a specified analysis. Based on this theory, 
designed columns, packed in laboratory, were applied in this dissertation. ESI requires low 
liquid flow rate and, thus, very small diameter HPLC columns. Currently, microflow 
(μl/min) and nanoflow (nl/min) HPLC have already been developed (10). Packed capillary 
columns range in inner diameter (I.D.) from 50-500 μm with 15 to 30 cm in length. The 
required flow range (e.g.100 nl/min to 5 μl/min) for a packed capillary column with 
conventional HPLC pump can be obtained by using a flow splitter prior to the injector. In 
addition to the compatibility with direct mass spectrometry, microflow and nanoflow 
HPLC also provide an advantage of smaller sample volumes and increased sensitivity.  
 
Two-dimensional Gel Electrophoresis 
Two-dimensional gel electrophoresis (2D gel) is still the best method for 
simultaneously resolving highly complex protein mixtures. In brief, 2D gels resolve 
proteins in the first dimension by charge (pI) and in the second dimension by molecular 
weight (MW) (Figure 0-3).  
The introduction of immobilized pH gradients (IPG) for the isoelectric forcusing 
step (IEF), has greatly improved the reproducibility of 2D gel electrophoresis (11). IPGs 
are based on the principle that the pH gradient is generated by a limited number of 
well-defined chemicals, which are co-polymerized with the acrylamide matrix. IPGs allow 
the generation of pH gradients of any desired range between pH 3 and 12. The first 
dimension of 2D gel electrophoresis, isoelectric focusing (IEF), is performed in individual 
IPG gel strips 5 mm wide. Prior to IEF, the IPG strip is hydrated with protein mixture in 
sample hydration buffer (containing chaotic reagent and ampholytes), and proteins are 
slowly loaded into the strip under voltage prior to isoelectric focusing. After 12 hours of  
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Figure 0-3. Schematic representation of 2D gel electrophoresis. 
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loading time, the voltage is then increased to achieve focusing. With the presence of a pH 
gradient in the IEF technique, a protein will migrate to the position in the gradient where its 
charge is zero. Proteins with a positive net charge will migrate toward the cathode until it 
meets its pI. Similarly, proteins with a negative net charge will migrate toward the anode 
until it meets its pI. IEF is performed under high voltages (> 1000 V) until the proteins have 
reached their final position in the pH gradient. 
After the focusing step, the strip is then treated with equilibration buffers 
containing a thiol reductant and denaturing reagent (i.e. SDS) followed by loading it on the 
second dimensional gel, polyacrylamide gel electrophoresis (PAGE). In this situation, the 
IPG strip with the focused proteins is like a ‘stacking gel’ in a 1D SDS gel electrophoresis. 
The proteins are then separated on the SDS-PAGE on the basis of their size in the same 
manner as the 1D gel electrophoresis. Gels are run at constant current until the blue dye 
front line reaches the bottom of the gel. After termination of the second dimension run 
(PAGE), it is necessary to immobilize the resolved proteins in the gel with a fixing solution. 
TCA (20%) or methanolic or ethanolic acetic acid are widely used as fixatives. Proteins 
can be visualized by several staining methods – silver staining, fluorescent staining, 
colloidal Coommassie Blue G-250 staining, and Coommassie R-250 staining. The protein 
of interest can be digested with proteolytic enzymes, such as trypsin. The digest is then 
subjected to MALDI-TOF-MS or ESI-MS analysis. 
 
MALDI-TOF-MS  
MALDI Source 
For purposes of proteomics, data on peptide masses is obtained by matrix-assisted 
laser desorption ionization-time of flight (MALDI-TOF), whereas MALDI refers to a 
method of ionization, and TOF refers to the mass analyzer. The question of how to obtain 
good data requires us to understand how a MALDI-TOF instrument works. It is easiest to 
start with the MALDI source for understanding the principle of MALDI-TOF instruments. 
The production of ions depends on the selection of laser and matrix. 
 Lasers and Matrix 
There are different kinds of lasers, including ultraviolet (UV) and infrared (IR) 
lasers. Because of their ease of use and low price, UV lasers are the most common. 
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Nitrogen lasers (λ = 337 nm) and Nd : YAG (λ = 266 or 355 nm) are used, among which 
nitrogen lasers are considered standard. IR lasers include Er : YAG lasers (λ = 2.94 μm) 
and CO2 lasers (λ = 10.6 μm). The production of ion current depends on the total energy in 
the laser pulse at a given wavelength. The pulse widths of lasers vary from a few tens of 
nanoseconds to a few hundred microseconds. Big molecular ions are generally observed at 
slightly higher laser power. However, high energy causes extensive fragmentation and 
lower mass resolution. It is important to set up a suitable laser pulse power, which starts 
desorption of the matrix, to obtain a high quality mass spectrum. 
High quality mass spectra also depend on the matrix selection. A good matrix must 
have the following properties: strong absorbance at the laser wavelength, low molecular 
weight, stability in high vacuum condition, and low chemical reactivity. After 
investigating numerous matrix candidates, only a few have been proven as good matrices 
(Table 0-1). Table 0-1 lists some common matrices and their applications in the 
compounds analysis.  
 
Principle of MALDI 
Matrix-assisted laser desorption/ionization is achieved in two steps. In the first step, 
the analyte is mixed with a chemical matrix solution containing small organic molecules, 
which absorb light at a certain wavelength. The most popular matrix compounds are 
α-cyano-4-hydroxycinnamic acid (CHCA), 2,5-dihydroxybenzoic acid (DHB), and 
3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid). A dried-droplet method is the 
most frequently used on-target preparation. The protocol for producing a dried droplet 
sample has several simple steps. First, make a saturated solution of the matrix chemical 
ands mix with sufficient peptide for a final concentration of 1-10 mM. Second, place a 
droplet (0.5-2 µl) of the former solution on the sample target of the mass spectrometer. Dry 
the droplet at room temperature or through blowing room-temperature air over the droplet 
to dry the spot. The result is a “solid solution” deposit of analyte-mixed matrix crystals, 
where the analyte molecules are distributed in the matrix and separated from each other.  
The second step involves irradiation of the solid solution by an intense pulse of 
laser light. The laser energy can be adjusted to ionize different samples. The matrix 
chemicals absorb photons from a laser beam, which induces rapid heating of the crystals. 
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Table 0-1. Some common UV-MALDI matrices. 
Matrix Applications 
α-Cyano-4-hydroxycinnamic acid Peptides, proteins, organic compounds 
3,5-Dimethoxy-4-hydroxycinnamic acid Higher mass biopolymers 
2,5-Dihyoxybenzoic acid Peptides, proteins, carbohydrates 
3-Hydroxypicolinic acid Oligonucleotides 
Trihydroxyacetophenone Oligonucleotides, peptides 
5-chlorosalicylic acid Water-insoluble polymers 
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 Such rapid heating causes localized sublimation of matrix crystals and dispersion of the 
matrix into the gas phase. During this process, the matrix serves to reduce sample damage 
from the laser pulse by absorbing most of the incident energy. At the same time, the matrix 
also plays important roles in the energy transfer from the laser to analyte. Ionization 
reactions can occur at any time during this process. However, it is still not fully understood 
how the ions are originally produced in MALDI. Chemical and physical ionization 
pathways for MALDI include gas-phase photonization, excited-state proton transfer, 
ion-molecule reactions, desorption of preformed ions, etc. It is most widely accepted that 
the ion formation mechanism involves gas-phase proton transfer in the expanding cloud 
with photonized matrix molecules. Both positive and negative ions can be formed during 
ionization process based on the nature of the sample. Usually, each peptide molecule 
accepts one proton from the matrix as it enters into the gas phase to form a single-charged 
ion. Because of the pulse property of laser desorption, a time-of-flight analyzer is chosen as 
a detector. The ions formed in the MALDI source are then extracted and directed into the 
TOF mass analyzer.     
 
TOF Analyzer 
The first linear time-of-flight (TOF) was developed in 1946 by Stephens (12). After 
ions are expelled from the source in bundles produced by laser desorption, they are 
accelerated by a high potential field. Ions with different mass-to-charge ratios have the 
same kinetic energy, but with different velocities resulting in different flight time through a 
field free drift tube. Mass-to-charge ratios are determined by the flight time in the drift tube 
between the source and the detector. When an ion leaves the ion source, its kinetic energy 
is described as: 
                                                 szeV
mv
=
2
2
                                                          (0.7) 
Where m and z are the mass and charge of the ion, v is the velocity of the ion, Vs is 
the acceleration voltage. 
The time needed to pass through the drift-tube (distance is d): 
                                              
v
dt =                                                                          (0.8) 
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Replacing v with the former equation (0.7), it gives a new equation as following: 
                                            )
2
(
2
2
eV
d
z
mt
s
=                                                                (0.9) 
This equation shows that the lower the m/z ratio, the faster it will reach the detector. 
The typical length of flight tube is 1-2 m, and acceleration voltage of at least 20 kV for 
keeping the sensitivity high.  
Due to variations in the velocities of ions of the same m/z, the resolution of linear 
mode is poor. Mass resolution is affected by the following factors: the length of the ion 
formation pulse (time distribution), where the ions are formed (space distribution), and 
initial kinetic energy of the ions (kinetic energy distribution). A technique called “pulse ion 
extraction” was first developed by Wiley and McLaren in the 1950s (13). A time delay 
between ion formation and extraction is used to reduce the kinetic energy distribution of 
ions with the same m/z ratio. The process of delayed pulses extraction has two simple steps. 
First, ions produced in the source are allowed to expand into a field-free region. Second, a 
voltage pulse is applied to extract the ions outside the source after a certain delay (hundreds 
of nanoseconds to several microseconds).  
In the delayed pulse extraction mode, ions initially separate according to their 
kinetic energy in the field-free region. For ions with the same m/z ratio, those with more 
kinetic energy move further toward the detector than those with less energy. Then the 
extraction pulse is applied after a certain delay time, which transmits more energy to the 
ions that remained for a longer time in the source. Thus, the ions with initially less energy 
receive more kinetic energy. Thus, ions with the same m/z ratios are energy focused.    
Reflectron mode of TOF analyzer was used in this dissertation (Figure 0-4). The 
reflectron field is composed of a series of grids and ring electrodes, which was first 
proposed by Mamyrin (14). It acts as an ion mirror by reflecting the ions and sending them 
back through the flight tube. The higher resolution in the reflectron mode is obtained by a 
reflecting field at the end of the flight tube equipped with higher potential and the same 
polarity as the accelerating voltage. Ions with the same m/z value but different velocities 
are time-focused with the reflector. Indeed, ions with more kinetic energy will penetrate 
the reflectron more deeply and will spend more time in reflectron. Thus, they reach the 
detector as the same time as those with slower velocity.  
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Figure 0-4. Schematic representation of reflectron mode of MALDI-TOF-MS. 
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            If two ions with the same m/z ratio but with different energies: one with kinetic 
energy Ek and another one with kinetic energy Ek’, we define the ratio of two kinetic 
energies as 
                                                 2
'
a
E
E
k
k
=                                                                     (0.10) 
So, the ratio of the velocity of two ions can be obtained 
                                                        a
V
V
is
is
=
'
                                                                 (0.11) 
Thus, the ratio of the time of these two ions in the field-free flight is 
                                                 att /' =                                                                      (0.12) 
And the ratio of the time of these two ions in the reflectron is 
                                                a
t
t
r
r
=
'
                                                                     (0.13) 
The total flight time (including flight time in field-free tube and reflectron field) for 
these two ions are 
                               rTOT ttt +=  , and rrTOT atatttt +=+= /'
''              (0.14) (0.15) 
When a > 1, ions with high kinetic energy take less time to pass through the 
field-free tube, but will spend longer time inside the reflectron field. Thus, the variations of 
the flight times compensate each other. A good compensation will yield the same total 
flight time for all ions with the same m/z ratios but with different kinetic energy, which 
requires the proper values for reflectron field strength, acceleration voltage, and the length 
of the field-free flight tube. 
 
Post Source Decay (PSD) 
The term post-source decay refers to the fragmentation of molecular ions, which 
occurs after ion acceleration field and prior to detection region. PSD analysis is an 
extension of MALDI-TOF-MS, which allows one to observe and identify structural 
information of precursor ions. The precursor ion can be selected by applying electrodes 
after the source on the ion path before entering into the field free tube. Ions can be deflected 
by applying potential. Turning off this potential for a short time allows the selected ions to 
pass through. After leaving the ion source, all ions have the same nominal kinetic energy, 
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most of them are unfragmented precursor ions and they already acquired internal energy by 
various mechanisms. During their flight through the field-free drift region they have a long 
time available for post source decay into product ions. These product ions still have 
basically the same velocity as their precursor ions, but have a much lower kinetic energy 
because of their lower mass. The kinetic energy of the product ions is a measure of their 
mass. The kinetic energy of fragment products is described as: 
                                                   
p
f
kpkf m
m
EE =                                                    (0.16) 
Where Ekf  and Ekp are kinetic energy of fragment and precursor ions respectively, 
mf  and mp are the mass of the fragment and precursor ions. 
Thus, the penetration depth of fragments in the reflectron is: 
                                                     
p
f
pf m
m
xx =                                                      (0.17) 
Where xf and xp are the penetration depth of fragment and precursor in the 
reflectron. 
Hence, the flight time of the fragment in the reflectron is: 
                                                      
p
f
rprf m
m
tt =                                                      (0.18) 
 This equation shows that the fragment ions take shorter time in the reflectron than 
the precursor. Measurement of the flight times of fragment ions corresponding to a 
particular precursor ion makes it possible to get the sequence information of this ion.  
Although PSD is not the best MS technique to obtain peptide sequencing, it was 
successfully used to identify the phosphorylated peptide in this dissertation. 
 
LC/MS Instrument 
Electrospay Ionization 
The success of electrospray ionization (ESI) started when Fenn and coworkers 
showed that multiply charged ions were obtained from proteins (15). Proteins in multiple 
charged forms are detected with the instruments whose mass range is limited to as low as 
2000 Da. Later on, the use of ESI extended not only to analyze polymers or biopolymers, 
but also to analyze small polar molecules. ESI is widely used throughout the biochemical 
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field, since it is easily coupled with high performance liquid chromatography (HPLC), 
micro-HPLC and capillary electrophoresis. A lot of researchers discussed electrospray 
principles and its biological applications(16-18). Based on the understanding of their 
theories, the following describes the principle of electrospray. 
An electrospray is produced by applying a strong electric field(19-22), which is 
obtained by the use of a potential difference of 3-6 kV between a capillary and its 
counter-electrode located at the entrance to the mass spectrometer 0.3-2 cm away. When a 
flow in stream containing sample is pumped through this narrow-bore capillary with high 
potential, the resulting high field induces a charge accumulation at the liquid surface 
located at the end of the capillary, which will break into droplets with multiple charges 
(Figure 0-5). Gas at a low flow rate is applied coaxially to disperse the spray into a mist of 
very fine, charged droplets. The ‘onset voltage’ to form a spray depends on the solvent, the 
surface tension of which is different for different solvents. As this voltage is applied, the 
shape of the drop changes (Figure 0-6), and the surface tension is broken. During this time, 
charge separation of ions occurs in solution as negative ions migrate to the needle surface 
and positive ions move toward to the counter electrode. As the solvent contained in the 
droplets evaporates, the droplets shrink to the point where the repelling coulombic forces 
reach the Rayleigh instability limit, thereby causing their division. These droplets continue 
to be divided, and they become smaller and smaller. This process of droplet desolvation 
and fissions continues until all solvent is completely removed and only ions in gas phase 
remain. 
A unique characteristic of ESI is the production of multiply charged ions for big 
molecules such as proteins and peptides. These multiply charged ions are either in 
positive-ion mode, or negative-ion mode, and also cover a range of charge states. On 
average, one charge is added per 1000 Da in mass. Many peptides have multiple proton 
accepting sites, resulting in singly charged or multiply charged ions in solution. Because 
tryptic peptides have lysine or arginine residues at their C-termini as well as N-terminal 
amino groups, and both of them can be protonated in acidic solutions, they normally have 
double charges. Obtaining multiply charged ions is an especially convenient feature, since 
ESI can analyze high-molecular-weight molecules using an analyzer with a weak nominal 
mass limit, such as a quadrupole mass filter. 
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Figure 0-5. Schematic representation of a typical ESI source. 
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Figure 0-6. Schematic representation of electrochemical process in ESI. 
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The Quadrupole Ion Trap  
In 1960, Paul and Steinwedel (23) (24) invented the ion trap, which was further 
developed to a useful mass spectrometer by Stafford et al. (25).  An ion trap is comprised of 
three hyperbolic electrodes: the ring electrode, the entrance endcap electrode and the exit 
endcap electrode. Both endcap electrodes have small holes in the center through which the 
ions can enter/exit.  The ring electrode is located halfway between the two endcap 
electrodes.  Paul and Steinwedel proposed that this ion trap could be used as a mass 
spectrometer by applying a resonant frequency on the endcap to expel the ions along z. 
Stable trajectory of ions at a given masse can be located by the mathematic analysis 
through the Mathieu equation. In the trap, the motion of ions is in three dimensions, x, y, 
and z, which is under the influence of the applied potentials on the ring electrode. However, 
because the ion trap is cylindrical symmetry 222 ryx =+     , two coordinates, z and r, are 
used to describe the motion of the trapped ions (Figure 0-7). 
The equations of the movement of ions inside the trap are described as followed: 
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Where ω is the angular frequency (in rad s-1) = 2πν, ν is the frequency of the radio 
frequency (RF) on the ring electrode, U is the direct potential and V is the amplitude of the 
RF voltage, r0 is the distance between the center of the ion trap and the ring electrode, Z is 
used for the number of charges, r and z are the distance between the ring and endcap 
electrodes, respectively. 
The following equation was established in 1866 by Mathieu in order to describe the 
propagation of waves in membranes: 
                                  0)2cos2(2
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uu ξξ                                                        (0.21) 
Where u stands for either z or r. Comparing the preceding equations with this Mathieu  
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Figure 0-7. Quadrupole ion trap. (A) Photograph of dissembled ion trap. (B) Schematic 
representation of an ion trap MS instrument. 
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equation, the following changes of variables allow the equation of motion to be depicted in 
the form of Mathieu equation: 
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As long as r and z both are less than r0 and z0, ions are trapped in the ion trap with a 
stable trajectory.  A function )( βα ie + is needed to integrate the Mathieu equation by the 
Floquet and Fourier method. The stable trajectories of ions requires both 0=α  and 
10 << uβ . The parameter βu can be obtained from qu and au parameters of the Mathieu 
equation. A simpler approximate equation of βu is as following for qu is less than 0.4. 
                                 2/12 )]2/([ uuu qa +=β                                                         (0.24) 
Because βu can be calculated from qu and au, and also based on the limitation of uβ  
for a stable trajectory, a, q values inside the limited values of βu for a stable trajectory are 
displayed in Figure 0-8. Based on the expression of equation (0.23), qz will increase if V 
increases and will decrease if m increases assuming the other parameters (including r0 ,z0 
and ω) are constant. If V is increased, the qz value of all the ions will become bigger. When 
qz= 0.908, β is equal to 1, the ion has reached its stability limit. This ion will have an 
unstable trajectory if the V is slightly increased, and will be ejected from the trap in the z 
direction, which allows the ions present in the trap to be analyzed. Thus, a mass spectrum is 
generated by sequentially ejecting fragment ions from low mass to high mass by scanning 
amplitudes of the fundamental rf potential that sequentially makes the ion trajectories 
unstable; 50% of the ejected ions will reach the detector.  
Ions can also be ejected from the trap by applying a supplementary potential on the 
endcap electrodes. This technique is called as “resonance ejection”, which allows ejection 
to occur at voltage lower than those required for ejection at qz = 0.908. Resonance is caused 
by matching the frequency of the supplementary potential to the secular frequency (fz ) of 
the ion, which is determined by the values of βz and the frequency of the fundamental rf. 
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Figure 0-8. Stability diagram for a quadrupole ion trap. The value at βu=1 along the qz axis 
is qz =0.908(26). 
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                                                  2/νβ zzf =                                                            (0.25) 
where fz is secular frequency, ν is the frequency of the fundamental rf. 
If the frequency of the supplementary potential is at fz, the ion will come in 
resonance and the amplitude of its oscillations will increase along the z-axis. If the applied 
amplitude is sufficient, the oscillations of the ion will be large enough to be ejected from 
the trap in z direction. When resonance ejection is used and the amplitude of the voltage is 
ramped from low to high amplitudes, all the ions are sequentially ejected from the trap and 
detected. It is also used to isolate ions in the trap by combination of forward and reverse 
resonance ejection ramps. 
After the production of ions, they are focused through a skimmer and two RF-only 
octapoles. A gating lens is used to manipulate the number of the injected ions to an 
acceptable limit with a reasonable resolution and sensitivity. A positive potential is used 
for positive ions. However, during injection of ions, a negative potential is used to draw 
ions into ion trap. A gating time can be calculated in order to inject the selected number of 
ions, which will not overfill the trap and produce a space-charge effect. After the injection 
of ions in the trap, they encounter helium to remove excess energy by collision. The 
pressure of helium in the ion trap is around 1x10-3 torr. Ions can be further analyzed 
according to their masses by scanning the fundamental rf voltage on the ring or 
combination with additional rf voltage to the endcaps as described before.  
In some circumstance, it may be desirable to obtain structure information of a 
particular ionized molecule subjecting it to MS/MS fragmentation. The special isolation of 
an ion with a particular m/z in the ion trap prior to the ion dissociation event is required for 
tandem mass analysis. There are several ways to perform tandem mass spectrometry in an 
ion trap. The general sequence of operation is described as follows.  
First, ions with a particular mass-to-charge ratio were isolated through expelling all 
other ions from ion trap. This approach can be obtained in several ways. One approach for 
isolation of a precursor ion is by selecting the precursor ion at the apex of the stability 
diagram. This is accomplished through the use of a dc potential to the ring electrode in 
addition to the preexisting fundamental rf. The ion of interest is brought to the apex of the 
stability diagram (Figure 0-9) by a combination of dc and rf potentials. All other ions will 
be ejected from ion trap at qz less than 0.908. Another approach to isolate a precursor ion is 
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by the use of a supplemental potential to the endcaps through resonance ejection of all ions 
except for the selected one.  
Secondly, a precursor ion isolated in an ion trap is then subjected to fragmentation 
into product ions. This fragmentation is improved by excitation of the selected ions 
through the application of a low-amplitude ac resonance signal across the endcap 
electrodes, which causes the ion kinetic energies to increase. These excited ions are then 
subjected to dissociate due to many collisions with the helium damping gas. 
Finally, tandem mass spectrum is obtained by one of the scanning methods: 
stability limit or with the assistance of resonance ejection as described before.  
Perhaps the biggest strength of the ion trap technique lies in the multiple stages of 
mass spectrometry. Up to 12 stages of tandem mass (MS12) have been performed using an 
ion trap, which greatly increase the structural information for a given molecule. Product 
ions can also be further isolated and dissociated to provide MSn mass spectra using this 
technique. MSn is obtained by retaining the fragment ions from MS/MS and further 
acquiring another round of fragmentation. MSn analysis is useful to yield highly detailed 
information in certain cases. For example, a dominant doubly charged fragment ion 
corresponds to the loss of the modification group from the interesting alkyl-phosphorylated 
peptide, which makes it impossible to localize the modification site. So, MS3 is further 
applied to determine the amino acid sequence, and localize the phosphorylation site.    
 
STATEMENT OF RESEARCH 
 
As mentioned before, the actions of pesticides on the organisms include 
anticholinergic mode and neurotoxic mode. Both of the properties of pesticides are 
investigated in this dissertation. The remainder of this dissertation is divided into two parts: 
anticholinergic study of pesticides (Part I), and toxic study of CPF in neuroblastoma cells 
(Part II).   
 
Anticholinergic Study of Pesticides     
The first part of this dissertation studied the butyrylcholinesterase (BChE) 
inhibition resulting from OPs and CBs. Three steps were included in this project. First of 
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all, a new methodology was developed for the detection and quantification of pesticide 
exposure using MALDI-TOF and eBChE as a model system (Chapter 2 of Part I). The 
methodology was based on the analysis of pesticide-inhibited BChE, particularly based on 
the detection of modified active site peptide produced from trypsin digests of the enzyme. 
Although MALDI method was proven to be useful for the analysis of single pesticide 
exposure, the lower response of phosphorylated peptide in MALDI and the suppression of 
the modified peptides in a peptide mixture make this method limited for the analysis of 
multiple pesticide exposure. In the second stage, an in vitro investigation was designed to 
examine the relative quantification of each pesticide exposure, and to identify the types of 
pesticide using LC/MS/MS and eBChE as a model system (Part I, Chapter 3). This 
LC/MS/MS technique was successfully applied to analyze a mixture of the phosphorylated 
peptides in vitro, and the precursor ions were monitored by a common fragment ion. 
Finally, the developed technique was applied to investigate hBChE inhibition in vitro and 
in serum samples (Part I, Chapter 4 and 5).  Chapter 4 of Part I focused on the method 
development for synthesizing the affinity column, which enabled the isolation of BChE 
from the serum. The performance characteristics of the synthesized affinity beads were 
evaluated. Chapter 5 described the application of the developed method (LC/MS/MS 
method) towards the analysis of hBChE inhibition in the serum sample. A calibration 
system was constructed for the analysis of hBChE inhibition, which was then applied 
towards the quantification of the enzyme present in the serum. A novel on-bead double 
digestion protocol was investigated. The reliability of this double digestion was also 
evaluated. 
 
Neurotoxic study of CPF 
The second part of this dissertation studied the neurotoxic properties of CPF, an 
organophosphate. Systematic studies at subcellular levels were designed to evaluate 
proteome changes in SH-SY5Y cells exposed to CPF. Two-dimensional gel 
electrophoresis (2DE) was applied with MALDI-TOF-MS to analyze differential protein 
expression. Results proved our hypothesis as described in Part II, Chapter 2. 
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PART I. STUDY OF SERUM BUTYRYLCHOLINESTERASE INHIBITION FROM 
PESTICIDE EXPOSURE 
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CHAPTER ONE 
 
INTRODUCTION OF PART I 
 
BUTYRYLCHOLINESTERASE BACKGROUND 
 
Dale predicted the existence of cholinesterase in 1914 (27). However, until 1932, 
the term ‘cholinesterase’ (CHE) was used to name an enzyme from a horse serum (28) by 
Stedman et al. The identification of CHE was based on the ability to hydrolyze 
acetylcholine (Ach) in horse serum, which was distinct from the other esterases known at 
the time. Stedman et al. were the first to use conventional rate studies to measure Ach 
hydrolysis catalyzed by the enzyme. They also observed that horse serum BChE 
hydrolyzes butyrylcholine more rapidly than Ach, which is one of the criteria to distinguish 
BChE from AChE. In 1950, Sturge and Whittaker proposed the terms 
“aceto-cholinesterase” for AChE and “butyro-cholinesterase” for plasma CHE. These 
terms were later changed to acetylcholinesterase (AChE) and butyrylcholinesterase 
(BChE). BChE is restricted as the class of CHE present in plasma, which is distinguished 
from AChE present in nerve system or red blood cells.  
 
Properties of hBChE 
Ninety-five percent of hBChE is a water soluble globular tetrameric G-4 form, the 
subunits of which are connected by two disulfide bonds (29). The G-4 form of hBChE has 
four identical subunits. The molecular weight of each subunit is 340,000, and it contains 
574 amino acids and 9 carbohydrate chains (about 23.9% of the subunit) (30). The 
remaining 5% of hBChE occurs as monomers and dimers. The concentration of BChE in 
human serum is 5 mg/l. Human serum only contains BChE, no AChE. However, human 
red blood cells contain AChE, but no BChE. The resulting concentration of BChE in whole 
blood is 36 nM taking into account that the packed red cells take up 40% of the volume of 
blood. BChE is a non-specific enzyme, which can hydrolyze a variety of esters, including 
butylthiocholine, butyrylcholine, propionylthiocholine, propionylcholine, 
acetylthiocholine, acetylcholine, heroin, and aspirin, among others. Another characteristic 
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of plasma BChE is its relative high stability. BChE can be stored at -70ºC and have little 
effect on the activity after being frozen and thawed several times. Furthermore, plasma 
BChE can be stored for several years at -20ºC without loss of activity (31). Therefore, 
outdated blood from blood banks is recommended for large studies, for example, BChE 
purification from serum. 
 
BChE in Diagnosis of Pesticide Poisoning 
Organophosphorous compounds (OPs) and carbamates (CBs) are extensively used 
as insecticides, fungicides and herbicides. The chemicals exert their toxic action by their 
ability to inhibit AChE, which plays an important role in the catalyzing the release and 
removal of acetylcholine at the neuromuscular junction. Diagnosis of poisoning by OPs 
and CBs is made on the basis of clinical symptoms and laboratory measurement of 
cholinesterase, including AChE and BChE, activity. However, serum BChE is the most 
sensitive enzyme for poisoning measurement. Plasma BChE activity decreases are 
separated into several inhibition levels. These levels are 20-50%, 80-90% and over 90%, 
which correspond to mild, moderate and severe poisoning, respectively. It has to be 
emphasized that the percentage decreases in enzyme activity are only guidelines and are 
not absolute indicators of the degree of poisoning. The severity of the symptoms can not be 
judged through the BChE activity decreases (32). As such, the assessment of clinical 
severity must be based on clinical symptoms, and the measurement of serum cholinesterase 
activity.  
 
Protective Role of BChE 
Although no physiological function has been assigned to BChE, it plays an 
important role in the protection against pesticides (33, 34). BChE reacts with a variety of 
anticholinesterase poisons stoichiometrically. Poisons hydrolyzed by BChE are unable to 
inhibit AChE, and in this way BChE guards against toxicity. The protective role of BChE 
is demonstrated by the finding that pesticide applicators can have reduced BChE activity 
with no clinical signs of poisoning. When the dose of pesticide is low so that only BChE 
activity but not AChE activity is reduced, there is no threat to health. For instance, if only 
BChE activity is reduced, even up to 70% decrease of a preexposure value, there is no 
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health threat (35). The protective role of BChE against pesticides can also be demonstrated 
by injecting purified BChE into the animals before they were treated with nerve agents. 
Pretreatment with BChE increased survival and alleviated post-exposure symptoms, which 
was proven by an in vivo animal study of mice and rats treated with the nerve agents. In 
further experiments (36), monkeys were injected with 503 nmols BChE, and then exposed 
to 2 times the LD50 of soman. Results showed that BChE was far more effective than the 
conventional treatment with pralidoxime (2-PAM). 
 
Inhibition of BChE by Pesticides 
In 1973, Hart and O’Brien (37) proposed an original description of the 
cholinesterase (including AChE and BChE) inhibition process. The inhibition process 
includes two steps: equilibrium of the OP compound with the active site of CHE and a 
phosphorylation reaction by forming a covalent bond between the phosphorus of the OP 
compound and the oxygen of the hydroxyl group of serine at the active site. In general, 
CHE (EH) combines with pesticides (PX) resulting in an enzyme-pesticide complex 
(EHPX) that is converted to an inhibited enzyme (EP) and a leaving group (HX) (Figure 
1-1-1). If the inhibited enzyme is caused by OPs, an aging reaction could happen by further 
removing an alkyl group from the covalently bound OP, leaving a very stable OP-enzyme 
derivative. BChE inhibited by OPs can be regenerated by some nucleophilic agents, such 
as pralidoxime (2-PAM), if the agent is used within a few hours of poisoning, before the 
OP-enzyme complex has had time to age. The esterase inhibited by CBs spontaneously 
reactivates by hydrolytic de-carbamylation, a process similar to that which happens with 
their natural substrates, such as acetylcholine (38, 39), but much slower. 
 
Purification of Plasma Cholinesterase 
Although BChE was discovered by Stedman et al. in 1932 (28), it was not 
sequenced until 1986 due to the difficulty of purification from plasma (40). Svensmark 
mentioned in 1965 that the molecular properties of BChE had not been studied extensively 
at that time mainly because of the lack of the pure enzyme (41). 
Many efforts have been made to purify BChE and AChE from a few sources such 
as pig parotid glands (42), dog pancreas (43), and human liver (44). However, most efforts  
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Figure 1-1-1. The scheme of CHE inhibition. Where EH is CHE (including AChE and 
BChE), PX is pesticide, EHPX is a reversible enzyme-pesticide complex and EP is the 
modified enzyme. Aged enzyme is the phosphorylated enzyme with the loss of the alkyl 
group from EP.  
 
EH + PX 
 
EP + HX 
 
EHPX 
Kaging 
Kreactivation 
[Aged Enzyme] 
[Active Enzyme] 
 36
have been put on the purification of the BChE and AChE from horse and human plasma. 
The purification of BChE has proven to be difficult due to several factors: i) the large size 
and the complex structure of BChE make it difficult to purify, ii) the low concentration of 
BChE in plasma (about 3 to 5 mg/l) and the complex protein composition of plasma make 
the purification of plasma BChE more difficult. The following describes a history of the 
BChE purification development.  
In the early history of BChE purification, the first step in most of the horse plasma 
BChE purification was 33% saturation with (NH4)2SO4, giving a two-fold purification. 
Later, the key step in the most successful procedures for purifying horse serum CHE was 
the acidification of (NH4)2SO4 serum fractions proposed by Strelitz, which gave a 
seven-fold purification (45). The Strelitz method was not widely used to purify hBChE  
from plasma because of the less stable property of hBChE than eBChE in solution at low 
pH value (46).  
Another significant purification development was the introduction of DEAE 
cellulose column chromatography in the purification procedure by Connel and Shaw (47). 
BChE is bound to the DEAE cellulose at pH 4.2, while most of the serum proteins are 
washed off. The BChE is then eluted with 0.2 M NaCl resulting in a 45-fold purification 
and 53% yield.  
The most significant improvement of the purification methods with the high 
efficiency and capacity is the use of affinity gels to supply the amount of pure enzyme 
needed for structural study. Affinity gels were originally made for the purification of 
AChE, particular for electric eel AChE. P-phenyl-trimethylammonium (PTA) gel was one 
of the first gels developed by Kalderon et al (48). However, PTA-gels were proven to be 
ineffective for purifying serum BChE. In 1972, a highly effective methylacridinium (MAC) 
affinity gels were introduced by Dudai et al (49). The potential of MAC gels for purifying 
serum BChE was reported by Blanchet et al (50). A 26 ml bed volume column of MAC 
gels was used to purify BChE from 20 ml horse serum, resulting in 2176-fold purification 
and 115% yield after a second passage. Although purification of BChE was improved 
using MAC, the wide usage of this affinity gel was hindered because of its difficult 
synthesis. 
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Finally, procainamide affinity gel was used to simplify the purification procedure 
into a two-step process introduced by Lockridge and La Du (51). Procainamide gel was 
relatively easy to synthesize compared with MAC gel. The synthesis procedure of the 
procainamide gel is briefly described as follows, the same procedure is also used in this 
dissertation. Sepharose 4B was activated with cyanogen-bromide and then coupled with 
6-aminohexanoic acid to make CH-Sepharose 4B, which was further coupled to the 
procainamide through a carbodiimide reaction at room temperature for 24 h (52). 
Procainamide gel was effectively used in the first step of a large-scale purification 
procedure.  
These affinity gels are far more effective than commonly used ion exchange gels, 
such as DEAE. The selectivity of these affinity gels is based on the interaction of the 
ligands with the active sites of BChE. The specificity of the affinity gels makes them 
widely applicable for the enzyme purification. Although the affinity gels are very effective, 
it is worth noting that they must still be supplemented by earlier techniques to obtain pure 
enzyme. 
 
RESEARCH STATEMENT  
 
This chapter provided a general background of BChE, including properties, 
physical function, pesticide inhibition mechanism, and the purification history of plasma 
BChE. Chapter 2 includes a method development for detection and quantification of BChE 
inhibition using MALDI-TOF-MS. Chapter 3 describes how to analyze a mixture of the 
phosphorylated peptides in vitro using LC/MS/MS. Chapter 4 focuses on the method 
development for BChE isolation from human serum. The specific character of the affinity 
column was evaluated. Finally, Chapter 5 presents the application of the developed method 
towards the human serum by combination affinity chromatography with MS.  
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CHAPTER TWO 
 
IDENTIFICATION AND QUANTIFICATION OF INHIBITED 
BUTYRYLCHOLINESTERASE AFTER EXPOSURE TO 
ORGANOPHOSPHATES AND CARBAMATES USING MALDI-TOF-MS  
 
INTRODUCTION 
 
The potential for civilian exposure to cholinesterase inhibitors is greater today than 
anytime in history. In addition to exposure to cholinesterase inhibiting pesticides, today the 
threat of chemical warfare (CW) terrorism raises the stakes. Several recent events such as 
the 1988 slaughter of Kurds in Iraq (53) and the 1995 Tokyo Subway Attack (54) point to a 
need for accurate and sensitive methods to monitor exposure to CW agents and pesticides. 
Identification of the type of cholinesterase inhibitor (CW or pesticides) is critical for 
deciding an appropriate treatment. We developed a new method for detection, 
quantification, and categorization of cholinesterase inhibitors using two types of pesticides, 
a proteomics approach and MALDI-TOF-MS. Our technique is based on the analysis of 
the inhibited active-site peptide produced from trypsin digestion of BChE. Our in vitro 
studies indicate that the type of pesticides can be determined by the mass difference 
between the inhibited and intact active-site peptide. In this chapter, we evaluated all 
phosphyl and carbamyl adducts on the active site serine of BChE from commercial 
organophosphates (OPs) and carbamates (CBs). Although we did not investigate CW 
agents in this study, information about their presence can be deduced from mass 
differences using the same approach.  
BChE present in serum is of toxicological and pharmacological importance. 
Although no physiological function has been assigned to BChE, it plays a key role in ester 
detoxification. Pesticides such as OPs and CBs inhibit AChE, which plays an important 
role in removing the neurotransmitter acetylcholine at the synapses. Because BChE is 
highly reactive with pesticides, it sacrificially protects AChE against pesticides. Therefore, 
serum BChE activity measurement is the most sensitive way to detect pesticide exposure.  
To determine pesticide exposure, U.S. Environmental Protection Agency (USEPA) 
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scientists proposed a blood esterase monitoring program for pesticide exposure (55) based 
on the measurement of red blood cell AChE and plasma BChE activity. The most 
conventional method for detection of pesticide exposure is based on the measurement of 
BChE activity by the Ellman method (56). However, the Ellman method has several 
drawbacks. First, the percentage decreases in BChE activity is only a guideline and it is not 
accurate to determine the degree of poisoning (32). Second, the source of cholinesterase 
inhibition can not be determined by detection of the decline of BChE activity using the 
Ellman method. This is because the decline of the enzyme activity can be caused from a 
number of ailments such as liver disease, anemia, acute infections, cardiac failure, and 
renal disease. Furthermore, since BChE is a nonspecific enzyme, many chemicals can 
influence activity measurement such as asprin, which will influence the accuracy of 
activity measurement.  
In addition to the Ellman method, Polhuijs et al. (57) developed a technique to 
monitor exposure to pesticides based on the analysis of pesticide inhibited BChE. In brief, 
the method is based on the reactivation of the inhibited enzyme with fluoride ions 
producing a phosphofluoridate. Identification and quantification of phosphofluoridate by 
GC/MS can be related to the BChE inhibition. This Polhuijs method requires a 
sophisticated chemical technique, and it is time consuming. The major limitation of the 
Polhuijs method from in vivo analysis is that the aged enzyme cannot be analyzed, because 
the aged enzyme blocks the reactivation reaction with fluoride ions. Doorn et al. (58, 59) 
used MALDI-TOF-MS to detect the inhibited peptide from a tryptic digest of AChE in 
order to study the mechanism of AChE inhibition with OPs. In addition, Fidder et al. (60)  
developed a procedure for detection of nerve agent exposure using LC/MS. This analysis is 
based on the detection of phosphorylated nonapeptides obtained after pepsin digestion of 
hBChE. Since pepsin is a nonspecific protease, reproducible pepsin digestion was difficult 
to achieve, thus limiting the universal application of this approach. 
We developed a new method for detection and quantification of the inhibited BChE 
after in vitro pesticide exposure using MALDI-TOF-MS. In this initial study, eBChE was 
selected because this enzyme is commercially available. Three OPs, methyl paraoxon, 
ethyl paraoxon and EPN oxon, represented all possible types of phosphoryl group found in 
commercial OPs. Carbaryl was selected to represent the N-methyl carbamates in common 
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commerce. Oxons were used in this in vitro study to represent OPs. OPs require Phase I 
metabolic biotransformation to become active inhibitors. By selecting oxons, no further 
metabolism was required to facilitate the in vitro study. OPs and CB inhibit BChE by 
forming a covalent bond with the active site serine by attaching a phosphoryl or carbamyl 
group resulting in inhibited enzyme. The modified peptide was generated by trypsin 
digestion of this inhibited eBChE. Using our new improved method, the category of 
pesticides was identified. The degree of poisoning was also determined based on the 
intensity of the modified peak and that of the intact active site peak from mass 
spectrometric analysis. Furthermore, these results demonstrate that our newly developed 
method is more sensitive than the Ellman method. 
 
EXPERIMENTAL 
Chemicals 
All the OPs (EPN, methyl paraoxon, and ethyl paraoxon) and carbaryl (Figure 
1-2-1) were purchased from Chem Service, Inc (West Chester, PA). Chemical purity of 
these inhibitors were >99% as assessed by the supplier. eBChE (610 units/mg solid, 50% 
protein of solid), butyrylthiocholine iodide (BTCh), 5, 5’-dithiobis-(2-nitrobenzoic acid) 
(DTNB) were purchased from Sigma Chemical Co. (ST. Louis, MO). Sequencing grade 
modified porcine trypsin was purchased from Promega Corporation (Madison, WI). EPN 
oxon (Figure 1-2-1) was oxidized from EPN (61). In brief, a 2 mM EPN solution in 
acetonitrile was mixed with the same volume of 40 mM bromine solution in acetonitrile. 
The resulting solution was mixed for one minute. After the reaction, the solution was dried 
by Speed Vacuum concentrator to remove the excess bromine and the residue dissolved in 
500 μl methanol prior to analysis. The chemical purity of EPN oxon was >99% as assessed 
by GC/MS. 
eBChE Inhibition 
eBChE (265 units) was dissolved in 400 µl 50 mM ammonium bicarbonate buffer, 
and incubated with OPs (dissolved in methanol) for 1 h, and with carbaryl for 
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30 min at 37ºC. The final concentration of methanol was less than 0.05% (v/v) and did not 
significantly affect enzyme activity. 
eBChE Activity 
A modified Ellman assay (56) was used to measure the eBChE activity. BTCh (4 μl 
of 0.25 M) and DTNB (16 μl of 0.02 M) were added to 1 ml phosphate buffer (50 mM, 
pH=8), and the resulting solution was used as a baseline for the later measurements. Then, 
an aliquot of inhibited eBChE or control was added in the same cuvet. The absorbance of 
the solution was measured at 412 nm for the first 10 min of the reaction. Plotting 
absorbance vs time, a straight line was obtained (R=0.99). The slope of the line was 
calculated from three parallel measurements, and the mean value of the slopes from 
triplicate analysis was used in all calculations. Raw data were converted to the relative 
activity (percent) of the control. 
Trypsin Digestion 
Acetonitrile was added as a mild protein denaturant (62) to each sample in order to 
increase trypsin activity, at a final concentration of 40% (v/v). The digestion was 
performed in a 60 mM NH4HCO3 buffer with a ratio of 20:1 eBChE to trypsin and 
incubated at 40 ºC overnight. Formic acid was used to terminate the reaction. 
MALDI-TOF-MS Analysis 
The matrix solution was 10 mg/ml α-cyano-4-hydroxycinnamic acid in 50% (v/v) 
acetonitrile / 50% (v/v) aqueous 0.1% (v/v) trifluoroacetic acid. Sample preparation for the 
MALDI experiment involved addition of 1 μl of 1 mM diammonium citrate solution to 1 μl 
analyte and 1 μl matrix solutions. The mixture (1 μl) was then applied to the MALDI 
Massive target (Bruker, Billerrica, MA). Samples were allowed to air dry and crystallize 
before the target was loaded into the mass spectrometer. An Autoflex MALDI-TOF 
(Bruker, Billerrica, MA) mass spectrometer was used for all analysis. Standard instrument 
parameters for peptide analysis were used. All spectra resulted from an average of 300 
laser shots. A standard peptide mixture consisting of angiotensin II and vasopressin was 
used to provide an external mass calibration. The trypsin autolysis product m/z 842.51 was 
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used for an internal mass calibration. The identity of an OP or CB adduct was confirmed by 
analyzing the post source decay (PSD) MALDI-TOF mass spectra of modified active site 
peptides. The time ion selector was set for the modified peptide and the ion selector 
window was ±1 % of the m/z value of the precursor ions. Mirror voltage acceleration 
voltage of 20 kV, 16 kV, 13.11 kV and 10.61 kV were used to obtain the PSD spectrum. 
Determination of IC50 and IC100   
The relative activity (the percentage activity of eBChE inhibited by the pesticides 
relative to the control), and the intensity ratios (the intensity of the modified or intact active 
site peptide to the native reference peptide at m/z 2222.5) were reported based on the 
triplicate analysis. Normalized intensity ratios (NIRs) were obtained through dividing the 
intensity ratios of intact peptide or modified peptide by the total intensity of all peptide 
signals that contains the active site serine, and these NIRs were further used for data 
analysis. All data were analyzed using Microsoft Office Excel 2003 (Redmond, WA). 
 
Determination of IC50s 
Two linear regression lines were obtained by plotting the NIR of the intact peptide 
vs concentration of OPs and the NIR of the modified peptide vs concentration of OPs. IC50 
from MALDI method was calculated from the intercept of these two regression lines. 
Determination of IC50 for methyl paraoxon is different from the other OPs, because the 
aged peptide (further removal of the alky group from phosphate group) contribution 
required an additional regression line. The IC50 for methyl paraoxon was determined when 
the NIR of the intact active site peptide equals to the sum of NIR of the inhibited and the 
aged peptide.  
IC50s were also obtained for the Ellman method by plotting relative activity vs 
concentration of OP. IC50 values were determined from the regression line equations 
assuming a relative activity of 50 %.  
IC50s for carbaryl from MALDI and the Ellman method were calculated using the 
same approach as OPs. A linear relationship of NIR or relative activity with logarithmic 
concentration of carbaryl (plot not shown) was used for the calculation.  
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Determination of IC100s 
IC100s for OPs from MALDI and Ellman method were determined by extrapolating 
lines of NIR of intact peptide and relative activity to the x-axis. IC100s were determined 
from this x-intercept. IC100 for carbaryl was determined using the same approach and linear 
regression lines of NIR or relative activity with logarithmic concentration of carbaryl. 
 
RESULTS 
 
MALDI-TOF-MS Analysis 
Mass spectra were collected for the control and pesticide-treated samples. Figure 
1-2-2 shows MALDI-TOF-MS spectra for the control and eBChE treated with OPs and 
carbaryl. The modified peptides were determined by comparing the mass spectra before 
and after treatment. For example, the modified peptide by ethyl paraoxon at an average 
mass 2336.1 was determined by comparing the mass spectra before (Figure 1-2-2 A) and 
after treatment (Figure 1-2-2 B). This modified active site peptide peak appeared in the 
mass spectrum for the pesticide-treated sample but not for the control sample. However, 
peaks with an average mass corresponding to the intact active site peptide (average mass 
2200.1) appeared in both control and treated sample with 1 μM ethyl paraoxon. A peak at 
m/z 2222.1 was also observed in both control and treated sample, which was used as native 
reference peptide in this study. 
The same method was also performed to determine modified peptides from methyl 
paraoxon, EPN oxon and carbaryl. Peaks with average masses corresponding to the 
modified and intact active peptides were observed in mass spectra of tryptic digests of OP 
and CB inhibited eBChE (Figure 1-2-2). Table 1-2-1 summarizes the observed MH+ peaks 
at average mass corresponding to the intact and modified active site peptide of eBChE 
treated with 1 μM of individual pesticide. MH+ (Table 1-2-1) were the average masses of 
the modified or the intact peptide containing the catalytic serine by the tryptic digestion.  
Modified groups were determined based on the mass differences (Table 1-2-1) 
between the modified peptide and the intact active site peptide. For example, the mass 
difference (Table 1-2-1) between the modified peptide at m/z 2336.5 and the intact active 
peptide at m/z 2200.5 was 136 Da for ethyl paraoxon. This mass difference takes into  
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Figure 1-2-2. MALDI-TOF-MS spectra of the tryptic digest of eBChE from (A) control 
and (B) treated sample by ethyl paraoxon. Peaks with average masses at m/z 2200.1 
demonstrate the presence of unmodified active site peptide. Peak at m/z 2336.1 (B) 
corresponds to the modified active site peptide with O,O-diethyl phosphorylated group.  
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Figure 1-2-2. MALDI-TOF-MS spectra of the tryptic digest of methyl paraoxon (C) and 
EPN oxon (D) treated eBChE, respectively. Peaks at m/z 2294.1 and 2308.2 (C) represent 
the modified peptide with O-methyl phosphorylated group, and O,O-dimethyl phosphate 
respectively. Peak at m/z 2368.3 (D) is the modified peptide with O-ethyl phenyl phosphate.
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Figure 1-2-2. MALDI-TOF-MS spectra of the tryptic digest of eBChE (E) treated sample 
by carbaryl. Peak at m/z 2257.3 (E) is the modified peptide with carbamylate group.  
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Table 1-2-1. Masses of observed MH+ (average mass)b for the intact and modified active 
site peptide of eBChE treated with 1 μM inhibitor 
 
 
 
Pesticide 
Intact 
(m/z) 
Inhibited
(m/z) 
∆ma 
(Da) 
Modified with 
group aged 
∆ma 
(Da) 
Modified 
with group
Methyl 
paraoxon 2200.5 2308.5 108 
P
CH3O
CH3O
O
 2293.5 93 
P
CH3O
O
O  
Ethyl 
paraoxon 2200.5 2336.5 136 
P
CH3CH2O
O
CH3CH2O  -----
 ---- ------- 
EPN 
oxon 2200.5 2368.5 168 P
CH3CH2O
OC6H5  ------
 ---- ------- 
Carbaryl 2200.5 2257.5 57 CO NHCH3  ------
 ---- ------ 
 
a Difference in mass between the modified and the intact active site peak. All these mass 
differences are taking account of the proton loss on the catalytic serine during the 
phosphorylation reaction. 
b The average mass of the modified or the intact peptide containing the catalytic serine by 
the tryptic digestion. 
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 account the proton loss on the catalytic serine during the phosphorylation reaction. Based 
on this mass difference, the modified group was deduced as O,O-diethyl phosphate. Using 
the same approach, two modified groups were determined for methyl paraoxon as 
O-methyl phosphate and O,O-dimethyl phosphate , which correspond to the modified 
peptides at m/z 2293.5 and 2308.5, respectively.  Similarly, the modified group for EPN 
oxon was O-ethyl phenyl phosphate. The corresponding modified peptide was observed at 
m/z 2368.5. The modified group for carbaryl was the carbamylate group that was observed 
at m/z 2257.5. 
 
Post Source Decay (PSD) Analysis 
To further confirm the phosphorylated and carbamylated peptide, PSD analysis in 
MALDI-TOF-MS was used. All of PSD analyses of modified peptide ions are shown in 
Figure 1-2-3, which correspond to the modified active site peptides with phosphate or 
carbamate generated from tryptic digests of eBChE treated with OPs or CB. The timed ion 
selector of MALDI was set for a series of precursors with average masses. These 
precursors were at m/z 2293.5 and 2308 (aged and inhibited peptide by methyl paraoxon) 
(Figure 1-2-3 A and B), at m/z 2336 (inhibited peptide by ethyl paraoxon) (Figure 1-2-3 C), 
at m/z 2368 (inhibited peptide by EPN oxon) (Figure 1-2-3 D), and at m/z 2257 (inhibited 
peptide by carbaryl) (Figure 1-2-3 E). ). In PSD analysis, a common fragment ion at m/z 
2182.1 was observed for all of the precursor ions (Figure 1-2-3). The fragment ion at 
2182.1 was formed by elimination on serine to form the homoalanine residue. However, 
precursor ion at m/z 2293.5 had an additional fragment ion at m/z 2199.5 (Figure 1-2-3 A), 
which was formed by removal of the phosphate group from the catalytic serine. 
Lost neutral fragments were deduced from the mass differences between the 
precursor ions and fragment ions (Table 1-2-2). The fragment ions at m/z 2199 and m/z 
2182.1 were generated by the loss of CH3OPO2 (94 Da) and CH3OP(O)(OH)2 (112 Da), 
respectively, from the precursor ion at m/z 2294 corresponding to O-methyl 
phosphorylated peptide. Similarly, the fragment ions at m/z 2182.1 of precursor ions at m/z 
2308, 2336, 2368, and 2257, were generated by the neutral loss of (CH3O)2P(O)OH (126 
Da), (CH3CH2O)2P(O)OH (154 Da), (CH3CH2O)P(O)(OH)(C6H5) (186 Da) and 
CH3NHC(O)OH (75 Da) from their precursor ions, respectively.  
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Figure 1-2-3. PSD analysis of precursor ion with average mass at m/z 2294.3 represents 
the aged peptide with O-methyl phosphate by methyl paraoxon (A), at m/z 2308.6 is 
inhibited peptide with O,O-dimethyl phosphate group (B). 
 
 
0 
100 
200 
300 
400 
500 
2150 2200 2250 2300 2350 m/z
2182.2 
2199.2 
2294.3 
Int. 
A
0 
200 
400 
600 
2150 2200 2250 2300 2350 m/z 
Int. 2182.2
2308.6 
B
 51
 
 
 
 
Figure 1-2-3. PSD analysis of precursor ion with average mass at m/z 2336.8 corresponds 
to the modified active site peptide with O,O-diethyl phosphorylated group generated from 
the tryptic digest of eBChE treated with ethyl paraoxon (C), peptide at m/z 2368.3 is with 
O-ethyl phenyl phosphate from EPN oxon (D). 
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Figure 1-2-3. PSD analysis of precursor ion with average mass at m/z 2257.2 corresponds 
to the modified active site peptide with carbamylated group (E).  
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Table 1-2-2. Masses of observed MH+ (average mass)a for the precursor ions and fragment 
ions from PSD analysis. 
 
Pesticide Precursor 
Fragment 
Ion 1 ∆m 
Loss of the 
Adduct 
Fragment 
Ion 2 ∆m 
Loss of the 
Adduct 
2293.5 2182.1 112  2199.2 94 
P
CH3O
O
O
Methyl 
paraoxon 
2308.5 2182.1 126 --------b ---b ----------b 
Ethyl 
paraoxon 2336.5 2182.1 154 --------b ---b ---------b 
EPN 
oxon 2368.5 2182.1 186 --------b ---b --------b 
Carbaryl 2257.1 2182.1 75 CO
NHCH3
OH  --------
b ---b --------b 
 
a The average mass of the modified or the intact peptide containing the catalytic 
serine obtained from the tryptic digestion. 
b No fragment 2 was found. 
P HO O
HO 
CH3O P O
HO 
CH3O 
P O
C6H5 P O
HO 
CH3CH2O
CH3O 
CH3CH2O 
CH3CH2O 
HO
 54
IC50 and IC100 Values 
The relative activities and the normalized intensity ratios (NIR) were reported 
(Table 1-2-3, 1-2-4, 1-2-5, and 1-2-6) based on the triplicate parallel analysis after the 
inhibition of eBChE by pesticides. Graphs of NIR vs concentration of pesticides were 
plotted according to these reported data. Plots of NIR vs concentration of OPs and carbaryl 
are shown in Figure 1-2-4. A linear relationship between the NIR of the modified peptide 
and intact peptide with the concentration of [OP] was observed for all three OPs. For the 
Ellman method, linear relationships between the relative activity and the concentration of 
OP were observed for all three OPs (Figure 1-2-5). While for CB, both methods produced a 
non-linear relationship between the NIR or relative activity and the concentration of 
carbaryl (Figure 1-2-4 D and Figure 1-2-5 B). To obtain IC50 (the concentration required 
for producing 50% BChE inhibition) and IC100 (the concentration required for producing 
100% BChE inhibition) data, the NIR or relative activity was plotted against the logarithm 
of concentration of carbaryl (plot not shown). 
IC50s and IC100s of EPN oxon for both methods were determined from Figure  
1-2-4 and Figure 1-2-5 (see Experimental section). The same approach was also applied to 
determine IC50s and IC100s of the other pesticides. IC50s from this study were 1.30 ± 0.08, 
0.90 ± 0.05, 1.19 ± 0.01, 3.57 ± 0.03 µM, and corresponding IC100s were 2.72 ± 0.09, 1.75 
± 0.06, 2.48 ± 0.01, and 17.3 ± 0.03 µM for methyl paraoxon, ethyl paraoxon, EPN oxon 
and carbaryl, respectively. To compare results from our new method, IC50s and IC100s from 
the Ellman method were also obtained. The IC50s from the Ellman method were 1.10 ± 
0.97, 0.79 ± 0.69, 0.97 ± 0.27, 4.9 ± 0.1 µM, and IC100s were 2.41 ± 0.80, 1.54 ± 0.86, 2.20 
± 0.31, and 23.6 ± 0.11 µM for methyl paraoxon, ethyl paraoxon, EPN oxon, and carbaryl, 
respectively.  IC50 and IC100 for carbaryl from both methods were determined from the 
linear regression between NIR or relative activity and logarithm of concentration of 
carbaryl (plots not shown).  
 The IC50 value of carbaryl was larger than those of OPs, which means eBChE is 
the least sensitive to carbaryl compared to OPs. These data were consistent with the facts 
provided by the supplier that carbaryl is a significant less potent inhibitor of eBChE (LD50 
of carbaryl 500 mg/kg; methyl paraoxon 3 mg/kg; and ethyl paraoxon 2 mg/kg).  
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Table 1-2-3. Normalized intensity ratios (NIRs) of intact peptide, modified peptide, and 
relative activities of eBChE treated with methyl paraoxon at different concentrations 
 
 
Concentration 
(μM) 
NIRs of Intact 
Peptide  
(m/z 2200.1) 
NIRs of Aged 
Peptide 
(m/z 2294.1) 
NIRs of 
Inhibited 
Peptide  
(m/z 2308.1) 
Relative 
Activity (%) 
0.00 1.00 ± 0 N/A N/A 100 ± 0 
0.10 0.97 ± 0.02 0 + 0.01 0.03 ± 0.01 96.6 ± 2.5 
0.20 0.87 ± 0.03 0.04 ± 0.01 0.08 ± 0.01 95.3 ± 3.1 
0.50 0.73 ± 0.05 0.10 ± 0.01 0.16 ± 0.02 54.2 ± 7.5 
1.00 0.52 ± 0.08 0.11 ± 0.03 0.37 ± 0.02 49.6 ± 1.0 
1.80 0.38 ± 0.07 0.13 ± 0.01 0.48 ± 0.05 23.0 ± 1.5 
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Table 1-2-4. Normalized intensity ratios (NIRs) of intact peptide, modified peptide, and 
relative activities of eBChE treated with ethyl paraoxon at different concentrations 
 
 
Concentration 
(μM) 
NIRs of Intact 
Peptide 
(m/z 2200.2) 
NIRs of Inhibited 
Peptide 
(m/z 2336.1) 
Relative 
Activity (%) 
0 1.00 ± 0 N/A 100 ± 0 
0.1 0.97 ± 0.01 0.03 ± 0.01 100 ± 3.5 
0.2 0.78 ± 0.05 0.22 ± 0.05 82.3 ± 2.5 
0.5 0.83 ± 0.06 0.17 ± 0.02 71.6 ± 3.0 
0.8 0.67 ± 0.05 0.33 ± 0.05 53.7 ± 1.5 
1 0.56 ± 0 0.44 ± 0.02 35.9 ± 2.5 
1.5 N/A 1.00 ± 0.05 0.65 ± 0.5 
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Table 1-2-5. Normalized intensity ratios (NIRs) of intact peptide, modified peptide, and 
relative activities of eBChE treated with EPN oxon at different concentrations 
 
Concentration 
(μM) 
NIRs of Intact 
Peptide 
(m/z 2200.1) 
NIRs of Inhibited 
Peptide 
(m/z 2368.1) 
Relative 
Activity (%) 
0 1.00 ± 0 N/A 100 ± 0 
0.2 0.93 ± 0.02 0.07 ± 0.01 100 ± 3.5 
0.5 0.76 ± 0.01 0.24 ± 0.02 71.2 ± 2.5 
0.7 0.64 ± 0.03 0.36 ± 0.03 50.3 ± 2.0 
1 0.49 ± 0.05 0.51 ± 0.04 32.5 ± 5.0 
2 0.23 ± 0.01 0.77 ± 0.02 1.76 ± 1.5 
2.5 N/A  1.00 ± 0.02 0.649 ± 0.5 
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Table 1-2-6. Normalized intensity ratios of intact peptide, modified peptide, and relative 
activities of eBChE treated with carbaryl at different concentrations 
 
Concentration 
(μM) 
NIRs  of Intact 
Peptide 
(m/z 2200.1) 
NIRs of Inhibited 
Peptide 
(m/z 2257.1) 
Relative 
Activity (%) 
1 0.84 ± 0.02 0.16 ± 0.02 95 ± 1.5 
1.5 0.75 ± 0.03 0.25 ± 0.03 90 ± 1.0 
2.5 0.68 ± 0.05 0.32 ± 0 81 ± 1.5 
3 0.58 ± 0.06 0.42 ± 0.04 73 ± 2.0 
4 0.50 ± 0.05 0.50 ± 0.03 50 ± 3.2 
5 0.42 ± 0.06 0.58 ± 0.05 40 ± 4.0 
8 0.23 ± 0.03 0.77 ± 0.02 33 ± 1.0 
10 0.13 ± 0.01 0.87 ± 0.05 27 ± 1.2 
15 0.03 ± 0.01 0.97 ± 0.03 18 ± 1.4 
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Figure 1-2-4. Plots of the normalized intensity ratio to the [methyl paraoxon] (A), [ethyl 
paraxon] (B).  
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Figure 1-2-4. Plots of the normalized intensity ratio to [EPN oxon] (C), and [carbaryl] (D). 
The intensity ratio is the intensity of the modified or the intact active site peptide relative to 
that of the native reference peptide (average m/z=2222.5). The intensity ratios of all 
peptides containing catalytic serine were added to obtain a sum value. The normalized 
intensity ratios (NIRs) were obtained by dividing the intensity ratios of intact peptide and 
modified peptide with the sum value. The IC100s were determined from the points by 
extrapolation of linear-regression to x-axis. Results are expressed as mean ± SD (n=3).  
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Figure 1-2-5. Plots of relative activity vs [OPs] (A) and [carbaryl] (B). Results are 
expressed as mean ± SD (n=3). 
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DISCUSSION 
 
The goal of this work was to develop an improved method for the detection of OP 
and CB exposure using a proteomic approaches and MALDI-TOF-MS. The advantage of 
this approach is that both the origin and the extent of the exposure to pesticide can be 
determined. This method is based on the analysis of the inhibited BChE, particularly based 
on the detection of active site peptide of BChE from tryptic digests. The amino acid 
sequence of the tryptic peptide containing active site serine from eBChE is 
SVTLFGESAGAASVSLHLLSPR (calculated MH+ at m/z 2200.5), where the catalytic 
serine is underlined.  
eBChE was separately incubated with each of the four pesticides studied in this 
chapter. The resulting inhibited eBChE was digested with trypsin and peptide containing 
active site serine was identified by MALDI-TOF-MS. Modified peptides were identified 
by comparing the MALDI mass spectra before and after treatment, and further confirmed 
by PSD analysis. During the modified peptide identification processes, we observed that 
the aged peptide was detected only from methyl paraoxon treated eBChE (Table 1-2-1). 
Usually, the rate of an aging reaction of a cholinesterase (ChE) inhibitor has an inverse 
relationship with the rate of spontaneous reactivation (63). Since the esterase inhibited by 
CBs undergoes fast reactivation by hydrolytic decarbamylation compared with OPs, it is 
understandable that no aged peptide was detected for carbaryl. In addition to this, the aging 
reaction also depends on the nature of the substitutents on the phosphorus atom attached to 
the active site residue of the enzyme. Mason et al (64) reported that the order of the aging 
reaction rate for the alkyl phosphate substitutents is dimethoxy > methoxy-phenyl = 
diethoxy , which is consistent with our observation. O’Brien also reported that the rate of 
aging of dialkylphosphorylated AChE is dimethoxy > diisoProxy > diethyoxy (65). Our 
findings that aged peptide was detected only for methyl paraoxon agree with the previous 
observations (64) that dimethoxy phosphorylated BChE by methyl paraoxon aged faster 
than BChE modified by both EPN oxon and ethyl paraoxon.  
When eBChE was treated with methyl paraoxon at concentrations lower than 0.1 
µM, only modified peptide at m/z 2308.1 was observed and no aged peptide showed in the 
MALDI spectrum. This is because that the aged peptide with (CH3O)OP(O) moiety had a 
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negative charge and a peptide in anionic form exhibited low ionization efficiency in 
MALDI experiment (66). As such, the detection of the aged peptide was limited using 
MALDI-MS, although ammonium citrate greatly improved the detection signal of the 
phosphorylated peptides. Another possible explanation is that the peptide inhibited by 
phosphorylation is very stable, thus the further aging reaction is unlikely to occur. We 
suggest that the former explanation is correct.  
In the PSD analysis, one common fragment ion at m/z 2182.1 was observed as a 
dominant fragment ion for each inhibited peptide (Table 1-2-2). A likely explanation is that 
the phosphate elimination occurs at a higher rate than skeletal bond cleavage. The available 
internal energy content of the ions is used to eliminate phosphate groups instead of 
producing a series of the sequence related fragment ions. The observations were consistent 
with those from the previous studies of a triphosphorylated peptide by MALDI (67) and a 
pentaphosphorylated peptide using LC/MS (68). Another interesting phenomenon was that 
it was more preferable to lose the alkyl phosphoric acid than the phosphate group from the 
precursor ions during fragmentation pathway. When internal energy of the precursor ion 
was high, the process was prone to lose the alkyl phosphoric acid, which produced a 
fragment ion with lower energy. As such, the fragment ion at 2182.1 was exclusively 
observed as the dominant product ion. This observation was consistent with Annan and 
Carr’s results (67), which have shown that singly phosphorylated peptides mainly lose 
H3PO4 with a relative minor loss of HPO3. Although the subjects of our study were alkyl 
phosphorylated peptides, the same results were observed. 
After the modified peptides were detected, the extent of the inhibition was 
determined based on the normalized intensity ratios of modified peptides to the reference 
peptide and intact peptide to the reference peptide. A peptide (average MH+ m/z 2222.5) 
generated from a tryptic digest of eBChE (amino acid sequence: 
AILQSGSSNAPWAVTSLYEAR) was used as the native reference peptide. It is known 
that the quantification of analyte using MALDI can be disturbed by some external 
influences, such as the crystal forms of matrix on target, the laser power used for collecting 
the mass spectra, and the different response of analytes for MALDI. Therefore, the native 
reference peptide at m/z 2222.5 was used to minimize or control for these influences. This 
tryptic peptide has no missed cleavage, no modified amino acid and the similar response to 
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MALDI as the intact active site peptide (average MH+ m/z 2200.5). All these properties for 
this peptide satisfied the criteria for an ideal native reference peptide as proposed by Ruse 
et al.(69). The relative intensity ratios between the peptide of the intact active site or the 
modified peptide and the native reference peptide reflect the extent of the pesticide 
exposure. 
 
Comparison of IC50s and IC100s from MALDI Method and from Ellman Method  
The normalized relative intensity ratios were reported and plotted as a function of 
the concentrations of pesticides based on the mass spectra collected from the tryptic digests 
of inhibited eBChE. Figure 1-2-4 shows plots of the NIR vs EPN oxon concentration and 
NIR vs carbaryl concentration. IC50s from MALDI method were obtained from the plots 
based on the recorded data (Table 1-2-2, 1-2-3, 1-2-4, and 1-2-5) for each OP (see details in 
Experimental section). The IC50s were 1.30 ± 0.08 μM for methyl paroxon, 0.90 ± 0.05 μM 
for ethyl paraoxon, and 1.19 ± 0.01 μM for EPN oxon. These results were compared with 
the IC50s obtained from the Ellman method, which were 1.10 ± 0.97, 0.79 ± 0.69, and 0.97 
± 0.27 µM for methyl paraoxon, ethyl paraoxon, and EPN oxon, respectively. IC100s of the 
OPs were determined graphically from linear regressions by extrapolation of 
linear-regression fits to the points on the x-axis (see details in Experimental section). The 
IC100s from our method were 2.72 ± 0.09 μM for methyl paraoxon, 1.75 ± 0.06 μM for 
ethyl paraoxon, and 2.48 ± 0.01 μM for EPN oxon. In order to compare the results from the 
MALDI method with the Ellman method, the plot of linear regression of the relative 
activity and the concentration of OPs were shown in Figure 1-2-5A. The IC100s from the 
relative activity were also determined graphically from Figure 1-2-5A using the same 
method as those from NIR. From the Ellman method, IC100s were 2.41 ± 0.80 μM for 
methyl paraoxon, 1.54 ± 0.86 μM ethyl paraoxon and 2.20 ± 0.31 μM for EPN oxon, 
respectively, which were very close to the values obtained by our method.  
An interesting phenomenon was observed that all the IC50s and IC100s of OPs were 
higher from the MALDI method than those from the Ellman method. The possible 
explanation is that the response of the modified peptides was lower than that of the intact 
active site peptide and resulting in the higher measured IC50s and IC100s. This observation 
is consistent with the study of Liao et al. (70), who have reported that the 
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desorption/ionization efficiencies for phosphorypeptides in MALDI-MS are about one 
order of magnitude lower than for their non-phosphorylated form. This lower response of 
the phosphorylated peptides in MALDI possibly results from the high negative electron 
density of oxygen attached on phosphorus atom, which will cause a partial negative charge 
on the phosphate group.  
 Similarly, the IC50 and IC100 of carbaryl from our method were determined from 
the linear-regression relationship of NIR vs logarithm of carbaryl concentration, which 
were 3.57 ± 0.03 and 17.3 ± 0.03 µM, respectively. In order to compare the results from the 
MALDI method with those from the Ellman method, the relative activities were reported 
and plotted as a function of the carbaryl concentration (Figure 1-2-5B).  IC50 and IC100 of 
carbaryl from the Ellman method were determined as 4.9 ± 0.10 and 23.6 ± 0.11 µM from 
this linear relationship between the relative activity and logarithm of concentration of 
carbaryl. 
In contrast, the results from carbaryl were different from that of OPs. For both 
methods, NIR or relative activity had nonlinear relationships with concentration of 
carbaryl, while for OPs, a linear relationship was obtained for both NIR and relative 
activity. This non-linearity was due to the different CB inhibition mechanism. ChE 
inhibition occurs via the formation of enzyme-inhibitor complex followed by 
carbamylation or phosphorylation of the active site and release of the leaving group. The 
aging reaction, resulting in the non-reversible enzyme, may occur after the inhibition 
reaction for OPs. No reactivation will happen for the phosphorylated enzyme. However, a 
spontaneous reactivation of carbamylated enzyme will happen very quickly for CBs. The 
different carbaryl inhibition mechanism resulted in the linear regression of NIR or relative 
activity versus logarithm of concentration of carbaryl. This result was in agreement with 
the study of Rao et al. (71), except that they plotted the linear regression of relative 
inhibition versus log [carbaryl]. 
In contrast to OPs, IC50 and IC100 of carbaryl from the Ellman method based on the 
measurement of eBChE activity were greater than those from the MALDI method. The 
response to MALDI for the carbamylated active-site peptide was higher than that of the 
phosphorylated peptide. Although ammonium citrate greatly increased the response of 
phosphorylated peptides as reported by Rao et al. (71), the ionization efficiency of 
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phosphorylated peptides were still not competitive with that of the intact peptide. Since 
carbaryl inhibits eBChE in a noncompetitive pattern, the natural substrate can 
competitively displace the carbamylate group from the enzyme-inhibitor complex and 
result in a greater measured activity. In addition, free thiols produced from DTNB in the 
Ellman reagents may help decarbamylation of inhibited enzyme and eventually helps to 
reactivate the cabamylated enzyme during the measurement of eBChE activity. Therefore, 
the measured enzyme activity was greater than the actual value. Competition with the 
phosphate group will not happen for the phosphorylated enzyme, because the 
phosphorylated eBChE is so stable that natural substrate cannot reactivate this inhibited 
enzyme. 
From all the above mentioned results, we can conclude that our newly developed 
method can detect and quantify pesticide exposure and IC50s and IC100s from the MALDI 
method are comparable with those from the Ellman method. This method is not only useful 
for the detection and quantification of eBChE exposure to OPs, but also useful for exposure 
to CBs, despite their spontaneous reactivation.  
 
CONCLUSION 
 
In conclusion, a new method was developed to provide unambiguous identification 
of the modified active-site peptide produced from tryptic digest of eBChE using 
MALDI-TOF-MS. Furthermore, this method can be applicable to quantify pesticide 
exposure using the linear relationship between the modified peptide intensity with OP 
concentration or logarithmic carbaryl concentration. The Ellman measurement of eBChE 
activity is limited for pesticide exposures at inhibition levels less than 20%. However, the 
reported method can provide information on eBChE inhibition levels as low as 5%. This 
assay was also suitable for the analysis of carbaryl inhibited eBChE, although 
carbamylated enzyme has higher spontaneous reactivation. 
Although CW agents were not investigated in this chapter, the analysis of the 
chemical exposures can be examined using the same methodology. For example, if eBChE 
is exposed to soman, a CW agent, the eBChE will be inhibited. The digest will be subjected 
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to the MALDI analysis after the inhibited eBChE is hydrolyzed by trypsin. The inhibited 
active site peptide should be observed at m/z 2280.3 in MALDI mass spectrum. The mass 
difference between the modified peptide at m/z 2280.3 and the intact peptide at m/z 2200.1 
is unique to soman. The identification of the soman inhibited peptide could be confirmed 
by PSD analysis. Furthermore, the extent of the soman exposure could be determined by 
the relative intensity ratios of the modified and intact active-site peptides. 
The broad use of pesticides in every day life and the increasing threat of terrorism 
of chemical war agents have raised the chances of multiple pesticide exposure. Because of 
the limitation of using MALDI to analyze complex peptide mixtures, a novel methodology 
is required for the analysis of multiple pesticide exposure. Chapter 3 will cover an in vitro 
study for the analysis of a mixture of phosphorylated peptides using LC/MS/MS 
techniques. 
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CHAPTER THREE 
 
ANALYSIS OF MULTIPLE PESTICIDE EXPOSURE USING LC/MS/MS 
 
INTRODUCTION 
 
The potential for multiple-pesticide exposure, either sequentially or concurrently, 
is greater today than anytime in history, due to the extensive use of pesticides. With the 
onset of the Gulf War Syndrome (72), the issue of multiple chemical exposures poses an 
ever increasing military and civilian threat. The rising public healthcare concerns over 
multiple chemical exposures require more sensitive and reliable methods to monitor 
multiple-chemical exposure. However, about 95% of all chemical studies were performed 
on individual chemicals(73). In this study, a novel methodology was developed to analyze 
multiple chemical exposures using LC/MS/MS techniques. An in vitro investigation was 
designed to examine the relative quantification of each pesticide exposure, and to identify 
the types of pesticide using eBChE as a model system. Although we did not examine 
chemical warfare (CW) agents in this study, investigation of BChE inhibition resulting 
from pesticides can provide insight into human exposure to these classes of compounds. 
As described in Chapter 2, the analysis of inhibited BChE was used to monitor 
pesticide exposure (57, 60). In our previous work (Chapter 2), we successfully identified 
and quantified the modified (phosphorylated or carbamylated) active site peptide generated 
from tryptic digests of inhibited eBChE using MALDI-MS. In this chapter, we continued 
to investigate the analysis of a mixture of phosphorylated active site peptides after 
multiple-pesticide exposure using LC/MS/MS.  
In the last decade, mass spectrometry has emerged as an increasingly viable 
technique for the analysis of protein modifications, such as phosphorylation. Although 
both electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser 
desorption ionization-mass spectrometry (MALDI-MS) have been used quite successfully 
for phosphoprotein analysis (74), ESI-MS offers a better choice for investigations with 
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more complex phosphoprotein mixtures because of online separation capabilities. Chapter 
2 described the successful identification of phosphorylated peptides by MALDI-MS, 
through comparisons of the peptide maps before and after treatment. However, a 
noteworthy limitation of the MALDI approach is observed in the low desorption/ionization 
efficiency of phosphorylated peptides. This lower response was established by comparing 
MALDI data with results from LC/MS/MS investigations. In addition, a further worsening 
of the detection signal for these analytes arises due to ion suppression in the presence of the 
other peptides. Therefore, investigations of a mixture of OP-modified active site peptides 
were much more challenging using MALDI methodology. A further limitation of the 
MALDI technique stems from the difficulty in obtaining sequence information of the 
phosphoprotein under study. Although the modified peptide was confirmed by 
post-source-decay (PSD) MALDI-MS analysis, it was not possible to obtain sequence 
information. Since loss of the phosphate moiety was the dominant fragmentation pathway 
and the yield of the other fragments was low, the collection and interpretation of sequence 
information from PSD mass spectra was difficult. It was evident that the MALDI 
methodology described here was not suitable for multiple pesticide exposure analyses. 
In this chapter, three OPs, methyl paraoxon, ethyl paraoxon, and EPN oxon, were 
used to inhibit eBChE, separately. Subsequently, the inhibited enzyme was digested with 
trypsin. The same amount of tryptic digests was mixed, and the resulting mixture was 
further analyzed using LC/MS due to its online separation capability. However, the 
phosphorylated peptide separation and the quality of their product spectra were still not 
good enough for the analysis. This is because the other abundant peptides in the mixture 
suppress the peptide ions of interest. Some situations make the phosphorylated peptide 
analysis even worse, such as coelution of four phosphorylated peptides as well as the other 
peptides and relatively long duty cycles (time for MS full scan and subsequent MS/MS). 
Therefore, an LC/MS/MS technique for the analysis of the phosphorylated peptide ions 
during on-line analysis, was applied for the investigation of the mixture. The ions of 
interest can be isolated and fragmented in the ion trap even in the presence of the other 
abundant peptides using LC/MS/MS techniques. The isolation ability of LC/MS/MS 
technology was evaluated by comparing the ion chromatogram (IC) of one kind of 
phosphorylated peptide enriched from the offline fractioned sample with that from the 
 70
un-fractioned sample. Results demonstrated that this LC/MS/MS technique was a powerful 
tool for the analysis of the phosphorylated peptide mixture. Results clearly showed that this 
method was applicable for the measurement of the relative abundance of each individual 
phosphorylated peptide in a complex peptide mixture. Furthermore, the phosphorylation 
and carbamylation sites were localized from LC/MS3 and LC/MS/MS analysis, 
respectively. 
 
EXPERIMENTAL 
 
Chemicals and Reagents 
All the chemicals, and enzymes, including their purity and grade, are the same as 
those described in Experimental Section of Part I, Chapter 2. 
eBChE Inhibition 
 The same eBChE inhibition protocol was used as described in Experimental 
Section of Part I, Chapter 2. 
 
Trypsin FDigestion 
The same trypsin digestion protocol was used as described in Experimental Section 
of Part I, Chapter 2. 
 
Offline Peptide Separation 
A tryptic digest of eBChE (200 µl, 184 µg) was injected onto the C18 reversed 
phase column (2.1 mm x 25 cm, 3 µm). Peptide separation was done by a linear gradient 
elution that started with 95% (v/v) solvent A [water + 0.1% trifluoroacetic acid] and 5% 
solvent B [acetonitrile + 0.1% trifluoroacetic acid] using a flow rate of 0.25 ml/min. 
Phosphorylated peptides were enriched by HPLC separation. For the first separation, the 
concentration of solvent B was increased to 95% (v/v) in 30 min, then kept at this 
concentration for 5 min. Fractions containing modified active site peptide were collected 
and concentrated using a Speed Vacuum concentrator. The residue was dissolved in 20 µl 
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of solvent A and subjected to the second offline separation. For the second separation the 
concentration of solvent B was increased to 85% over 50 min and then to 95% over 1 min, 
and kept this concentration for 2 min. Peaks were detected at 214 nm. Each peak was 
manually collected in 1 ml vials. 
 
Instrument 
MALDI-TOF-MS Analysis 
The sample preparation, target spotting technique and parameters of the instrument 
were the same as described in the Experimental Section of Part I, Chapter 2. 
LC-MS Analysis 
A tryptic digest of eBChE (9 µL, about 19 pmol) was injected into the capillary 
column. Separations were performed with an HP 1100 HPLC modified with a custom 
splitter to deliver mobile phase at 4 μl/min to a custom C18 capillary column (300 μm id x 
15 cm, packed in-house with Macrosphere 300 Å 5 μm C18 (Alltech Associates, Deerfield, 
IL)). A linear gradient was used to elute peptides from the capillary column that started 
with 95% (v/v) solvent A [water + 0.1% formic acid] and 5% solvent B [acetonitrile + 
0.1% formic acid] using a flow rate of 0.2 ml/min. The concentration of solvent B was 
increased to 20% over 8 min and then to 90% over 25 min, and kept at this concentration 
for 8 min. The heated capillary temperature of the mass spectrometer was 175 °C. The 
number of microscans was 5 and the scan range was from 150 Da to 2000 Da. The 
acquisition time was 45 min. For LC/MS/MS technique, the isolation width was 5 Da (m/z), 
normalized collision energy was 35%, activation Q was 0.25 and the activation time was 
30 ms. 
RESULTS AND DISCUSSION 
 
Sequence Information of Phosphorylated Peptides 
In order to confirm the identity of the phosphorylated peptides, LC/MS/MS was 
applied to obtain the amino acid sequence information. A representative LC/MS/MS of the 
phosphorylated peptide (calculated MH2+ at m/z 11682+) by ethyl paraoxon is shown in 
Figure 1-3-1. As shown in Figure 1-3-1, a dominant fragment ion at m/z 10912+ was 
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observed corresponding to the loss of the alkyl phosphate group HOP(O)(OCH2CH3)2. The 
low intensity of the other fragment ions made it impossible to obtain the fragmentation 
information of the phosphorylated peptide ions. A similar phenomenon was observed in 
the MS/MS spectra of the other three phosphorylated peptides (data not shown), where the 
dominant product ion was at m/z 10912+. The common fragment ion corresponded to the 
neutral fragment loss of the alkyl phosphoric acid from the phosphorylated ions. As such, 
the alkyl-phosphorylated peptides were differentiated by the neutral fragment loss. 
In order to acquire sequence information of the phosphorylated peptide ions, 
MS/MS of the dominant product ion was obtained. Figure 1-3-2 shows the MS/MS of 
10912+, which was the common daughter ion for all of the phosphorylated peptides. A high 
quality tandem mass spectrum was obtained for the common product ions (Figure 1-3-2). 
The sequence of the active site peptide of eBChE digested by trypsin is known to be 
SVTLFGESAGAASVSLHLLSPR (calculated MH+ at m/z 2200.5, numbered 1 to 22 from 
right to left), where the active site serine is underlined (75). The MS/MS spectrum of the 
intact active site peptide is also reported (Figure 1-3-3). It is known that fragmentation of 
peptides usually occurs at the peptide bonds to produce a series of fragment ions, where 
ions containing an N-terminal are “b” ions and ions containing an C-terminal are “y” ions. 
Most fragment ions were observed as y-ions in the tandem mass spectra of both intact 
peptide and the common product ion of phosphorylated active site peptides (Figure 1-3-2 
and Figure 1-3-3). By comparing the tandem mass spectra of Figure 1-3-2 and Figure 1-3-3, 
an identical set of unphosphorylated fragment ions corresponding to y14 - y3 was observed. 
Mass shifts with 18 Da were observed for y15Δ - y19Δ ions (Figure 1-3-2) compared with 
those y ions from the intact peptide. This mass shift was due to the elimination of alkyl 
phosphoric acid on the catalytic serine resulting in a homoalanine residue. All the 
fragmentation information confirmed that the precursor ion at m/z 11682+ was the 
phosphorylated peptide. Furthermore, the modified group can be deduced based on the 
mass difference (77 Da) between the precursor ion and fragment ion. The lost fragment 
should be 2 times that of the mass difference due to the doubly charged precursor and 
product ions. As such, the modified group was identified as O,O-diethyl phosphate (154 
Da). The other phosphorylated peptides can be determined using the same approach. In 
addition, the phosphorylation site was also localized as serine at position 15. 
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Figure 1-3-1. MS/MS of the alkyl-phosphorylated peptide by ethyl paraoxon. The doubly 
charged precursor ion at m/z 11682+ was selected for collision-induced dissociation. The 
dominant fragment ion was doubly charged ion at m/z 10912+ corresponding to the loss of 
the O,O-ethyl phosphoric acid from the precursor ion. 
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Figure 1-3-2. MS/MS/MS of the alkyl-phosphorylated peptide by ethyl paraoxon. The 
doubly charged product ion at m/z 10912+ was selected for collision-induced dissociation. 
Product ions with neutral loss of the alkyl phosphoric acid are indicted by Δ.
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Figure 1-3-3. MS/MS of intact active site peptide. The doubly charged precursor ion at m/z 
11002+ was selected for collision-induced dissociation. The amino acid sequence of the 
intact active site peptide is SVTLFGESAGAASVSLHLLSPR (calculated MH2+ at m/z 
11002+, the active site serine is underlined, and numbered as 1 to 22 from right to left). 
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Identification of the Carbamylated Peptide 
The MS/MS spectrum of the doubly charged precursor ion at m/z 11292+ was also 
obtained (Figure 1-3-4). The pattern of tandem MS for the carbamylated peptide was 
different from those of phosphorylated peptides. Although the doubly charged ion at m/z 
10912+, due to the loss of the carbamylated group, was also observed, it was not the 
dominant fragmentation ion. Enough fragmentation information was collected to identify 
the doubly charged precursor ion at m/z 11292+ from the tandem mass spectrum. 
Comparing the product mass spectra of the carbamylated peptide and the intact peptide, an 
identical set of unmodified fragment ions corresponding to y14-y3 was observed. Mass 
shifts with 57 Da, due to the attached carbamylated-group (57 Da) on the active site serine 
residue, were observed for y15Δ-y19Δ ions (Figure 1-3-4). It was evident that the 
precursor ion at m/z 11292+ was the carbamylated peptide, and the carbamylation site was 
identified as serine at the position 15 from the LC/MS/MS analysis. 
 
Comparison of Sensitivity of MALDI and LC/MS/MS 
In Chapter 2, we successfully detected and quantified inhibited eBChE resulting 
from OP and CB exposure using MALDI-TOF-MS methodology. In order to compare the 
detection sensitivity of the MALDI-TOF-MS method and the LC/MS method, the tryptic 
digests of eBChE treated by ethyl paraoxon at different concentrations were used. Table 
1-3-1 lists the peak area ratios (peak area of phosphorylated peptide to that of intact peptide) 
from LC/MS analysis and the intensity ratios (intensity of the phosphorylated peptide to 
that of the intact peptide) from MALDI-MS at different concentrations of ethyl paraoxon 
(0, 0.05, 0.5, 1.0, and 1.5 µM).  
The peak area ratios from the LC/MS method were higher than the intensity ratio 
from the MALDI-MS method for the same tryptic digest. This is because the low response 
of phosphorylated peptides detected by MALDI. The poor detection signal of the 
phosphorylated peptide by the MALDI method resulted from the electron withdrawing 
property of the phosphate group on the modified peptide. The low response of 
phosphorylated peptides was also due to the suppression effects in the presence of the other 
peptides from the tryptic digest of eBChE. In contrast, the online separation of LC/MS/MS 
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Figure 1-3-4. MS/MS of the carbamylated peptide. The doubly charged precursor ion at 
m/z 11292+ was selected for collision-induced dissociation. Fragment ions with the attached 
carbamylate on the serine are indicated by Δ.  
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Table 1-3-1. The relative ratio of modified peptide peak area or intensity by ethyl 
paraoxon to the intact peptide peak area or intensity from the RICa LC/MS/MS and that 
from MALDI. 
 
 
a: RIC stands for reconstructed ion chromatogram; 
b: the data from the previous work (Chapter 2);  
c: the relative ratio of the modified peak (at m/z 2336.2) area by ethyl paraoxon to 
that of the intact peptide (at m/z 2200.2).
Concentration of ethyl 
paraoxon (µM) 
I2336.2/I2200.2b from 
MALDI 
I2336.2/I2200.2c from RIC of 
LC/MS/MS 
0.05 0 0.47 
0.5 0.20 1.72 
1 0.79 3.02 
1.5 ∞ 35.06 
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method decreased the complexity of the peptide mixture, and increased the response for 
each individual peptide  accordingly. Furthermore, the CID of the selected ion for the 
LC/MS analysis dramatically increased the interest-peptide response. The data (Table 
1-3-1) clearly showed that the LC/MS/MS method was more sensitive than MALDI 
method. For instance, no phosphorylated peptide was detected from the sample treated 
with 0.05 µM ethyl paraoxon, and no intact peptide was identified when the concentration 
of ethyl paraoxon was at 1.5 µM using the MALDI method. However, both the modified 
peptide and the intact peptide were detected at 0.1 µM and 1.5 µM ethyl paraoxon using the 
LC/MS/MS method. 
MALDI and LC/MS/MS Analysis for Offline-fractionated Peptides 
In order to reduce the complexity of the peptide mixture and enrich the 
phosphorylated peptide, a tryptic digest of ethyl paraoxon inhibited eBChE was 
fractionated by offline HPLC with UV detector (see Experimental section). Every peak 
was manually collected as a different fraction using UV detector at 214 nm. After two 
offline separations, the MALDI spectrum of every fraction was obtained to determine 
which fractions contained the modified peptide. The modified peptide at m/z 2336.2 was 
identified all the fractions from 13th to 18th. Only the 15th fraction was analyzed using 
LC/MS/MS. Figure 1-3-5 shows the MALDI mass spectrum of the 15th fraction separated 
from the tryptic digest of the eBChE inhibited by ethyl paraoxon (see Experimental 
section). Although most of the small peptides were removed from the mixture, the 
modified peptide at m/z 2336.2 was observed in the 15th fraction as well as the other 
peptides. The modified peptide ion with a double charge at m/z 11682+ was selected, 
specially isolated and fragmented using the LC/MS/MS technique. Figure 1-3-6 shows the 
ion chromatogram (IC) of LC/MS/MS of the precursor ion at m/z 11682+. The 
phosphorylated peptide was monitored by its dominant doubly charged fragment ion at m/z 
10912+ (lower panel of Figure 1-3-6), which corresponded to the neutral loss of 
(CH3CH2O)2P(O)(OH) from the precursor ion. A typical Gaussian-shaped peak at 
retention time 26.50 min was observed. The peak area was related to the amount of the 
phosphorylated peptide present in the mixture. 
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Figure 1-3-5. Representative MALDI-TOF-MS spectrum of the 15th fraction separated by 
HPLC containing the modified peptide with O,O- diethyl phosphate group from the tryptic 
digest of eBChE treated with ethyl paraoxon. The modified peptide is labeled with an 
arrow. 
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Figure 1-3-6. Reconstructed ion chromatogram (RIC) of the modified active site peptide 
after two offline HPLC fractionations. RIC of the doubly charged precursor ions at m/z 
11682+  is shown in the upper panel. RIC of the fragment ion at m/z 10912+, which 
corresponds to the loss of the alkyl phosphoric acid HOP(O)(OCH2CH3)2 and is used to 
monitor the phosphorylated peptide, is shown in the lower panel.
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LC/MS/MS Analysis for Unfractionated Phosphorylated-peptides  
From the above discussion, LC/MS/MS was capable of analyzing the enriched 
phosphorylated-peptide after two offline separations. At this stage, we were curious to 
determine whether or not the assay could be used for the isolation of the phosphorylated 
peptide from the un-fractionated peptide mixture. Figure 1-3-7 shows the RIC of 11682+ 
from the un-fractionated tryptic digest of inhibited eBChE resulting from ethyl paraoxon 
exposure. LC/MS/MS techniques were performed to analyze particular ions of interest. 
The fragment ion at m/z 10912+ was used to monitor the precursor ion. A sharp and narrow 
peak, corresponding to the precursor ion m/z 11682+ at retention time 26.55 min, was 
observed. 
By comparing the results from the fractionated (Figure 1-3-6) and un-fractionated 
(Figure 1-3-7) digests of the inhibited eBChE by ethyl paraoxon, the RIC of the modified 
peptide from the fractionated sample was found to not be better than that of the 
unfractionated one. A side shoulder peak of the RIC for the phosphorylated peptide from 
the fractionated sample, which was a peptide with the same m/z as that of the 
interest-peptide. The disadvantages of the fractionated methodology were its time 
consuming nature and the low sample recovery. All the results clearly showed that the 
LC/MS/MS technique was a powerful tool for the isolation of the phosphorylated peptide 
ions without offline separation before analysis. 
LC/MS/MS for Un-fractionated Carbamylated- peptides  
The carbamylated peptide was baseline-isolated from un-fractioned tryptic digests 
of the carbamylated eBChE (Figure 1-3-8) using LC/MS/MS analysis. The fragment ion at 
m/z 10912+ was also used to monitor the carbamylated peptide ion. Because the fragment 
ion was not the dominant ion in the product mass spectrum, the peak area of the fragment 
ion at 10912+ was much less than that of the precursor ion (Figure 1-3-8). Although the 
LC/MS/MS method was applicable for the isolation of carbamylated peptide, the amount 
of the carbamylated ions can not be monitored by the fragment ion at m/z 10912+. 
Relative Quantification of the Phosphorylated Peptides  
One kind of phosphorylated peptide was successfully analyzed using LC/MS/MS 
method without any offline fractionation prior analysis. We were curious to find out
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Figure 1-3-7. Ion chromatogram (IC) of the modified active site peptide without offline 
fraction prior to LC/MS analysis. The modified peptide with O,O-diethyl phosphate adduct 
(MH2+ at m/z 11682+) is shown in the upper panel and the fragment ion at m/z 10912+ with 
the loss of the alkyl phosphoric acid HOP(O)(OCH2CH3)2 is shown in the lower panel.  
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Figure 1-3-8. IC of the modified active-site peptide with carbalate group (MH2+ at m/z 
11292+) in the upper panel and RIC of the fragment ion 10912+ with the loss of the 
carbamate group CH3NHC(O)OH in the lower panel.
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whether the same assay could be used for the analysis of a mixture of phosphorylated 
peptides. eBChE was inhibited with 1.2 μM methyl paraoxon, 0.5 μM ethyl paraoxon, and 
0.2 μM EPN oxon, separately. Each of these three treated samples was subsequently 
digested with trypsin, respectively. The same amount of the tryptic digest (0.9 µg/μl) of the 
inhibited BChE by methyl, ethyl and EPN oxon were mixed, and analyzed with LC/ 
MS/MS technique. 
As described in Chapter 2, inhibited peptides resulting from methyl paraoxon 
exposure were detected as phosphorylated peptides with O-methyl phosphate (calculated 
MH+ at m/z 2294.5) and O, O-dimethyl phosphate (calculated MH+ at m/z 2308.5). The 
inhibited peptide from ethyl paraoxon was identified with O,O-diethyl phosphate 
(calculated MH+ at m/z 2336.5). Similarly, the inhibited peptide from EPN oxon was 
detected with O-ethyl phenyl phosphate (calculated MH+ at m/z 2368.5). All the above 
results were obtained using MALDI-TOF-MS technique (Chapter 2).  
Phosphorylated peptides were further confirmed through the sequence information 
using LC/MS/MS analysis (Figure 1-3-1 and Figure 1-3-2). Collision induced dissociation 
(CID) of the phosphorylated peptides ions were specially selected to isolate and fragment 
in the ion trap. If only data dependent acquisition for the CID of the four precursor ions was 
used, the phosphorylated peptide by EPN oxon was always omitted (data not shown). Data 
dependent acquisition is set up to analyze the most abundant ions each time. Because the 
four phosphorylated peptides eluted from the capillary column during a short time interval 
(2.23 minutes for elution of all the four selected ions, Figure 1-3-9) and the suppression 
from the other abundant ions, not all of the ions of interest can be analyzed. A time segment 
LC/MS/MS technique was used to solve the problem, which was referred that the mass 
spectrometer was set up to analyze one kind of precursor ion during a certain time period 
and ignore all the other peptides. Using the time-segmented LC/MS/MS technique, the 
phosphorylated peptides from the mixture of the tryptic digests of eBChE were baseline 
separated (Figure 1-3-9). 
 As described before, all phosphorylated peptides had a similar product mass 
spectrum. Only one dominant fragment ion at m/z 10912+ was observed, which 
corresponded to the loss of the alkyl phosphoric acid (neutral fragment) from the precursor 
ions. As such, the phosphorylated peptides were deduced by the neutral fragment ion from 
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Figure 1-3-9. Ion chromatograms (IC) of common fragment ion (m/z 10912+). Precursor 
ions were determined by the neutral loss fragments. Panel A is with neutral loss fragment 
112 Da, corresponding to CH3OP(O)(OH)2 (112 Da), from the precursor ion MH2+  at m/z 
11472+ modified by methyl paraoxon; panel B is with neutral loss fragment 126 Da, 
corresponding to (CH3O)2P(O)OH (126 Da), from the precursor ion MH2+ at m/z 11552+ 
modified by methyl paraoxon; panel C is with neutral loss fragment 154 Da, corresponding 
to (CH3CH2O)2P(O)(OH)2 (154 Da), from the precursor ion MH2+ at m/z 1168+2 modified 
by ethyl paraoxon; panel D is with neutral loss fragment 186 Da, corresponding to 
(CH3CH2O)(C6H5)P(O)(OH)2 (186 Da), from the precursor ion MH2+ at m/z 11842+ 
modified by EPN oxon. 
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the precursor ions. For instance, the neutral loss-fragment in panel A (Figure 1-3-9) was 56, 
which was the mass difference between the doubly charged precursor ion and the doubly 
charged fragment ion at 10912+. The precursor ion was then deduced as 11472+ 
corresponding to the modified peptide with O-methyl phosphate (112 Da). Using the same 
approach, all the precursor ions for panel B, C, and D (Figure 1-3-9) were deduced based 
on the neutral loss of O,O- dimethyl phosphoric acid (126 Da), O,O-diethyl phosphoric 
acid (154 Da), and O-ethyl phenyl phosphoric acid (186 Da), respectively. 
The stoichiometries of the phosphorylated peptides were obtained by comparing 
the integrated peak intensities. An assumption was made that all the alkyl phosphorylated 
peptides ionized at the same efficiencies in electrospray source. The integrated peak area of 
the various phosphorylated peptide indicated the extent of exposure to each OP. The 
relative ratio of the integrated peak intensities was AA1147 : AA1155 : AA1168 : AA1184 
= 2.5 : 4.3 : 2.7 : 1 (AA is the area of the peak). The AA1147 was then added with AA1155 
to obtain a total value, which demonstrated the total exposure to methyl paraoxon. As such, 
the relative ratio was methyl paraoxon : ethyl paraoxon : EPN oxon = 6.8 : 2.7 : 1. This 
indicated that eBChE was exposed to methyl paraoxon 6.8 times more than EPN oxon, and 
2.7 times more than ethyl paraoxon. The result of this method was consistent with the 
actual incubation concentration ratios, which was methyl paraoxon : ethyl paraoxon : EPN 
oxon = 1.2:05:0.2 = 6.0 : 2.5 : 1. The relative standard error was 8% between the detected 
value and the actual value. Such difference was caused by the different inhibition 
efficiency of OPs. Based on the results from our previous work (Chapter 2), the inhibitory 
ability of methyl paraoxon was lower than that of ethyl paraoxon and EPN oxon. The lower 
inhibition efficiency produced less inhibited peptides, which corresponded to the extent of 
pesticide exposure by methyl paraoxon. It has to be emphasized that the quantification was 
not absolute, because no internal standard was used. However, a relative quantification was 
obtained, and was consistent with the actual pesticide concentrations.  
 
CONCLUSION 
 
A new methodology was developed here to provide identification and baseline 
separation of a mixture of phosphorylated active site peptides using LC/MS/MS. The 
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LC/MS/MS methodology was more sensitive due to its online separation, which reduced 
the complexity of the peptide mixture. Using the methodology, no offline separation was 
needed before the analysis, which avoided the sample loss during the preparation 
procedure. The methodology was successfully used in the analysis of single pesticide 
exposure. In this study, a common dominant fragment ion at m/z 10912+ was observed in 
tandem mass spectra of all phosphorylated peptides, and was used to monitor the precursor 
ions. The phosphorylated peptides were differentiated by the neutral loss from the 
precursor ions. The common fragment ion at m/z 10912+ was further fragmented to acquire 
the sequence information and modification site of the phosphorylated peptides. 
LC/MS/MS was a powerful technique for obtaining sequence information and for 
localizing the phosphorylation site of the modified peptides. The methodology was also 
successfully applied for the analysis of d peptide modifie by carbaryl. Finally, the time 
segment of LC/MS/MS analysis of the selected ions was a great tool for baseline separation, 
detection, identification, and quantification of the phosphorylated active site peptides in a 
single analysis run.  
The application of the LC/MS/MS methodology for the analysis of multiple 
pesticide exposure to human will be the subjects of future experiments. A purification 
method for the isolation of BChE from human serum is a challenge. Chapter 4 describes 
how to solve this problem. 
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CHAPTER FOUR 
 
DEVELOPMENT OF A PURIFICATION SCHEME FOR THE ANALYSIS OF 
HUMAN SERUM BUTYRYLCHOLINESTERASE 
 
INTRODUCTION 
 
BChE has been notoriously difficult to purify. Although it was discovered in 1932 
as an enzyme that hydrolyzes esters (76), hBChE was not sequenced until 1986(40) due to 
the lack of adequate amounts of pure enzyme. The relatively low concentration of plasma 
BChE (3-5 mg/l), and the complex protein compositions in serum make BChE purification 
difficult. Affinity gels are widely used in the purification procedure due to their relatively 
specific characters. In this work, affinity gels were synthesized in laboratory to enable 
hBChE isolation from serum. 
The invention of affinity gels was a milestone in the BChE purification history, 
which has been applied for more than 35 years. Before the application of affinity gels, a 
conventional purification method was employed for the BChE isolation. This method was 
based on the use of an ammonium sulfate fraction at neutral and acid pH (45, 76). A 
drawback of this method is poor purification and yield. Furthermore, the method is not 
suitable hBChE purification, because the enzyme is not stable at low pH. A big 
improvement in the esterase purification occurred  in 1970. Affinity gels were used for the 
BChE purification, which were originally developed for the purification of AChE by 
Kalderon (77). Until 1978, affinity gels with procainamide ligands, which totally changed 
the BChE purification history, were first introduced in a small-scale purification of hBChE 
by Lockridge & La Du (51). The use of the procainamide affinity gels enabled the 
production of high purity and high yield BChE from serum.  
Ralston et al. (52) applied two large-scale methods for the purification of horse and 
human serum BChE using procainamide gels. In brief, the procainamide-Sepharose 4B 
gels were used to treat large volumes of serum followed by the elution of BChE. The eluted 
fractions containing BChE were then subjected to ion-exchange chromatography on 
DEAE-Sephadex, and the bound BChE was eluted with choline chloride gradient. The 
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eluted fractions containing BChE were further purified with preparative polyacrimide-gel 
electrophoresis. This assay needs a large amount of sample, which was not available in this 
dissertation.  
This chapter describes a procedure for synthesizing procainamide-affinity gels. The 
ability of the synthesized affinity gels to isolate hBChE was also evaluated and compared 
with that of the normal Sepharose 4B column. Laboratory-synthesized affinity gels were 
also applied for the analysis of the serum hBChE. In order to analyze hBChE present in 
serum, a new strategy was developed in this chapter. An on-bead digestion protocol was 
developed in the study. The new assay was based on the combination of affinity 
chromatography with LC/MS. In brief, affinity beads synthesized in our laboratory were 
used to isolate BChE from serum. The enriched BChE bound on the affinity beads was 
further subjected to trypsin digestion. The tryptic digest was subsequently analyzed using 
LC/MS/MS. Collision induced dissociation (CID) was applied to analyze peptide of 
interest generated from a tryptic digest of hBChE. Our results clearly demonstrated that 
procainamide-Sepharose 4B was a powerful tool for the isolation of both intact and 
inhibited BChE from human serum. 
 
EXPERIMENTAL 
 
Materials 
Frozen human serum was obtained from cognitively normal control subjects 
through the neuropathology core of the University of Kentucky Alzheimer’s Disease 
Center (ADC), Lexington, KY, using UK Institutional Review Board (IRB) approved 
protocols. The serum was diluted to 10 times the original volume with 0.10 M NaCl / 50 
mM-sodium phosphate buffer, pH 8.0. Butyrylthiocholine iodide (BTCh), 5, 
5’-dithiobis-(2-nitrobenzoic acid) (DTNB), procainamide hydrochloride, 
1-(3-dimethyl-aminopropyl)-3-ethylcarbodi-imide hydrochloride (EDC), CNBr and 
6-aminohexanoic acid were purchased from Sigma Chemical Co. (ST. Louis, MO). 
Sequencing grade modified porcine trypsin was purchased from Promega Corporation 
(Madison, WI). 
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Preparation of Affinity Gels 
Procainamide-Sepharose 4B affinity gel was synthesized in three steps as described 
by Cuatrecasas and Anfinsen (78). The washed and settled Sepharose-4B beads (10 ml) 
were activated with 2.5 g CNBr for 30 min at pH 11 to produce CNBr-activated beads. 
After reaction, 1 mg beads were washed with acetone and dried by Speed Vacuum 
concentrator. IR spectra (KBr) of dried beads were determined. 6-Aminohexanoic acid, 
0.1416 g dissolved in 8 ml 0.2 M Na2CO3 buffer pH 9.29, was added to the washed 
CNBr-activated beads and gently stirred at 4 ºC overnight. As such, CH-Sepharose 4B was 
produced, and IR spectra (KBr) of 1 mg such dried beads were obtained. CH-Sepharose 4B 
beads (5 ml) were re-suspended in 5 ml 1M HCl pH 4.5. Procainamide (2.72 g) dissolved 
in 5 ml 1M HCl pH 4.5 was added to the former suspension. EDC was added dropwise as 
an aqueous solution to a final concentration of 0.1 M. The mixture was rotated overnight at 
room temperature. The total amount of procainamide bound to beads was determined 
through measuring the free procainamide in the washing solutions based on the extinction 
coefficient of 16,900 M-1 cm-1 at 278 nm.  
 
Affinity Isolation 
Settled affinity gels (27 μl) were incubated in diluted serum, 100 μl serum diluted 
to 1 ml with 0.10 M NaCl / 50 mM-sodium phosphate buffer, pH 8.0, for 4 h at 4 ºC. After 
incubation with serum, beads were washed with 10 ml buffer A (20 mM phosphate, 1 mM 
EDTA, pH 6.9), followed by 10 ml of 0.10 M NaCl in buffer A, further washed with 10 ml 
0.15 M NaCl in buffer A, and finally equilibrated with 5 ml 25 mM NH4HCO3.  
Evaluation of Affinity Gels 
The same bead incubation procedure was used as described above. BChE activities 
of the diluted serum before and after incubation with affinity beads (modified beads) or 
original beads (unmodified beads) were detected and compared. 
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hBChE Activity 
The same procedure was used to measure hBChE activity in diluted serum as 
described in Experimental Section of Part I, Chapter 2. 
The procedure for direct measurement of the bound hBChE activity on beads is as 
follows. Beads suspended in solution of 50% glycerol in water (v/v) were used for the 
enzyme activity measurement. The absorbance of the suspended bead solution with a 
mixture of BTCh (1mM) and DTNB (0.32 mM), was measured at 412 nm for the first 10 
min of the reaction. Raw data were converted to the relative activity (percent) of the diluted 
serum before the incubation with beads. 
 
On-bead Digestion 
Affinity beads with bound proteins were incubated in 10 μl trypsin (0.01 μg / μl in 
25 mM NH4HCO3 buffer) overnight at 37 ºC. The supernatants with peptides from tryptic 
digestion were separated from the beads, and were ready for mass spectrometric analysis. 
LC-MS Analysis 
HPLC separation program, C18 capillary column, and parameters of the mass 
spectrometer were the same as described in the Experimental Section of Part I, Chapter 3. 
 
MALDI-TOF-MS Analysis 
The sample preparation, target spotting technique and parameters of the mass 
spectrometer were the same as described in the Experimental Section of Part I, Chapter 2. 
 
RESULTS AND DISCUSSION 
 
Preparation of Affinity Beads 
IR was used to confirm the first two reactions of the affinity gel synthesis (reaction 
of Step 1 and 2 shown in Figure 1-4-1). Beads (1 mg) after each reaction were washed with 
acetone and dried by Speed Vacuum concentrator. IR spectra (KBr) of dried beads were 
recorded (Figure 1-4-2 to 1-4-4). The following peaks, shown in the IR of CNBr-activated 
beads (Figure 1-4-3), but absent in the original beads (Figure 1-4-2), were: 2593.6 cm-1 
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(C≡N), 1735 cm-1 (C=N). This observation was consistent with previous study (63), that 
confirmed the formation of C≡N and C=N bond on the Sepharose 4B beads. The peak at 
2593.6 cm-1 (C≡N) shown in the IR of CNBr-activated beads (Figure 1-4-2), was absent in 
that of CH-Sepharose 4B beads (Figure 1-4-4). As shown in Figure 1-4-4, a peak at 3400 
cm-1 in the IR of CH-Sepharose 4B beads suggested the –COOH groups bound on beads, 
which indicated that the 6-aminohexanoic acid was attached to the CNBr-activated beads. 
The total amount of procainamide bound to beads was determined through 
measuring the unbound procainamide in the washing solutions based on the extinction 
coefficient of 16,900 M-1 cm-1 at 278 nm. The yield of the affinity gels was of 12.7 μmol 
procainamide / ml of the swollen beads. 
 
Evaluation of Affinity Isolation 
Equal volume of settled affinity beads (synthesized in laboratory) and original 
beads were incubated in the same diluted serum. hBChE activity was measured (see 
Experimental section) at 412 nm. Slopes of the line resulting from the plot of absorbance vs 
time, were obtained. Table 1-4-1 summarized all of the slopes indicating hBChE activities 
from the diluted serums before and after incubation with affinity beads and original beads. 
Three parallel experiments were performed. After incubation with affinity beads, the 
percentage of hBChE left in solution was 18.1 %. However, the percentage of the 
remaining BChE in solution after incubation with non-modified beads was 87.8 %. Results 
from preliminary experiments indicated that the binding of hBChE to 
procainamide-Sepharose 4B beads was 6.7 times more than that to the original beads. 
The specific character of the affinity beads can also be confirmed by direct 
measurement of the bound BChE activity on beads. Beads suspended in solution of 50% 
glycerol in water (v/v) were used for the enzyme activity measurement. Table 1-4-2 lists 
the slopes from three parallel experiments. The percentage of hBChE bound to 
procainamide-Sepharose 4B gels was 55.7 ± 4.7 %. However, only 1.93 ± 2.5 % was 
detected for the original beads. This result showed that hBChE bound to the affinity gels 
was about 29 times more than that bound to the original beads. 
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Figure 1-4-1. Activation of Sepharose by CNBr and subsequent coupling of ligand.
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Figure 1-4-2. IR spectrum (KBr) of dried original beads (unmodified beads). 
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      Figure 1-4-3. IR spectrum (KBr) of dried CNBr-activated beads. 
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Figure 1-4-4. IR spectrum (KBr) of dried CH-Sepharose 4B beads.
 
 
 
 
-COOH 
 98
 
 
 
 
 
 
 
 
 
 
Table 1-4-1. hBChE activities of the diluted serum before and after incubation with beads.  
 
Exp. 
Slope before 
incubation 
Slope after 
incubation 
with affinity 
beads 
% left after 
incubation 
with affinity 
beads 
Slope after 
incubation 
with original 
beads 
% left after 
incubation 
with original 
beads 
1 0.2590 0.0406 15.7 0.19245 84.3 
2 0.2059 0.036 17.5 0.19945 96.9 
3 0.2224 0.04675 21.0 0.18305 82.3 
  Ave. ± SD 18.1 ± 2.7 Ave. ± SD 87.8 ± 7.9 
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Table 1-4-2. hBChE activities from direct absorbance measurement on beads. 
 
Exp. 
Slope before 
incubation 
Slope on 
affinity beads
% hBChE on 
affinity beads
Slope on 
original 
beads 
% hBChE on 
original 
beads 
1 0.2590 0.1307 50.4 0.013 4.9 
2 0.2059 0.1219 59.2 0.001 0.5 
3 0.2224 0.1276 57.4 0.001 0.4 
  Ave. ± SD 55.7 ± 4.7 Ave. ± SD 1.9 ± 1.5 
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 The big difference between the two measurements was because the light was 
diffracted by the suspended beads during the absorbance measurements. We suggested that 
the activity measurement in solution was more reliable than the measurement direct on 
beads. Despite the difference, both measurements proved that affinity beads (synthesized 
in laboratory) were able to enrich hBChE from the serum. 
 
LC/MS/MS Analysis 
The procainamide-Sepharose 4B gels facilitated the enrichment of hBChE in the 
presence of the other serum proteins. However, the high concentration of albumin and 
immunoglobulins in the serum increased the amount of nonspecific binding to the affinity 
beads, and increased the number of proteins subjected to proteolytic digestion. 
Consequently, a much more complex peptide mixture, generated from these non-specific 
binding proteins, made it more difficult to detect the peptide of interest from hBChE. In 
order to reduce non-specific binding of serum proteins, high concentrations of salt were 
used to wash the affinity beads (see Experimental Section).  
After the stringent washing steps, the entire isolated protein complex was digested 
with trypsin while still bound on the affinity beads. The resulting digest was then subjected 
to LC/MS/MS analysis. The presence of hBChE was confirmed by the collision-induced 
dissociation (CID) of a selected ion MH+ at m/z 2282.5+, which represents a tryptic peptide 
of hBChE. The sequence of the ion was AILQSGSFNAPWAVTSLYEAR (calculated 
average mass 2281.2). So, doubly charged ions at m/z 11412+ were isolated and fragmented 
in the ion trap with the presence of other abundant peptides. Figure 1-4-5 shows the IC of 
11412+ from a trypsin digest of hBChE and the tandem mass spectrum of this selected 
peptide using the LC/MS/MS method. 
The presence of hBChE on beads was also confirmed by the detection of the tryptic 
active-site peptide at m/z 2928.5, the sequence of which was 
SVTLFGESAGAASVSLHLLSPGSHSLFTR (the catalytic serine is underlined). Figure 
1-4-6 shows the RIC and tandem mass spectrum of 14642+ from on-bead tryptic digest of 
hBChE using LC/MS/MS method. The poor MS/MS spectrum of the selected ion was 
because it was out of mass detection limit of the ion trap, which was less than 2000 Da. 
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Figure 1-4-5.  (A) RIC of the selected peptide (MH2+ at m/z 11412+) for collision-induced 
dissociation of LC/MS/MS analysis from tryptic digest of hBChE. (B) Product ion 
spectrum of the selected peptide ion, the sequence of which was 
AILQSGSFNAPWAVTSLYEAR.  
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Figure 1-4-6.  (A) RIC of the selected peptide (MH2+ at m/z 1464+2) for collision-induced 
dissociation of LC/MS/MS analysis from tryptic digest of hBChE. (B) Product ion 
spectrum of the selected singly charged peptide, the sequence of which was 
SVTLFGESAGAASVSLHLLSPGSHSLFTR (the catalytic serine is underlined).   
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In order to prove that procainamide-Sepharose 4B beads are able to isolate 
inhibited BChE, eBChE was used. Since an ion trap cannot detect ions higher than 2000 Da, 
it is unsuitable to detect the inhibited active site peptide by ethyl paraoxon (calculated MH+ 
at m/z 3096+) from a tryptic digest of hBChE. The modified peptide by ethyl paraoxon 
(calculated MH+ m/z 2368+) generated from a tryptic digest of eBChE is much smaller than 
that from hBChE (calculated MH+ at m/z 3096+). Therefore, the inhibited eBChE by ethyl 
paraoxon was used to evaluate the enrichment ability of the inhibited enzyme. Figure 1-4-7 
shows the RIC and MS/MS of this selected ion at m/z 11852+ from a tryptic on-bead digest 
of inhibited eBChE. The results clearly showed that procainamide-Sepharose 4B beads 
were able to isolate inhibited eBChE. 
From the above discussion, tandem mass spectrum of the active site peptide 
generated from the tryptic digest of eBChE was better than that from hBChE. Two reasons 
are responsible for this phenomenon. First, the tryptic active-site peptide (calculated MH+  
at m/z 2200.5) from eBChE is smaller than that (calculated MH+  at m/z 2928.5) from 
hBChE. Furthermore, the performance of procainamide-Sepharose 4B gels at retaining 
BChE from native human serum is worse than that from eBChE (52). 
 
MALDI-TOF-MS analysis 
The enrichment of the active and inhibited hBChE for procainamide-Sepharose 4B 
beads was also proved by MALDI-TOF-MS analysis. Figure 1-4-8 A shows the MALDI 
spectrum of the tryptic on-bead digest of the enriched hBChE. After serum was incubated 
with carbaryl, the inhibited hBChE was enriched on the affinity beads. Then, the isolated 
hBChE bound on the beads was subjected to trypsin digestion. The resulting tryptic digest 
was analyzed using MALDI-TOF-MS technique. The peak at m/z 2985.5 corresponded to 
the modified active site peptide with carbamylate group CH3NHC(O) (Figure 1-4-8B). 
Although there is no detection mass limit for MALDI-TOF, low responses of both the 
active site peptide and the modified active site peptide of hBChE were observed. The 
suppression of the peptide of interest, resulting from the presence of the other peptides, was 
responsible for the low detection signal. Despite the low detection response, data shown 
here demonstrate that procainamide-Sepharose 4B gels were able to isolate the intact 
hBChE, as well as to isolate the inhibited hBChE. 
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Figure 1-4-7.  (A) IC of the selected peptide (MH2+ at m/z 11852+) for collision-induced 
dissociation of LC/MS/MS analysis from tryptic digest of eBChE. (B) Product ion 
spectrum of the selected singly charged peptide, where 10912+ corresponds to the inhibited 
peptide with loss of O-ethyl phenyl phosphoric acid.   
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Figure 1-4-8. Representative MALDI-TOF-MS spectra of control (A)  and tryptic digests 
of hBChE treated with carbaryl (B). Labeled peaks with average mass correspond to the 
presence of unmodified and modified active site peptides. The peak at m/z 2985.5 
corresponds to the active site peptide modified with carbamylation group (CH3NHC(O)). 
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CONCLUSION 
 
Affinity beads were successfully synthesized in the laboratory. The specific 
character of the affinity beads was proven by the hBChE activity measurement in the 
diluted human serum before and after incubation with affinity beads. Results demonstrated 
that the procainamide-Sepharose 4B beads enriched BChE at least 6.7 times more than the 
original beads. The specific enrichment for both intact and inhibited BChE was proven by 
both LC/MS/MS and MALDI-TOF-MS analysis. Our results confirmed that 
procainamide-Sepharose 4B was a powerful technique for isolation of both intact and 
inhibited BChE from human serum. The phosphorylated and carbamylated peptides were 
successfully detected, which indicated that the developed method was not only useful for 
the analysis of OP exposure, but also useful for the analysis of CB exposure. The 
developed method was based on the combination of the affinity chromatography and mass 
spectrometry. Furthermore, the detection of tryptic active site peptide of both hBChE and 
eBChE indicated that the on-bead digestion protocol worked efficiently.  
 Although the developed method was successfully applied to the detection of a 
small amount of BChE in human serum, the detection signal was much less than expected 
for both LC/MS/MS and MALDI-TOF-MS techniques. A noteworthy limitation of 
MALDI as described in Chapter 5, LC/MS/MS is a better choice for the hBChE analysis in 
human serum. However, a low detection signal was observed for LC/MS/MS techniques in 
this Chapter, because the tryptic active-site peptide was out of the detection mass range of 
the ion trap. A new digestion method is required to produce a suitable size of peptide 
containing the active-site serine of hBChE, which will be the next step in the analysis of 
hBChE inhibition in real sample, as described in Chapter 5. 
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CHAPTER FIVE 
 
ANALYSIS OF HUMAN BUTYRYLCHOLINESTERASE EXPOSED TO 
ORGANOPHOSPHATES AND CARBAMATES IN SERUM WITH A 
COMBINATION OF AFFINITY CHROMATOGRAPHY AND MASS 
SPECTROMETRY 
 
INTRODUCTION 
 
There is an increasing concern over the extensive use of pesticides, such as OPs and 
CBs, in the agricultural and other industries. The concern is based on the fact that OPs and 
CBs cause the inhibition of key synaptic enzymes, including AChE. Some OPs are in the 
form of chemical warfare (CW) agents, two of which, sarin and VX, were involved in the 
1995 Tokyo subway terrorist attack (79). With the increasing terrorism and the escalating 
use of CW agents in the battlefield like the Iran-Iraq conflict, the healthcare systems for 
both military and civilians require a sensitive and reliable monitoring program for 
detection of pesticide exposure. While most OPs and CBs are not extremely neurotoxic, 
investigation of their cholinesterase inhibition can provide insight into human exposure to 
these classes of compounds. In this chapter, a method is described for the identification and 
quantification of OP and CB exposure in serum, with a combination of affinity 
chromatography and LC/MS/MS.  
The interest in hBChE as a bioscavenger of OPs and CBs is increasing because of 
the extensive use of these chemicals. The rising concern in hBChE study is also because 
chemical warfare (CW) agents (80) are used by terrorists based on their properties of the 
mass destruction and low costs. OPs (including CW agents) and CBs exert their inhibitory 
action by forming a covalent bond with the active site serine of BChE in a highly reactive 
mode. Therefore, the cholinesterase inhibitors scavenged by BChE are unavailable for 
further reaction with AChE, which is present in the nervous system and is much more 
important than BChE. Although its true physiological function remains undetermined, 
BChE is of pharmacological and toxicological importance. A major clinical application of 
inhibited plasma BChE analysis is to detect OP and CB exposure. 
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Fidder et al .(60) published a method for the analysis of human serum samples from 
the victims in the 1995 Tokyo subway terrorism. The Fidder method is based on the 
detection of nonapeptides obtained from pepsin digests of hBChE. Pepsin is known as a 
nonspecific protease, which cleaves proteins more or less randomly. The use of Fidder 
method is limited due to the poor reproducible pepsin digestion. In addition, synthesized 
phosphorylated peptide is used for the quantification of inhibited hBChE. The 
radioactive-phosphorylated peptide is synthesized using F-moc chemistry, which is time 
consuming, requires a lot of chemical techniques, and needs a specialist for handling the 
radioactive reagents. Furthermore, isolation of hBChE from serum involves multiple steps: 
elution of proteins from the procainamide affinity column followed by heating the 
fractions containing hBChE; digest filtered proteins on the filter; wash of peptides from 
filters, and concentration of digested solution before LC/MS/MS analysis. It is known that 
this multi-step procedure results in a low recovery due to lose of analyte during processing. 
In this chapter, a novel improved procedure was developed for the analysis of 
hBChE inhibition that has overcome all of the limitations of the Fidder method. Although 
our method was also based on the analysis of the modified active site peptide of the 
inhibited hBChE using electrospray tandem mass spectrometry, the improved 
methodology provided higher sensitivity and reproducibility than the Fidder method. We 
developed a new digestion method called ‘double digestion’, which incorporated a trypsin 
digestion followed by a protease V8 digestion. A compatible size of the active site peptide 
with LC/MS/MS was produced from the double digestion, which gave a reproducible 
digest. The sequence of the intact active site peptide generated from double digestion is 
SAGAASVSLHLLSPGSHSLFTR (average mass 2195.2), where the active site serine is 
underlined. Results clearly show that double digestion works as efficiently as trypsin 
digestion. An on-bead digestion was also developed here to minimize the analyte loss 
during the sample preparation. In addition, a calibration system was constructed based on 
the detection of modified active site peptides in vitro using LC/MS/MS technique. The 
developed calibration system was applied to analyze the hBChE inhibition in serum 
sample. Furthermore, results demonstrated that the improved methodology was applicable 
for the detection and quantification of multiple pesticide exposure. 
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EXPERIMENTAL 
 
Chemicals 
Highly purified hBChE (EC 3.1.1.8) was a kind gift of Dr. Oksana Lockridge, 
University of Nebraska Medical Center (Nebraska, USA). This hBChE was provided as 
2790 units/ml buffer (10 mM potassium phosphate, 0.15 M NaCl, 0.02% sodium azide). 
Slide-A-Lyzer Dialysis Cassettes purchased from Pierce (Rockford, IL) were used to 
remove salts from the former solution. The desalted hBChE solution was collected and 
dried by Speed Vacuum concentrator, and the residue was dissolved in ammonium 
bicarbonate buffer (pH=7.8). The concentration of hBChE was determined by the enzyme 
activity measurement. Frozen human serum was obtained from cognitively normal control 
subjects through the neuropathology core of the University of Kentucky Alzheimer’s 
Disease Center (ADC), Lexington, KY, using UK Institutional Review Board (IRB) 
approved protocols. The serum was diluted to 10 times the original serum volume with 
0.10 M NaCl/50 mM-sodium phosphate buffer, pH 8.0. Butyrylthiocholine iodide (BTCh), 
5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) EPN, ethyl paraoxon and carbaryl were used 
as described in Experimental Section of Part I, Chapter 2. Sequencing grade modified 
porcine trypsin was purchased from Promega Corporation (Madison, WI). Sequencing 
grade protease V8 from Staphylococcus aureus V8 was purchased from Roche 
(Indianapolis, IN). The synthesized procainamide affinity beads (Chapter 4) were used for 
the study in this chapter. 
Instrumentation 
Electrospray LC/MS/MS Analysis 
All mass spectrometric experiments were conducted on a mass spectrometer 
(Finnigan LCQ) equipped with a standard electrospray interface. Digested hBChE (5 µl, 
about 2 µg) was injected into a capillary column. HPLC separation program, C18 capillary 
column, and parameters of the mass spectrometer were the same as described in the 
Experimental Section of Part I, Chapter 3. 
MALDI-TOF-MS Analysis 
The sample preparation, target spotting technique and parameters of the mass 
spectrometer were the same as described in the Experimental Section of Part I, Chapter 2. 
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hBChE Inhibition 
hBChE (316 units) was dissolved in 1ml 50 mM ammonium bicarbonate buffer 
(pH=7.8), and incubated with OPs or carbaryl (dissolved in methanol) at 37 ºC for 1 h or 30 
min, respectively. The final concentration of methanol was less than 0.05% (v/v) and did 
not significantly affect enzyme activity.  
 
hBChE Activity 
hBChE activity was measured using the Ellman assay (56). Briefly, the absorbance 
of the solution, containing hBChE with a mixture of BTCh (1 mM) and DTNB (0.32 mM), 
was measured at 412 nm for the first 10 min of the reaction. 
 
Double Digestion 
Tryptic digestion was performed in 40% ACN with a 20:1 excess of hBChE to 
trypsin. hBChE (10 µl of 316 units/ ml solution) was subjected to trypsin digestion for each 
experiment. The digest was performed in a 50 mM ammonium bicarbonate buffer (pH=7.8) 
at 37 ºC overnight. Half of the tryptic digest was terminated by formic acid and analyzed 
using MALDI-TOF-MS. The remaining 5 µl of hBChE solution continued to be incubated 
with a 20:1 excess of hBChE to protease V8 for 24 h at 25 ºC. Formic acid was used to 
terminate the double digestion. The resulting digest was analyzed using MALDI-TOF-MS 
and LC/MS/MS techniques. 
Procedure for Analysis of hBChE Inhibition in Serum 
A schematic of the procedure for analysis of hBChE inhibition is shown in Figure 
1-5-1. In brief, 100 µl of serum sample was incubated with carbaryl for 30 min as described 
by Rao et al. (71)), or with OPs for 1 h as described by Doorn et al. (58, 59). After reaction, 
the serum sample was diluted with 1000 µl of 0.1 M NaCl in 50 mM phosphate buffer (pH 
8) to reduce the non-specific protein binding on the affinity beads. The settled affinity 
beads (50 µl) were incubated with the diluted serum sample for 4 h at 4 ºC to ensure 
complete reaction of hBChE with procainamide-Sepharose 4B beads as described by 
Ralston et al. (52). After incubation, the diluted serum solution was removed, and affinity 
beads were washed with 10 ml buffer A (20 mM phosphate, 1 mM EDTA, pH 6.9), 
followed by 10 ml 0.10 M NaCl in buffer A, and further washed with 10 ml 0.15 M NaCl in 
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buffer A, and finally equilibrated with 5 ml 25 mM NH4HCO3 (pH 7.8). After the washing 
solution was removed, the remaining affinity beads with bound proteins were incubated 
with 10 μl of 0.01 μg / μl trypsin in 25 mM NH4HCO3 for 24 h at 37 ºC. Sequentially, 0.13 
μg protease V8 was added and incubated for 24 h at 25 ºC. Supernatants with peptides from 
double digestion were separated from beads, and were ready for mass spectrometric 
analysis. 
RESULTS 
 
Identification of the Modified Peptides from Double Digestion 
MALDI mass spectra for both the control and the treated sample were obtained. 
The modified peptides in the digests of inhibited hBChE, after double digestion, were 
determined by comparing the mass spectra before and after treatment. Figure 1-5-2 and 
Figure 1-5-3 show the mass spectra of a control sample and a sample treated by OPs and 
carbaryl. The peak at m/z 2253.2 was identified as a carbamylated peptide, since it is 
present in the mass spectrum of the treated sample (Figure 1-5-2 B), but absent in the 
control sample (Figure 1-5-2 A). However, peaks at m/z 2196.2 corresponding to the intact 
active site peptide appear in both control and treated sample. 
Modified peptides by ethyl paraoxon (Figure 1-5-3 A) and EPN oxon (Figure 1-5-3 
B) were also determined using the same approach. Peaks with average masses, which 
correspond to the modified and intact active peptides, were observed in mass spectra 
generated from the digest of the inhibited hBChE after double digestion. Table 1-5-1 
summarizes the observed peaks with average masses of MH+, corresponding to the intact 
and modified active site peptide of hBChE treated with 5 µM pesticides. Modified groups 
were determined based on the mass differences (Table 1-5-1) between the modified 
peptide and the intact active site peptide. For instance, the modified group for carbaryl was 
determined as carbamate (O=C-NHCH3, 58 Da), which is based on the mass difference of 
the modified peptide (average m/z at 2253.2) and intact active site peptide (average m/z at 
2196.2). This mass difference takes into account the proton loss on the catalytic serine 
during the carbamylation reaction. Using the same approach, the modified group from 
ethyl paraoxon was determined as O,O-diethyl phosphate, which corresponded to the  
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Figure 1-5-1. Schematic of the procedure for the analysis of hBChE inhibition in serum 
matrix.
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Figure 1-5-2.  MALDI-TOF-MS spectra of the digest of hBChE after double digestion 
control (A), carbaryl treated sample (B). Peak at m/z 2253.2 corresponds to the modified 
active site peptide with carbamylated group. 
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Figure 1-5-3.  MALDI-TOF-MS spectra of the hBChE digest after double digestion, 
which was inhibited by ethyl paraoxon (A), by EPN oxon (B). Labeled peaks display the 
average masses of peptides. Peaks at m/z 2332.3, and 2364.2 correspond to the modified 
active site peptide with O,O-diethyl phosphate, and O-ethyl phenyl phosphate, 
respectively. 
0 
500 
1000 
1500 
In
te
ns
. [
a.
u.
] 
2150 2200 2250 2300 2350 2400 m/z
Modified Peptide with (CH3CH2O)2P(O) 
A 
2332.3 
0 
100 
200 
300 
500 
In
te
ns
. [
a.
u.
] 
2150 2200 2250 2300 2350 2400 m/z
2196.2 2364.2 
Modified Peptide with  
(C6H5)(CH3CH2O)P(O) 
B 
Active Site 
Peptide 
 115
modified peptide at m/z 2332.5. Similarly, the modified group from EPN oxon was 
identified as O-ethyl phenyl phosphate, which corresponded to the modified peptide at m/z 
2364.2. 
 
LC/MS/MS Analysis to Identify the Amino Acid Sequence of Modified Peptides 
MS/MS was used to further confirm intact peptide and modified peptides generated 
from the digests of inhibited hBChE after double digestion. The amino acid sequence of 
carbamylated peptide was identified as (S-carbamate)AGAASVSLHLLSPGSHSLFTR 
using MS/MS (MH3+ at m/z 751.73+ Figure 1-5-5). An identical set of y ions were observed 
in the tandem mass spectrum of the carbamylated peptide (Figure 1-5-5) with that of the 
intact peptide (Figure 1-5-4). However, b ions had 57 Da mass shifts, because they 
contained the active site serine with an attached carbamylated group. All the information 
confirmed that the triply charged precursor ion MH3+ at m/z 751.73+ was the carbamylated 
peptide. 
The tandem mass spectrum of phosphorylated peptides is shown in Figure 1-5-6. 
Although precursor ions of phosphorylated peptides were different (MH3+ at m/z 777.73+ 
for ethyl paraoxon, and at m/z  788.73+ for EPN oxon), they had the same tandem mass 
spectrum. Only one fragment ion at m/z 726.83+ dominated in the MS/MS spectra of the 
phosphorylated peptides (Figure 1-5-6). The common fragment ion was produced by a 
neutral loss at the active site serine resulting in a homoalanine residue. Therefore, the 
phosphorylated precursor ions can be identified by the neutral loss. 
In order to know the amino acid sequence of the phosphorylated peptides, the 
tandem mass spectrum of the product ion at m/z 726.83+ was also obtained (Figure 1-5-7). 
All the y-ions (Figure 1-5-7) were the same as those in the tandem mass spectrum of the 
intact peptide (Figure 1-5-4). However, b-ions had 18 Da mass shift for singly charged ions 
and 9 Da mass shift for doubly charged ions, because b-ions contained active site serine. 
Results clearly showed that precursor ions MH3+ at m/z 777.73+ and 788.73+ were 
phosphorylated peptides, which corresponded to O,O-diethyl phosphorylated peptide and 
O-ethyl phenyl phosphorylated peptide, respectively. 
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Table 1-5-1. Masses of observed MH+ (average mass)a for the intact and modified active 
site peptide of hBChE treated with 5 μM inhibitor. 
 
 
Pesticide intact inhibited ∆mb Modified with group 
Carbaryl 2196.2 2253.3 57 CO NHCH3  
Ethyl 
paraoxon 2196.2 2332.5 136 
P
CH3CH2O
O
CH3CH2O  
EPN 
oxon 2196.2 2364.2 168 P
CH3CH2O
OC6H5  
              
 
a The average mass of the modified or the intact peptide containing the 
catalytic serine after double digestion. 
b Difference in mass between the modified and the intact active site peak.   All 
these mass differences takes into account the proton loss from the catalytic 
serine during the phosphorylation reaction. 
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Figure 1-5-4. MS/MS of the triply charged intact active site peptide ion (MH3+ at m/z 
732.73+). The amino acid sequence of the intact active site peptide is 
SAGAASVSLHLLSPGSHSLFTR (numbered from right to left), where the catalytic 
serine is underlined. 
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Figure 1-5-5. MS/MS of the triply charged carbamylated peptide ion (MH3+ at m/z 
751.73+). Carbamylated peptide is identified by the mass shifts of b-ions, which contain 
active site residue serine. 
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Figure 1-5-6. MS/MS of the triply charged phosphorylated peptide ions (MH3+ at m/z 
777.73+ for ethyl paraoxon and 788.73+ for EPN oxon). The dominant fragment ion MH3+ at 
m/z 726.83+ corresponds to the precursor ions with the loss of alky phosphoric acid. 
Phosphorylated peptides can be differentiated by the neutral loss from the precursor ions. 
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Figure 1-5-7. MS/MS/MS of the phosphorylated peptide ions. The amino acid sequence of 
the peptide is SΔAGAASVSLHLLSPGSHSLFTR, where SΔ stands for the dehydrated 
serine. Phosphorylated peptides are identified by the mass shifts of b-ions, which contain 
active site serine. 
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Evaluation Double Digestion using MALDI 
The inhibited hBChE by carbaryl was digested with trypsin. Half of the tryptic 
digest of hBChE was subjected to MALDI-TOF-MS analysis. The remaining 
tryptic-digested hBChE was subsequently incubated with protease V8 for 24 h at 25 ºC. 
The resulting digest was then analyzed using MALDI-TOF-MS. The intensities of both 
intact and carbamylated peptides were obtained from the MALDI analysis (data not 
shown). The total intensity of active site peptides was obtained by adding the intensity of 
the intact peptide and that of the modified peptide. The relative intensity ratio was the 
intensity of intact peptide or modified peptide divided by the total intensity. Based on these 
reported data, graphs of relative intensity ratio vs carbaryl concentrations were plotted for 
both of the hBChE digests from trypsin digestion and from double digestion (Figure 1-5-8). 
IC50s (concentration required for 50% hBChE inhibition) and IC100s (concentration 
required for complete hBChE inhibition) were determined from these plots (Figure 1-5-8). 
From trypsin digestion, IC50 and IC100 were determined as 21.00 µM and 41.84 µM, 
respectively (Figure 1-5-8 A). These values were very close to the IC50 and IC100 from 
double digestion, which were 20.19 and 40.60 µM, respectively (Figure 1-5-8 B). In 
addition, the slopes for the intact peptide and the modified peptide were the same for both 
digestion methods. Therefore, it is evident that double digestion had high efficiency and 
reproducibility as single trypsin digestion.  
 
Calibration System Construction using LC/MS/MS 
Every digest of hBChE treated by CB and OPs, generated from double digestion, 
was analyzed using LC/MS/MS methodology. Peak areas of intact peptides and modified 
peptides were obtained from LC/MS/MS analysis (data not shown). The total peak area 
was calculated by adding the peak area of the intact peptide and that of the modified 
peptide. The relative area ratios were the peak area of intact peptide or modified peptide 
divided by the total peak area. Based on these reported data, the relative area ratios vs CB 
or OP concentrations were plotted (Figure 1-5-9 and Figure 1-5-10). A linear relationship 
between the relative area ratio and the pesticide concentration was observed. A calibration 
system for carbaryl, ethyl paraoxon, and EPN oxon was developed. 
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Figure 1-5-8. Plots of intensity ratios vs carbaryl concentrations (µM). Plots for trypsin 
digestion (A), and for double digestion (B) are from MALDI analysis. 
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Figure 1-5-9. Plots of peak area ratios vs pesticide concentrations using LC/MS/MS. 
Calibration curves are for carbaryl (A) and for ethyl paraoxon (B). 
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Figure 1-5-10. Plots of peak area ratios vs EPN oxon concentrations using LC/MS/MS. 
(µM) 
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Analysis of Single Pesticide Exposure 
Serum was incubated with 0.2 µM carbaryl for 30 min, and with 0.1 µM ethyl 
paraoxon for 1h, separately. hBChE was then enriched on the affinity beads. The affinity 
beads with bound proteins were subjected to double digestion (see Experimental section). 
The resulting digests of the isolated hBChE were analyzed using LC/MS/MS technique. 
Triplicate analysis was performed as described above. Three triply charged precursor ions 
were selectively analyzed in the ion trap. Precursor ions MH3+ were at m/z 732.73+ for 
intact active site peptide, 751.73+ for carbamylated peptide, and 777.73+ for phosphorylated 
peptide by ethyl paraoxon. Five main fragment ions, at m/z 680.13+, 726.72+, 919.72+, 
955.32+, 1019.32+, were used to monitor the precursor ions of intact active site peptide and 
carbamylated peptide (Figure 1-5-4 and Figure 1-5-5). A dominant fragment ion at m/z 
726.83+ was used to monitor the phosphorylated peptide (precursor ion) by ethyl paraoxon 
(Figure 1-5-6). Figure 1-5-11 demonstrates the RIC of the intact and modified active site 
peptides in one of the three analyses using LC/MS/MS technique. The concentrations of 
carbaryl and ethyl paraoxon were determined from the constructed calibration system 
based on the average relative area ratios of triplicate analysis. The detected concentration 
was 12.3 ± 0.1 µM for carbaryl, and 6.26 ± 0.4 µM for ethyl paraoxon from the calibration 
curves (Figure 1-5-11 A and B). Because hBChE concentration for calibration curves was 
75 times higher than that in the serum sample, the detected concentrations needed to be 
normalized. The normalized concentration was 0.16 ± 0.01 µM for carbaryl, and 0.08 ± 
0.01 µM for ethyl paraoxon, which were very close to the actual incubation concentration. 
The assay was successfully performed for the analysis of pesticide exposure at a 
high level inhibition. We questioned the lowest limit of hBChE inhibition could be 
detected using the assay. To determine this, serum was incubated with EPN oxon, resulting 
in 5 % hBChE inhibition. The extent of hBChE inhibition was confirmed by the enzyme 
activity measurement (data not shown). hBChE was isolated, digested, and analyzed using 
affinity chromatography and LC/MS/MS techniques. Figure 1-5-12 shows the RIC of 
precursor ions at m/z 732.73+ and 788.73+ for intact peptide and modified peptide, 
respectively. The relative peak area ratio was 5 % for the modified peptide, which 
indicated that 5 % of hBChE inhibited. This result was consistent with the hBChE activity 
measurement. 
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Figure 1-5-11. IC of intact and modified peptides. Representative of one set of results from 
three parallel experiments after serum treated with 0.2 µM carbaryl (A), and 0.1 µM ethyl 
paraoxon (B).Five main fragment ions at m/z 680.12+, 726.72+, 919.72+, 955.32+, 1019.32+  
were used to monitor intact active site peptide and carbamylated peptide, and the dominant 
fragment ion at m/z 726.83+ was used to monitor the phosphorylated peptide by ethyl 
paraoxon.  
 
0 5 10 15 20 25 30 35 40 Time (min)0 
100 0 
100 0 
100 
34.53
34.57 
34.74
Intact Peptide Peak
Carbamylated Peptide Peak
A 
0 5 10 15 20 25 30 35 40 Time (min)0 
100 0 
100 0 
100 32.26
31.67
31.67
32.26
Intact Peptide Peak
Phosphorylated Peptide Peak
B 
 127
 
 
 
 
 
 
 
 
Figure 1-5-12. IC of intact peptide (MH+ at m/z 732.73+) and modified peptide (MH+ at m/z 
788.73+) by EPN oxon. The intact peptide was monitored by 5 main fragment ions at m/z 
680.12+, 726.72+, 919.72+, 955.32+, 1019.32+. Modified peptides were monitored by the 
dominant fragment ion at m/z 726.83+ corresponding to the phosphorylated peptide ion 
with neutral loss of O-ethyl phenyl phosphoric acid. 
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Analysis of Multiple Pesticide Exposure 
From the abovementioned results, the assay was useful for the analysis of single 
pesticide exposure, even at low level exposure down to 5% hBChE inhibition. We were 
curious to find out whether the same assay could be used for the detection of multiple 
pesticide exposure. Serum was incubated with 0.27 µM carbaryl for 30 min, 0.07 µM ethyl 
paraoxon for 1h, and 0.05 µM EPN oxon for 1h, respectively. These concentrations were 
chosen, because each pesticide inhibited 50 % of serum BChE at their corresponding 
concentrations (proven by the enzyme activity measurement, data not shown). Equal 
volume of diluted serum after reaction was mixed. The mixture was incubated with affinity 
beads for 4 h. After incubation, affinity beads with enriched hBChE were washed, and 
subsequently digested with trypsin and protease V8. The digests were analyzed using the 
LC/MS/MS (Figure 1-5-13) method. Peaks of the carbamylated peptide (MH3+ at m/z 
7523+), and two phosphorylated peptides (MH3+ at m/z 7783+ for ethyl paraoxon, MH3+ m/z 
7883+ for EPN oxon) were baseline separated in a single analysis run. Phosphorylated 
peptides were determined by the mass differences (neutral loss) between the common 
fragment ion and precursor ions. Peak areas of these modified peptides indicated their 
relative abundance present in serum. The relative area ratios were AA752 : AA778 : 
AA788 = 0.90 : 1.1 :  0.99, where AA is peak area. 
 
DISCUSSION 
 
The goal of this study was to develop an improved methodology to detect and 
quantify hBChE inhibition after OP and CB exposure in serum matrix. The developed 
methodology was based on the combination of affinity chromatography with LC/MS/MS 
analysis, which greatly improved the reproducibility and sensitivity compared with the 
Fidder method. It also provided a critical evidence for an asserted exposure to pesticides. 
Several digestion methods with different proteolytic enzymes were investigated. 
The active site peptide of hBChE from tryptic digests is at m/z 2928.5, which is out of the 
detection mass range of the ion trap analyzer, which is less than 2000 Da. Therefore, a new 
digestion method was required to produce a suitable size of active site peptides. Pepsin and 
chymotrypsin were applied to digest hBChE alone or in combination with trypsin  
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Figure 1-5-13. RIC of carbamylated peptide (MH3+ at m/z 7523+) from carbaryl (A), 
phosphorylated peptide (MH3+ at m/z 7783+) from ethyl paraoxon (B), and phosphorylated 
peptide (MH3+ at m/z 7883+)  from EPN oxon (C). Five main fragment ions m/z 680.13+, 
726.72+, 919.72+, 955.32+, and 1019.32+ were used to monitor precursor ion at MH3+ 7523+ 
(A), common dominant fragment ions at m/z 726.82+ were used to monitor precursor ion 
MH3+ at 7783+ (B), and at 7883+ (C). 
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digestion (data not shown). Unfortunately, no peptide containing the active site serine was 
detected due to the non-specific properties of the two proteolytic enzymes. 
A double digestion was successfully developed, which greatly improved the 
digestion reproducibility. Two specific proteolytic enzymes, trypsin and protease V8, were 
used sequentially. After double digestion, the intact active site peptide, carbamylated 
peptide, and phosphorylated peptide were identified by MALDI analysis and further 
confirmed by LC/MS/MS analysis. The amino acid sequence of the intact peptide 
generated from double digestion is SAGAASVSLHLLSPGSHSLFTR, where the catalytic 
serine is underlined. Only one peptide, containing the active site serine residue, was 
observed from the untreated hBChE digests, which was much better than the pepsin 
digestion developed by Fidder et al .(60). In the Fidder study, several peptides containing 
the active site serine were observed. 
Double digestion was evaluated by comparing calibration curves of the inhibited 
hBChE by carbaryl from trypsin digestion with that from double digestion using 
MALDI-TOF-MS (Figure 1-5-8). Slopes of the calibration curves from trypsin digestion 
were the same as those from the double digestion. In addition, IC50s and IC100s from the 
two calibration curves were very close to each other, the relative standard error was within 
5%. The result indicated that double digestion worked as well as single digestion by trypsin. 
After the evaluation of double digestion, a calibration system of the double digested 
peptides was required for the analysis of pesticide exposure. 
Calibration systems were constructed for both OPs and CB based on the analysis of 
hBChE inhibition in vitro using LC/MS methodology. From the LC/MS analysis, relative 
peak area ratios of the intact peptide and modified peptide were obtained and plotted 
against OP and CB concentrations. A linear relationship between peak area ratios and 
pesticide concentrations was observed. IC50s determined from the calibration curves for 
ethyl paraoxon and EPN oxon were 5.35 ± 0.04 µM and 3.66 ± 0.06 µM, respectively. 
After normalizing the detected concentration of hBChE to the same concentration in serum, 
the normalized IC50s were 0.07 µM and 0.05 µM for ethyl paraoxon and EPN oxon, 
respectively. These normalized IC50s were consistent with those from the study by Misser 
et al. (81) and Johnson et al. (82). Misser group (81) reported that IC50 of ethyl paraoxon is 
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71 ± 7 nM. The average IC50 of EPN oxon is 51 nM based on the reported data by Johnson 
group (82) that IC50s for L-EPN oxon and D-EPN oxon are 66 and 36 nM. 
An interesting phenomenon was observed for the calibration curve of carbaryl, 
which demonstrated a linear relationship between the modified peak area ratios and 
carbaryl concentrations in this study. In contrast, a linear relationship was detected 
between NIRs of modified peptide vs logarithmic carbaryl concentration for the eBChE 
study (Chapter 1). This observation may result from differences between hBChE and  
eBChE. Although eBChE has a 90.1% identity with the hBChE sequence, the amino acid 
composition at active site of eBChE is significantly different from hBChE. As we 
described before, the tryptic active site peptide for eBChE is at m/z 2200 while for hBChE 
is at m/z 2928. The different amino acid sequence at active site of BChE may cause a 
different reaction mechanism with inhibitiors. As such, the observation of the linear 
relationship between the modified peptide and carbaryl concentration for eBChE is 
different from that of hBChE. 
A purification procedure needs to be developed before application of the assay to 
analyze hBChE inhibition in serum. Procainamide-Sepharose 4B affinity beads were 
synthesized in laboratory. As described in Chapter 4, the yield of the affinity bead was of 
12.7 μmol procainamide / ml of beads. The yield was high enough for isolation of hBChE 
from serum due to the low concentration of enzyme (3-5 mg/l). Results from Chapter 4 also 
clearly showed that the synthesized affinity beads could enrich hBChE from serum matrix. 
Procainamide-Sepharose 4B affinity chromatography ideally facilitated the 
enrichment and separation of hBChE from the rest of serum proteins. However, since the 
concentrations of proteins like albumin and immunoglobulins surpass that of hBChE by 
several orders of magnitude, the non-specific binding of these proteins on the affinity 
beads can not be omitted. Although LC/MS/MS is useful in isolating ions of interest, it is 
still unlikely to analyze one kind of ions in the presence of other high-abundant ions 
(several orders more than the ions of interest). Therefore, a more stringent washing 
procedure (with a buffer containing high concentration of salt) was applied to minimize 
nonspecific binding proteins on the affinity beads. Care must be taken here, because the 
high salt-concentration buffer can also wash off hBChE from affinity beads resulting in a 
low yield of isolated analyte. In addition to the stringent washing steps, incubation of 
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affinity beads in the diluted serum solution with 0.1 M NaCl buffer also helped to reduce 
the non-specific proteins bound to beads. 
 In order to increase the recovery efficiency, the affinity-chromatography/on-bead 
digestion approach, performed in a single microtube, was applied in the study of hBChE 
inhibition in serum. The common conventional affinity chromatography requires elution of 
proteins from the column to isolate hBChE from serum followed by concentrating the 
fractions containing hBChE. More experimental steps are required to further purify the 
former fractions, such as filtration, resulting in more proteins or peptides loss. Since 
hBChE concentration in the serum is low and sample is limited, an on-bead digestion was 
developed in this chapter. The on-bead digestion approach reduced analysis time and the 
number of experimental steps, which resulted in minimizing the proteins loss and 
decreasing the possibility of inducing sample contamination during the preparation 
process. 
From the abovementioned results, a calibration system was already constructed, 
and a purification procedure was successfully developed. At this stage, results 
demonstrated that the assay was ready for the analysis of hBChE inhibition in serum 
samples. Serum was exposed to 0.2 µM carbaryl and 0.1 µM ethyl paraoxon, separately. 
To reveal the application of the assay, the treated serum was analyzed. The average 
normalized detected concentration from triplicate analysis was 0.16 ± 0.01 µM for carbaryl 
and 0.08 ± 0.01 µM for ethyl paraoxon. The relative standard error was 20% for both 
analyses, which was much better compared with at least 50 % detection error based on the 
recovery value  using the Fidder’s method. The lower detection value was caused from the 
low recovery of the inhibited hBChE during the purification procedure. The binding ability 
of the inhibited hBChE on affinity beads was less favorable than the intact hBChE, since 
the modification group (including carbamylated and alkyl phosphorylated group) at the 
active site blocks the interactions with ligands on the beads. 
The detection limit of pesticide exposure was also investigated using the assay 
developed in this chapter. Serum was incubated with EPN oxon, which caused 5 % hBChE 
inhibition based on the enzyme activity measurement. From the three parallel experiments, 
the average relative peak area ratio of the modified peptide was 5 % using LC/MS/MS 
method. Although the peak of modified peptide was absolutely detected, the signal was 
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very weak at such a low inhibition level. No further investigation of a lower inhibition level 
was performed.  
At this stage, the assay was successfully applied to detect hBChE inhibition after 
single pesticide exposure, even at low inhibition level of 5%. Since the chances of multiple 
pesticide exposure are much more than single pesticide exposure in the daily life, we were 
curious to find out whether the same methodology is useful for the investigation of 
multiple pesticide exposure. The assay was applied for the detection of hBChE inhibition 
after exposed to multiple pesticides. The carbamylated peptide and phosphorylated 
peptides were baseline separated in a single analysis run. The relative abundances of these 
modified peptides, which were related to the extent of exposure to individual pesticide, 
were estimated by the peak area ratios. In this study, the peak area ratio (AA752 : AA778 : 
AA788 = 0.90 : 1.1 :  0.99) was consistent with the original ratio (1:1:1). The detected 
relative amount of carbamylated peptide was lower than the expected value because the 
reactivation of the carbamylated enzyme occurred during the incubation time with affinity 
beads.  
 
CONCLUSION 
 
An improved novel methodology has been developed for the detection and 
quantification hBChE inhibition in serum by combination of affinity chromatography and 
LC/MS/MS analysis. A novel double digestion was initially developed in this chapter, 
which made it possible to analyze hBChE inhibition using LC/MS methods.  Results 
clearly showed that the double digestion method worked as efficiently as single trypsin 
digestion. In addition, a novel on-bead double digestion protocol was investigated, which 
eliminated the number of experimental steps, reduced the protein loss during sample 
preparation. The on-bead digestion greatly improved the sample recovery resulting in high 
detection sensitivity and elevated accuracy. The developed methodology was successfully 
used in the analysis of both single pesticide exposure and multiple pesticide exposure in 
serum. 
 The improved assay was applied for the analysis of single pesticide exposure in 
serum sample. The detected values were within 20% relative standard error, which was 
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much better than the Fidder’s method. The detection limit of the assay for the pesticide 
analysis was also determined at hBChE inhibition level as low as 5 %. For the analysis of 
multiple pesticide exposure, all the modified peptides were baseline separated, and the 
extent of exposure to each pesticide was estimated by the individual peak area. Results 
from the assay were consistent with the predicted values. Furthermore, carbamylated 
peptides were differentiated from phosphorylated peptides based on the different pattern of 
tandem mass spectra. Phosphorylated peptides were determined based on the mass 
differences (neutral loss) between the common fragment ion and precursor ions. Therefore, 
the types of pesticides and the extent of pesticide exposure to serum can be determined 
using the developed methodology. Because of its high sensitivity, good reproducibility and 
reliability, it is promising to apply the assay in clinical diagnosis in the near future.  
Following the onset of the Gulf War Syndrome (72), the issue of multiple chemical 
exposures poses an ever increasing military and civilian threat. Although analysis of the 
hBChE exposed to chemical warfare (CW) agents was not investigated, the types and 
extent of CW agent exposure should be detected and quantified using the same assay. 
However, an unpredicted exposure, like the 1995 Tokyo Subway Attack (79), requires a 
quick investigation from forensic analysis. How to apply the method in field is a challenge 
for all mass spectrometry specialists. This will be the subject for the future research. 
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CHAPTER SIX 
 
CONCLUSIONS 
  
With the introduction of the organophosphate pesticides (OPs) and carbamates 
(CBs) into American agriculture, there has been considerable interest in their chemistry, 
mode of action, and toxicity. From the public health perspective, a reliable monitoring 
program is required to detect and quantify pesticide exposure. The U.S. Environmental 
Protection Agency (USEPA) scientists proposed a blood esterase monitoring program for 
pesticide exposure in 1991, which is based on the measurement of red cell blood AChE and 
plasma BChE activity. However, because of the intrinsic drawbacks of these existing 
monitoring methods, such as non-specificity, a novel and reliable method is required to 
detect the source of inhibition, and quantify the extent of pesticide exposure. 
Because of their high sensitivity, tolerance of protein mixtures and high-throughput, 
MALDI-TOF-MS and LC/MS/MS were used to detect and quantify OP and CB exposure 
in this dissertation. OPs and CBs inhibit BChE by forming a covalent bond with the active 
site serine by attaching a phospholate or carbamylate group. The developed methodology 
is based on the analysis of inhibited BChE in vitro and in serum. As such, quantification of 
inhibited BChE can serve as a measurement of pesticide exposure.  
A MALDI-TOF-MS methodology was designed for the sensitive detection and 
accurate quantification of pesticide exposure. eBChE was chosen as a model system to 
develop the methodology, because it is commercially available. The degree of poisoning 
was determined by the intensity ratios of the modified peptide and the intact active site 
peptide. The types of pesticides can also be determined by the mass difference between the 
modified peptide and the intact active site peptide. Although the MALDI methodology was 
successfully applied for the analysis of single pesticide exposure, it is limited for analysis 
of multiple pesticide exposure. So, a methodology involving LC/MS/MS istechniques was 
further investigated, because LC/MS/MS has more benefits, such as high sensitivity, lower 
limit of detection (LOD) and simultaneous analysis of multiple pesticide exposure. For In 
vitro study, the LC/MS/MS methodology was successfully applied for the analysis of a 
mixture of the phosphorylated peptides generated from tryptic digests of the inhibited 
eBChE. LC/MS/MS was proven as a great tool for separation, detection, identification, 
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quantification, and categorization of phosphorylated peptide mixture in a single analysis 
run.  
Application of the developed LC/MS/MS methodology for measuring pesticide 
exposure in vitro and in human serum clearly demonstrated the power of MS-based 
methods in pesticide analysis. Results provided critical evidence for the trace exposure to 
OPs and CB as low as 5 % hBChE inhibition in serum, which the traditional Ellman 
method can not. A novel double digestion was firstly developed in this study, which made 
the assay feasible to analyze hBChE inhibition using LC/MS methodology. In addition, a 
novel on-bead double digestion protocol with high recovery was developed, which reduced 
the experimental steps and minimized the analyte loss during the sample preparation. The 
developed methodology, by combination of affinity chromatography and mass 
spectrometry, greatly improved the sensitivity, reproducibility and accuracy in the hBChE 
inhibition analysis. The reliability of the developed methodology was proved by the 
successful use in the analyses of both the single pesticide exposure and the multiple 
pesticide exposure in serum. Results from the developed methodology were consistent 
with the predicted values. 
The methodology developed here was very well-suited for detecting and 
quantifying the pesticide analysis. This study reveals a promising future of the proteomics 
approach and mass spectrometry for the analysis of pesticide exposure due to their high 
sensitivity and high reliability. However, LC/MS/MS methodology is not the only 
technique for measuring pesticide exposure. The combined use of all methods is valuable, 
both in diagnosis of poisoning and in determination of exposure. The other methods, such 
as determination of urinary metabolites using GC/MS, can also provide an indication of 
exposure. Unfortunately, it is not possible to relate the concentration of urinary metabolites 
to the level of intoxication. LC/MS/MS techniques are some of the best analytical tools for 
pesticide analysis providing high sensitivity and analysis of multiple pesticide exposure in 
a single analysis run. As with any poisoning, the best mode of action is treatment, which 
relies on the identity and quantification of toxin exposure. Detection, diagnosis and 
treatment at early exposure and at low level are the key ingredients to save victim lives.  
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PART II. A STUDY OF ORGANOPHOSPHATE PESTICIDE-INDUCED PROTEOME 
ALTERATION IN SH-SY5Y CELLS 
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CHAPTER ONE 
 
INTRODUCTION 
 
CHLORPYRIFOS BACKGROUND 
Chlorpyrifos (CPF) is an organophosphate pesticide, widely used to control a 
variety of pests including fire ants, turf and ornamental plant insects, mosquitoes, 
cockroaches, and termites. It is also used as a soil insecticide, in seed treatment, and 
applied to dormant and foliar plants. An estimated average of 21 million pounds active 
ingredient of CPF was used on 20 million acres of U.S. crops per year from 1987 
through 1989. The domestic use of CPF has been curtailed by U.S. regulatory 
provisions (83) because of its adverse neurological consequences, particularly in 
situations of fetal and childhood pesticide exposure. Nevertheless, CPF remains a 
widely used pesticide, and will continue to be so for the foreseeable future. As such, the 
mode of action and toxicity of CPF has generated considerable interest. 
 
Mode of Action of Cholinesterase Inhibition 
The mechanism of esterase inhibition by CPF is similar to that observed in other 
OPs. OPs exert their acute effects in both insects and mammals by inhibiting AChE in 
the nervous system. As described in Part I, Chapter 1, CHE combines with inhibitors 
(OPs or CBs) to form a Michaelis complex, followed by phosphorylation at the active 
site serine of CHE with the loss of the X (leaving group of OPs). Two possible 
pathways can follow this reaction. Reactivation may occur spontaneously at a rate 
dependent on the effect of the attached group at the active site serine. Alternately, an 
“aging” reaction can occur, which involves the cleavage of an R-O-P-bond with the 
subsequent loss of R (alkyl group on the phosphorus), resulting in the formation of a 
charged mono-substituted phosphoric acid residue on the enzyme. Once the “aging” 
reaction has occurred, the enzyme will never be reactivated. 
AChE functions to terminate neurotransmission by hydrolyzing acetylcholine 
(Ach), a neurotransmitter produced at cholinergic nerve endings in response to nervous 
stimuli. Inhibited AChE causes an accumulation of acetylcholine (Ach) (84), thus 
prolonging the action of Ach. If CPF is administered to developing organisms at high 
concentration levels to cause systemic toxicity, a cholinergic hyperstimulation is 
observed. As shall be shown in the following paragraphs, anticholinergic toxicity is just 
part of CPF action. 
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Developmental Neurotoxicity  
The fact that CPF may cause neurobehavioral damage during brain 
development is becoming a major biomedical and social concern (85). As described 
below, CPF has additional effects on brain development that may be overshadowed by 
its cholinergic component. A variety of studies have clearly indicated that CPF has 
adverse effects on brain development more than cholinesterase inhibition. Recent 
findings indicate that potential exposures to pregnant women and children above the 
“No Observable Adverse Effect Level” show that children are at higher risks of later 
behavior deficits (86). Animal studies also confirm that exposure of neonates to CPF 
result higher risks than adults (71). The LD50 values of CPF for neonates are about an 
order of magnitude lower than that for adults.  
Roy at al (87) describe an alternate experiment to show CPF action on neural 
development. Rat embryo cultures were treated with CPF for 48 h at a concentration an 
order of magnitude below that found in human meconium (88) at the neural tube stage 
of development. The authors found mitotic abnormalities and apoptosis in the 
developing brain. However, it should be noted that choline acetyltransferase, the 
enzyme responsible for Ach biosynthesis, is not detectable at the neural tube stage of 
development. As such, Ach is not available at this stage. So, inhibition of 
cholinesterase by CPF would not produce cholinergic stimulation. It is evident that the 
consequence of CPF action is not linked to anticholinergic toxicity. 
Other studies (89, 90) have further confirmed that alternate mechanisms might 
play important roles in CPF action on the developing brain. It has been hypothesized 
that prenatal CPF exposure, at concentrations below the threshold for detectable 
cholinesterase inhibition without systemic toxicity, induces later-appearing deficits. 
This hypothesis has been directly tested using in vivo and in vitro models of postnatal 
CPF exposure. One-day-old rats were treated with CPF (91), and acute inhibition of 
DNA synthesis was observed in areas with low cholinergic innervations (cerebellum), 
as well as in regions with cholinergically enriched zones (brainstem and forebrain). 
These results were different from that for nicotinic (AChE inhibitor) treatment - only 
DNA synthesis had clearly been altered at expected regions with high cholinergic 
enrichment. Another study was conducted to test the hypothesis in a much more direct 
way. A certain amount of CPF was injected directly into brain, which skipped the 
activation process to CPF oxon, and the same observation as CPF in vivo study was 
obtained. All these results show that CPF affects DNA synthesis by an initial, 
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noncholinergic mode of action. CPF exposure at a concentration insufficient to produce 
systemic toxicity, not only causes DNA synthesis inhibition, but also affects other 
biological processes, including deficits in the number of neural cells (92), suppression 
of gene expression and reduction of macromolecular constituents (important in cell 
differentiation) (79, 93), abnormalities of synaptic function, and resulting in 
abnormally behavioral performance (79, 94).  
In vitro experiments further showed that CPF causes developmental 
neurotoxicity through alternate mechanisms than those involved in cholinesterase 
inhibition. For example, when undifferentiated PC12 cells were treated with CPF at 
low level concentrations without causing detectable CHE inhibition, DNA synthesis 
suppression was observed (95). Other similar studies (96) also found potent inhibition 
of neurite outgrowth. These studies were unrelated to cholinesterase inhibition. 
Although many investigations have been undertaken to understand the 
noncholinergic mechanisms in the developmental neurotoxicity of CPF, the actual 
mechanisms remain elusive and complicated. To this day, no systematic studies at the 
subcellular, molecular levels have been undertaken to evaluate proteome changes in 
neuronal cell line cultures exposed to CPF at low concentrations. In order to study the 
toxcity caused by CPF in neuroblastoma cells, and as a result of the low levels of 
choline acetyltransferase, the SH-SY5Y was chosen as a model for this work. 
 
 
 
SH-SY5Y CELL LINE 
 
The neuroblastoma cell line SH-SY5Y (SK-N-SH-SY5Y), which was 
subcloned from human neuroblastoma SK-N-SH, is a nearly diploid dopaminergic 
neuronal cell line with high levels of dopamine β-hydroxylase (a key enzyme in 
adrenergic neurotransmitter synthesis). SK-N-SH was established in 1970 from the 
bone marrow biopsy of a 4-year-old girl with metastatic neuroblastoma, and consists of 
two cell types with the neuroblast phenotype being predominant. When SH-SY5Y cells 
are grown in 15% fetal calf serum, they have neuroblast-like properties in their 
undifferentiated state. Treatment with dibutyryl cyclic AMP or nerve growth factor 
(NGF) results in morphological and physiological differentiation (84). SH-SY5Y cell 
lines have low levels of choline acetyltransferase, which makes them a good candidate 
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for neurotoxicity studies. The SH-SY5Y cell line is a convenient resource for research 
on neuronal cell biology in vitro. 
 
TWO-DIMENSIONAL ELECTROPHORESIS WITH IMMOBILIZED PH 
GRADIENTS  
 
Two-dimensional gel electrophoresis (2D gel) was developed by O’Farrell in 
1975 (97). Proteins are separated based on their intrinsic charges (pI) by isoelectric 
focusing (IEF) in the first dimension and followed by molecular weight (MW) based 
separations with SDS-PAGE in the second dimension. 2D gels can resolve complex 
mixtures of proteins and simultaneously analyze hundreds or even thousands of 
proteins. After the introduction of immobilized pH gradients (IPG) for IEF, the 
reproducibility of 2D gel data greatly improved (11). The pH gradients of IPGs are 
prepared by a limited number (6-8) of well defined chemicals (the ‘immobilines’). 
These chemicals are co-polymerized with the acrylamide matrix, which enhances the 
reproducibility of 2D gels. Due to the high reproducibility and high loading capacity of 
IPG strips, 2D gel electrophoresis has become the core technology of proteome 
analysis in combination with either matrix-assisted laser desorption / ionization-time of 
flight - mass spectrometry (MALDI-TOF-MS) or electrospray mass spectrometry 
(ESI-MS). 
Prior to IEF, IPG dry strips are rehydrated with sample solution containing 8 M 
urea, 0.5–2% (non-ionic or zwitterionic) detergent, 0.2% dithiothreitol (DTT) and 
0.2% carrier ampholytes. The rehydrated strips are then placed onto the cooling plate of 
an electro-focusing chamber (Figure 2-1-1). A program, including desired rehydration 
time, voltage gradient, and temperature, is set for IEF running condition. After IEF, 
IPG strips are incubated with equilibration buffers containing dithiothreitol (DTT) for 
10 min in the first step. They continue to be equilibrated in the buffer containing 
iodoacetamide for 10 min in the second step. After equilibration, the IPG gel strip is 
placed on the top of a pre-cast polyacrylamide gel (PAGE) and overlaid with agarose 
solution. After termination of the second dimension run (SDS-PAGE), it is necessary 
to immobilize the resolved proteins in the gel with fixing solution. Twenty percent 
TCA, methanolic or ethanolic of acetic acid are extensively used as fixatives. Proteins 
can be visualized by several staining methods – silver staining, fluorescent staining, 
colloidal coommassie blue G-250, and Coommassie R-250 staining. Both fluorescent 
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staining (laboratory synthesized ruthenium reagents) and Colloidal Coommassie blue 
G-250 staining were used in this project, as both approaches afford high sensitivity and 
MS compatibility. Gel images were then captured with the VersaDoc Imaging system 
(Bio-Rad), and quantitatively analyzed by PDQuest software (Bio-Rad). All protein 
spots with a relative quantitative difference equal to or greater than a 2-fold change 
were excised and further analyzed by MALDI-TOF-MS, following tryptic in-gel 
digestion. Finally, these proteins were identified by database searching with the 
MASCOT algorithm.  
 
DATABASE SEARCH USING MASCOT ALGORITHM 
 
 Several algorithms have been used to identify proteins by searching an 
appropriate database using peptide mass-fingerprinting mass spectra or tandem mass 
spectrometry (MS/MS) data. Currently, MASCOT (98) and SEQUEST (15) algorithms 
for database searching are the most popular in proteomics. Only MASCOT was used in 
this dissertation, so a brief overview of this algorithm will be discussed. 
The scoring algorithm of MASCOT is based on probability with a number of 
additional advantages: i) it is simple to judge whether a result is significant or not, ii) 
different types of matching (peptide masses or MS/MS fragment ion masses) can easily 
be combined into a single search, iii) it is feasible to compare scores from different 
searches and different databases, iv) searching parameters can be readily optimized. 
 
MOWSE Score 
The MOWSE scoring algorithm was first described in 1993 by Pappin et al. 
(99). Based on this algorithm, experimental data are first compared with the calculated 
peptide masses for each protein in the sequence database. Each calculated value within 
a user-defined mass tolerance of an experimental value is taken as a match. Molecular 
weight, pI values, and sources for the intact protein can be used as pre-filters. 
A statistical weighting factor is empirically assigned to each individual peptide 
match instead of counting the number of matching peptides. All matching fragments 
contribute to the final score for every database entry scanned.  
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Figure 2-1-1. Photograph of a Bio-Rad isoelectric focusing chamber and focusing tray.
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A frequency factor matrix, F, is created. Each row in F represents an interval of 100 
Da in peptide molecular weight, and each column is an interval of 10 kDa in intact protein 
molecular weight. The cells therefore contain the number of times that a particular 
fragment molecular weight occurred in a protein. It is similar for each protein in the 
database. Each cell value is divided by the total number of peptides in each 10 kDa protein 
interval to obtain cell frequency values. These frequency values are further divided by the 
largest cell value for each 10 kDa column to get the MORSE factor matrix M.    
The matrix of weighting factors is described as follows: 
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The MOWSE search program is based on these distribution frequency values for 
each cleavage reagent. For each matching peptide, a score is assigned by looking up the 
appropriate normalized distribution frequency value. When there are several matching 
peptides in any one target protein, the total frequency value equals the product of the 
distribution frequency for each peptide. Consideration of the average protein molecular 
weight as 50 kDa, the final score for each entry is calculated as follows: 
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where Mprot is the molecular weight of the entry and jim ,∏  is the product of distribution 
factors for all the matching peptides between the experimental data and peptides calculated 
from the database. 
 
STATEMENT OF RESEARCH 
 
This part of the dissertation describes the first time systematic investigation of the 
CPF-induced toxicity at subcellular levels using SH-SY5Y as a model system. The 
hypothesis of this study is that changes in protein expression underlie neuronal anomalies 
associated with CPF exposure. After SH-SY5Y cell lines were treated with CPF, proteins 
from this cell line were collected and analyzed by 2DE-PAGE and MALDI-TOF-MS. 
Results clearly demonstrated that CPF has significant effects on cell process. 
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CHAPTER TWO 
 
CHLORPYRIFOS-INDUCED PROTEIN ALTERATIONS IN THE SH-SY5Y 
CELL LINE 
 
INTRODUCTION 
Most children in the US have been exposed to chlorpyrifos (CPF), an 
organophosphate pesticide. In recent years, there has been heightened concern about 
exposure of pregnant women, infants and children to CPF in view of its developmental 
neurotoxic effects. Despite recent curtailment of its domestic use in US (U.S. 
Environmental Protection Agency 2000), CPF remains one of the most widely used 
pesticides in the world. Unfortunately, to date, no systematic studies at the subcellular level 
have been undertaken to evaluate CPF-induced proteome changes in neurons. In this 
chapter, investigation of whole proteome alterations induced by CPF is described. CPF 
concentrations at levels below the threshold for symptoms of systemic toxicity were 
studied using the SH-SY5Y cell line as a model system. The combination of 
two-dimensional gel electrophoresis (2DE) with matrix-assisted laser 
desorption/ionization-time of flight- mass spectrometry (MALDI-TOF-MS) was applied to 
take a closer look at protein alterations induced by exposure to this pesticide. 
CPF is primarily recognized for its ability to induce physiological toxicity in 
humans and animals via acetylcholinesterase (AChE) inhibition. However, a variety of 
studies showed that CPF has additional effects besides cholinesterase inhibition. Levin et 
al. studied rats subjected to prenatal (90) and postnatal (94) exposure to CPF and evaluated 
their behavioral performance in adolescence and adulthood. The results showed that both 
prenatal and postnatal exposure to CPF induced long-term changes in cognitive 
performance. Other animal studies also confirmed that exposure of neonates to CPF 
subjected to higher risks than adults (71). The LD50 values of CPF for neonates are about 
an order of magnitude lower than that for adults. At the cellular level, S.J. Garcia et al. 
suggested that CPF had shifting targets, initially impairing neuronal development 
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(gestational days (GD) 17-20), and then influencing glia (postnatal days (PN 11-14). These 
findings were the result of examinations of neuroprotein markers (89) using biochemical 
techniques, such as western blot. 
 Studies both in vivo and in vitro confirm that CPF at sublethal levels can 
compromise cellular processes involved in brain development (100). However, the actual 
mechanism for CPF perturbation in neuronal development at the molecular level is 
complicated and remains unclear. All these studies show that CPF can influence neuronal 
development by targeting a diverse range of events including cell proliferation, migration, 
differentiation, neuritogenesis, synaptogenesis and synaptic function. Long-term 
irreversible consequences can happen by perturbing these processes (46). The perturbing 
processes are through adverse effects on the structure and function of the nervous system. 
Until now, no systematic studies at the molecular level have been undertaken to investigate 
these influences on neuronal development as initiated by CPF.  
In this chapter, a description of the first systematic study of CPF-induced adverse 
effect on cell process at the molecular level is provided. We hypothesized that changes in 
protein expression underlie neuronal anomalies associated with CPF exposure. The 
SH-SY5Y neuroblastoma cell line was used as a model system due to the low level of 
choline acetyltransferase (the enzyme responsible for acetylcholine biosynthesis). Through 
a combination of 2DE and MALDI-TOF-MS, the whole proteome in SH-SY5Y cells was 
examined to identify altered proteins resulting from CPF exposure. The reproducibility of 
2DE was also evaluated in this chapter. The differential proteins (which showed 2-fold 
change between the control and treated sample, based on the optical density measurement) 
were detected. Altered proteins were identified by comparing the experimental mass 
spectra with theoretical mass spectra from the insilico digestion of the protein database. 
The results clearly demonstrated that altered protein expressions induced by CPF exposure 
were linked to developmental damage observed in neuroblastoma cells.  
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EXPERIMENTAL 
 
Materials 
 Isoelectric pH gradient (IPG) strips (5 mm wide, 7 cm or 18 cm long, pH 3-10 
linear gradient), urea, Tris (electrophoresis grade), TEMED (electrophoresis purity 
reagent), acrylamide, heavy mineral oil, and a 2-D Starter kit were obtained from Bio-Rad 
(Hercules, CA). Dithiothreitol (DTT, electrophoresis grade), iodoacetamide 
(electrophoresis grade), ammonium bicarbonate, and SDS were all obtained from Sigma 
(St. Louis, MO). For protein staining of gels, fluorescent ruthenium reagents (lab 
synthesized); colloidal Coomassie Blue (J.T. Baker Chemical Co., Philipsburg, N.J.) were 
employed. Glacial acidic acid (ACS grade, EM Science, Gibbstown, N.J.), and methanol 
(HPLC grade, Fisher Scientific, Fair Lawn, NJ) were employed. For MALDI analysis of 
peptides, α-cyano-4-hydroxycinnamic acid (HCCA) matrix was purchased from Sigma (St. 
Louis, MO) and used without further purification. Trifluoroacetic acid employed in the 
extraction of peptides from de-stained gel spots was obtained from Fisher Scientific (Fair 
lawn, NJ). High-purity water (18.2 MΩ cm-1) was prepared using a water purification 
system (Nanopure II, Barnstead, Van Nuys, CA) and was employed for all protocols in this 
study. 
 
Cell Culture  
SY5Y neuroblastoma cells were grown to 75% confluence in 75 cm2 flasks in 
Dulbecco modified essential medium (Omon) supplemented with 55 mM glucose, 26 mM 
NaHCO3, 16 mM KCl, 1.36 mM pyruvic acid, 10 mg/mL gentamicin sulfate, and 10% 
clarified bovine serum (pH 7.2). Cells were incubated at 37ºC in 94% air/6% CO2. Cultures 
were split 1:3 every 2-3 days using 0.25% trypsin/0.03% EDTA. When cells reached 
confluence, they were switched to Locke’s medium containing 154 mM NaCl, 56 mM KCl, 
2.3 mM CaCl2, 1.0 mM MgCl2, 3.6 mM NaHCO3, 10 mM glucose, 5 mM HEPEs (pH 7.2) 
with 10 mg/l gentamicin sulfate. Control cells were treated with dimethylsulfoxide 
(DMSO) only and treated with CPF at 50 µM in 1% DMSO. 
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Cell Viability Assay 
Cell were plated in 96 well culture plates and treated with CPF. After treatment, 
cell viability was assayed by the addition of 10 μl of 1 mg/ml 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)/well (100 µl Locke 
medium) and incubated for the last hour of treatment. After removal of the media, the 
formazan crystals produced from MTT by mitochondrial enzymes in active cells were 
dissolved in 100 μl DMSO. Formazan absorbance was measured at 620 nm using a 
multi-well plate reader. The mean value of 8 parallel experiments for cell viability was 
used. Raw data were converted to the relative percentage of control absorbance, and 
expressed as the mean ± SEM % control absorbance.  
 
Preparation of Cell Lysate for 2DE-PAGE 
After the culture was switched to Locke’s medium, treatment was initiated with 50 
µM CPF in 1% DMSO for 16 h or 24 h. After treatment, cultures were washed with 
phosphate buffered saline (PBS) pH 7.4, and cells were scraped into 3 ml PBS and pelleted 
by centrifugation at 800 x g for 10 min. The pellet was re-suspended in 200 μL 
distilled/deionized water and homogenized using a micro-Dounce homogenizer. Protein 
content of this cell lysate was determined using a Pierce BCA kit. 
 
Protein Sample Preparation 
Following sonication for 20 minutes, 350 µg aliquots of protein lysate were 
evaporated to dryness and subjected to 2D gel electrophoresis. The protein was then 
solubilized in rehydration buffer (8 M urea, 2 % CHAPS, 50 mM dithiothreitol (DTT), 
0.2% (w/v) Bio-lyte 3/10 ampholytes and a trace of Bromophenol Blue). The protein 
solution was ready for Isoelectric focusing experiments. 
2D Gel Electrophoresis Validation 
In order to evaluate 2DE reproducibility, four proteins were used in this study. The 
used proteins were bovine serum albumin (BSA), ovalbumin (Ova), carbonic anhydrase 
(CA), and soybean trypsin inhibitor (STI). Each protein (0.1 μg) was mixed, and then 
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solubilized in sample preparation buffer containing 0.5 M Tris-HCl pH 6.8, glycerol, SDS 
and 0.1% bromophenol blue. The resulting solution was loaded onto strips (5 mm wide, 7 
cm long, pH 3-10 linear gradient). A second experimental set was designed for the 
evaluation of 2DE reproducibility, in which 0.1 μg of Ova, CA and STI, and 0.2 μg BSA 
were mixed. As described above, three parallel experiments were performed for statistical 
analysis. The optical density (OD) of each spot was normalized based on the percentage of 
the total valid spots on the 2D gel using PDQuest software. 
 
2D Gel Electrophoresis 
An aliquot of 350 μg of protein lysate from SY5Y cells was dissolved in 350 μl 
rehydration buffer. The solution was then added to an IPG strip (5 mm wide, 18 cm long, 
pH 3-10 linear gradient) (Bio-Rad). Following rehydration for 24 h, strips were subjected 
to isoelectric focusing (IEF) at 20ºC. Table 2-2-1 lists the gradient program used for the 
experiment. Total focusing time was 23 h. After IEF was complete, strips were removed 
from the Protean IEF (Bio-Rad) cell. They were then equilibrated with 6 ml buffer A (6 M 
Urea, 2% SDS, 0.375 M Tris-HCl pH 8.8, 20% glycerol) containing an additional 0.12 mg 
DTT for 15 minutes in the first step. Subsequently, strips were incubated with buffer A 
containing 0.15 mg iodoacetamide for 15 minutes in the second step. Strips were removed 
from equilibration solution and placed on the top of pre-cast SDS gel (1 mm thick, 20 cm x 
20 cm and 8%-16% linaer acrylamide gradient). The strips were sealed into position with 
0.5% low melting point agarose in 25 mM Tris, 192 mM glycine, 0.1% SDS, and a trace of 
bromophenol blue. Gels were run at a constant current 16 mA/ gel for 30 min, then 24 mA/ 
gel until the blue dye front line reached the bottom of the gel. 
SDS gels were fixed in 30% EtOH/10% acetic acid overnight, then washed with 
20% EtOH four times over 2 h. Gels were finally stained with lab-synthesized fluorescent 
ruthenium reagent (50 µl in 250 ml 20% EtOH) overnight. Gels were scanned using 
VersaDoc Imaging system (Bio-Rad) and 2D gel images were analyzed with PDQuest 
software (Bio-Rad).  
In-Gel Digestion  
Protein spots of interest were excised manually from the gel, and then placed into 
micro well plates. A Proteineer dP robot (Bruker) was used for the in-gel digestion. The 
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Table 2-2-1. Gradient program of IEF. 
 
 Voltage (V) Time (h) 
Step 1 300 5 
Step 2 1000 1 
Step 3 2500 1 
Step 4 5000 16 
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digestion program was set up as follows: i) gel pieces were washed with 50 mM NH4HCO3 
followed by washes with 25 mM NH4HCO3 in 50% acetonitrile for three cycles (10 min/ 
cycle), then gel pieces were dried with acetonitrile for 5 min; ii) trypsin solution (10 µl, 6.7 
μg/ ml) was added to each well and incubated with the gel pieces for 30 min at 20 ºC and  
for 4 h at 50 ºC; iv) the supernatant containing peptides was recoved for MS analysis. 
 
 
Mass spectrometry 
 A drying thin layer strategy was used to spot an affinity Anchorchip with a matrix 
solution of 10 mg/ml α-cyano-4-hydroxycinnamic acid in 0.2% TFA/acetone (1:9 by 
volume). Tryptic digests (4 µl) were loaded onto each matrix spot and allowed to desorb on 
the target for 10 min. The residue of sample solution was removed from the target followed 
by washing the spot with 0.1% TFA. An Autoflex MALDI-TOF mass spectrometer 
(Bruker) was used to obtain mass spectra. Analysis in the reflectron mode was 
accomplished with 19 kV accelerating potential and a lens voltage of 20 kV. Each 
spectrum was obtained from an average 300 laser shots. A standard peptide mixture 
consisting of angiotensin II and vasopressin was used to provide an external mass 
calibration. A trypsin autoproteolysis product m/z 842.5 was used for an internal mass 
calibration.  
 
 
Database search 
Proteins were identified by searching the National Center for Biotechnology 
Information (NCBI) database or Sprot using the MASCOT algorithm. The search 
parameters allowed for the oxidation of methionine. Mass accuracy at 150 ppm was used 
for the database search. Peptides were excluded if their masses corresponded to those for 
porcine trypsin, human keratins or other irrelevant proteins.  
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RESULTS 
 
Cell Viability 
Cell viability was investigated for CPF at a series of concentrations: 10, 25, 50, 100, 
250, 500 and 1000 µM (Figure 2-2-1). These concentrations were investigated to find a 
suitable exposure level for the study of CPF-induced toxicity in SH-SY5Y cells. Results 
were calculated for each treated sample as the percentages of control sample based on the 
measurement of formzan absorbance (related to cell viability). Cell viability (as a 
percentage of control cells) was expressed as the mean ± SEM % from eight parallel 
experiments. Statistical analysis was carried out using ANOVA with Dunnett’s post hoc 
test for the cell viability of individual samples using commercially available ABSTAT 
software. The outcome from these statistical analysis showed that concentrations of CPF 
greater than 250 µM caused a significant (p < 0.05) decrease in cell viability. No 
significant change was observed in cell viability when the CPF incubation concentration 
was between 10 to 100 µM. CPF at 50 µM was chosen, because no systematic toxicity 
would happen at this concentration. 
 
 
Evaluation of 2D Gel Reproducibility 
BSA, Ova, CA and STI were used to evaluate 2D gel reproducibility. In the first set 
of experiments, 0.1 µg of each protein was used to do small format 2D gel experiments. All 
the OD values of the spots were normalized based on the percentage of the total valid spots 
on the 2D gel analyzed with PDQuest software. Table 2-2-2 lists the experimental values of 
proteins along with expected percentages. The relative standard errors for BSA, Ova, CA, 
and STI were 3.5 %, 3.0 %, 0.9 %, and 4.2 %, respectively. For the second set of 
experiments, 0.1 µg of Ova, CA and STI, along with 0.2 µg of BSA were used in small 
format 2 D gel analyses. Table 2-2-3 lists the experimental ratios of proteins along with 
expected values for the second experimental set. The relative errors for BSA, Ova, CA, and 
STI were 3.09, 1.17, 3.97, and 6.65%, respectively.  
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All the relative errors were within 10%. The results clearly showed that 2D gel is a 
reliable method for protein quantification and therefore well suited for the investigations 
present here.  
 
 
Proteome Analysis of SH-SY5Y Cells 
In this study, approximately 350 μg of total protein was loaded for each gel. 
Proteins were separated on an isoelectric focusing strip (18 cm long, pH 3-10 from left to 
right) in the first dimension, and resolved by linear gradient (8-16%) SDS-PAGE in the 
second dimension. The gels with separated proteins were stained with a lab-synthesized 
fluorescent ruthenium reagent. A typical set of 2D SDS gels for the treated (50 μM CPF for 
24 h) and control sample is shown in Figure 2-2-2. Three independent assays are 
represented. Figure 2-2-2 illustrates a typical example of a gel image region containing 
up-regulated proteins in treated sample. The normalized optical densities of spots 1, 2 and 
3 were plotted in Figure 2-2-2 C. 
Table 2-2-4, and Table 2-2-5 present an overview of the CPF-induced down-, and 
up-regulated proteins that could be identified in one or more of the three experiments 
(Figure 2-2-3 refers to experiment set 2) using MS. Both tables list the National Center for 
Biotechnology Information (NCBI) accession numbers, the positions on the gels of Figure 
2-2-3, and the calculated molecular masses of the identified proteins. Figure 2-2-3 
identifies the spots corresponding to the identified proteins in experiment set 2 on the 2D 
gels of the sample from control and treated SY5Y cells. A total of 37 unique proteins from 
56 spots were identified, out of which 16 proteins from 26 ± 4 spots were down-regulated, 
and 21 proteins from 30 ± 3 spots were up-regulated (mean ± SD for three experiments). 
Spot count differences between experiments likely arise due to inter-individual differences 
in the protein spot patterns. Altered proteins were categorized as chaperone proteins, 
cytoskeletal proteins, enzymes, redox enzymes etc.  
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Table 2-2-2. Experimental and theoretical ratios of proteins with relative standard errors 
for the first experimental set. 
 
Protein Exp. #1 Exp. #2 Exp. #3 
Avg.  
( x ± s) Expected 
Relative 
error (%) 
BSA 0.91 0.95 1.04 0.97±0.06 1.00 3.00 
Ova 1.07 1.01 0.84 0.97±0.12 1.00 3.00 
CA 0.93 0.99 1.05 0.99±0.06 1.00 1.00 
STI 0.97 0.92 1.24 1.04±0.17 1.00 4.00 
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Table 2-2-3. Experimental and theoretical ratios and their relative standard error for the 
second experimental set.   
 
Protein Exp. #1 Exp. #2 Exp. #3 
Avg.  
( x ± s) 
Expected 
Value. 
Relative 
error (%) 
BSA 1.78 1.72 1.80 1.77±0.04 1.71 3.09 
Ova 0.87 0.85 0.82 0.85±0.03 0.86 1.17 
CA 0.85 0.84 0.78 0.82±0.04 0.86 3.97 
STI 0.81 0.79 0.80 0.80±0.01 0.86 6.65 
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Figure 2-2-1. Viability of SH-SY5Y cells exposed to vehicle alone (control), 10, 25, 50, 
100, 250, 500, and 1000 µM chlorpyrifos (CPF) for 24 h. Concentrations greater than 250 
µM caused a statistically significant (p < 0.05) decrease in cell viability. 
 
 
 
 
 
 
 
1: Control 
2: 10 µM CPF 
3: 25 µM CPF 
4: 50 µM CPF 
5: 100 µM CPF 
6: 250 µM CPF 
7: 500 µM CPF 
8: 1000 µM CPF 
*P < 0.05 
*
* * 
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 Figure 2-2-2. A typical example of gel image regions contain up-regulated proteins in the 
sample from the SY5Y cells treated with 50 μM CPF for 24 h. Gel images for the control 
sample (A), and for the sample treated with 50 μM CPF for 24 h (B). The experiment 
shown is representative of three trials. 
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        Figure 2-2-2. The normalized optical densities of spots 1, 2, and 3.  
 
 
 
 
 
 
 
 
 
C 
 159
 
Table 2-2-4. Summary of down-regulated proteins in SH-SY5Y cells treated with 50 µM 
CPF for 24 h compared with control samples. 
 
 
 
 
 
Protein 
NCBI 
Accession no. Spot no. 
Molecular 
mass (KDa) 
Morwse 
Score 
Coverage 
(%) 
Chaperone Proteins 
HSP90-alpha 172222 1, 2 80 118 22 
HSP70 5729877 4,17 70 279 38 
HSP27 662841 26 22 121 14 
Enzymes 
ATP synthase, H+ transporting 32189394 6 56 96 30 
Enolase1, alpha 4503571 15 47 117 32 
Thioredoxin peroxidase B, chain A 9955007 9 21 61 14 
Glyceraldehyde-3-phosphate 
dehydrogenase 31645 3 36 54 12 
Mitochondrial short-chain 
enoyl-coenzyme A hydratase 1 433413 12 31 97 19 
Cytoskeletal Proteins 
Actin, beta 15277503 23, 7,14 40 104 22 
Ubiquilin 24659706 5 62 96 30 
Tubulin 14389309 8,16,21 49 103 29 
Vimentin 2119204 13,24 54 147 28 
Other Proteins 
Histone family 4504259 18,19,20,22 14 75 30 
Heterogeneous nuclear 
ribonucleoprotein C isoform b 4758544 10 32 62 14 
CGI-150 protein 16198390 11 33 73 14 
R33729-1 3513302 25 16 57 24 
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Table 2-2-5. Summary of the up-regulated proteins in SH-SY5Y cells treated with 50 µM 
CPF for 24 h compared with control samples. 
 
Protein 
NCBI 
Accession no. 
Molecular 
mass (KDa) Spot no. 
Morwse 
Score 
Coverage 
(%) 
Chaperone Proteins 
HSP90 72222 83 2,3,4 190 40 
HSP gp96 precursor 15010550 90 12,15 168 29 
HSP70 16507237 72 16 100 19 
BIP protein 6470150 71 17 170 30 
HSP70 protein isoform 1 5729877 71 18,22 85 10 
T complex protein 1 135538 60 9 91 18 
Chaperonin containing TCP 1 5453603 57 10 77 18 
TATA binding protein interacting protein 
49Kda 4506753 50 27 112 13 
Enzymes 
Propyl 4-hydroxylase 20070125 57 23 56 6 
Glucose-6-phosphate dehydrogenase 26224790 55 20 88 10 
Protein disulfide isomerase- related 1710248 46 11 62 14 
Enolase 1 4503571 47 21 218 36 
Regulatory domain of human PP2a 4558258 65 24 84 15 
Cytoskeletal Proteins 
Tubulin, beta 2119276 49 19 96 24 
Vimentin 2119204 53 13,14 248 44 
Profilin 1 4826898 15 7, 5 83 15 
Coffilin 1 5031635 18 25 70 22 
Similar to tubulin , 
beta 5 12804891 38 26 103 17 
Other Proteins 
Neuro-endocrine specific protein VGF 17136078 67 1 65 11 
GDP dissociation inhibitor 1 4503971 51 6 104 32 
Human mitochondrial single-stranded 
DNA binding protein 148790 15 8 59 11 
H2B histone family 4504259 14 28 92 41 
Eukaryotic translation initiation factor 3 
(fragment) 23503064 36 29 130 33 
Annexin V 999926 36 30 101 17 
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Figure 2-2-3. (A) 2D sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) of 350 μg total protein from the control SH-SY5Y cells. Proteins were 
separated on an isoelectric focusing strip (pH 3-10 from left to right) in the first dimension 
and by linear gradient (8-16%) SDS-PAGE in the second dimension. A lab-synthesized 
fluorescent ruthenium reagent was used to stain. The down-regulated proteins (Table 2-2-4 
and Table 2-2-6) are labeled on the control (A) gels. 
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Figure 2-2-3. (B) 2D sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) of 350 μg total protein from the SH-SY5Y cells treated with 50 μM CPF. 
Proteins were separated on an isoelectric focusing strip (pH 3-10 from left to right) in the 
first dimension and by linear gradient (8-16%) SDS-PAGE in the second dimension. A 
lab-synthesized fluorescent ruthenium reagent was used to stain. The up-regulated proteins 
(Table 2-2-5 and Table 2-2-7) are labeled on the treated sample gel. 
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Among the altered proteins, some correspond to different isoforms of the same 
protein. Such isoforms aligned as a horizontal row of several spots on the 2D gel, with 
different pI values and the same molecular weight, and likely resulted from 
posttranslational modifications. In particular, HSP 90 was identified in 3 spots (Figure 
2-2-1) as an up-regulated protein. A similar pattern was observed for enolase with the spots 
numbered as 15 in Figure 2-2-3 A and 21 in Figure 2-2-3 B. From amino acid composition 
of the enolase, the expected pI is 7.01, however the actual pIs for these two isoforms are 
about 5.8 and 6.6. The isoform at spot 15 in Figure 2-2-3 A (pI 5.8) was detected as 
down-regulated a protein, but the other isoform at spot 21 in Figure 2-2-3 B (pI 6.6) was 
detected as an up-regulated protein. A similar situation was also observed for other proteins 
like heat shock proteins, actin proteins, and tubulin proteins.  
 
Proteome analysis of SH-SY5Y cells treated with 50 µM CPF for 16h  
The previous discussion explored proteome alterations of SH-SY5Y cells after 
treatment with 50 μM CPF for 24 h. At this stage, we were curious to find out what 
proteome changes would occur after exposure to CPF for a shorter period of time. In order 
to study time-dependent proteome changes of SH-SY5Y cells caused by CPF, a separate 
proteome analysis was undertaken following exposure to 50 μM CPF for 16 h. The 
resolved protein spots on gels, which showed a 2-fold change in concentration between 
control and treated sample based on OD density measurement, were digested by trypsin. 
The tryptic digests were further analyzed by MALDI-TOF-MS. The proteins were then 
identified by searching the Sprot database using the MASCOT algorithm. 
Table 2-2-6 and Table 2-2-7 present an overview of the additional down- and 
up-regulated proteins and proteins with changing trends induced by 50 μM CPF for 16 h 
compared with an incubation time of 24 h. A total of 48 unique proteins from 68 spots, 
which includes the same 37 identified unique proteins as those from the samples treated for 
24 h, were identified. Out of the altered proteins, 23 were down-regulated and 25 were 
up-regulated after incubation with 50 μM CPF for 16 h. These proteins were identified by 
three trials using mass spectrometry. Figure 2-2-3 displays all of the spots (including the 
additional proteins identified from the samples treated with 16 h,) corresponding to the 
identified proteins on the 2D gels of the sample from the control (Figure 2-2-3 A) and the 
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treated SH-SY5Y samples (Figure 2-2-3 B). These identified proteins can be classified as 
chaperone proteins, cytoskeletal proteins, enzymes and other proteins. 
 
DISCUSSION 
Cell Viability 
MTT assay based on the measurement of the reduced product from MTT was 
applied to examine cell viability for the cytotoxicity assessment caused by CPF. During 
investigation, cell viability was observed as high as 140% for the cells treated with 25 µM 
CPF compared with control cells (Figure 2-2-1). A possible explanation for the high MTT 
assay value is that CPF promoted enhanced mitochondrial activity producing more 
formazan from MTT. Since enhanced mitochondrial activity induced by CPF can cause an 
increase in the abundance of reactive oxygen species in cells, cellular oxidative stress may 
be a consequence of CPF exposure.  The increase of the measured cell viability indicated 
the increase of oxygen radicals, which is consistent with the result of Crumpton et al. (111) 
who showed that increased reactive oxygen species are associated with CPF in PC12 cells. 
 
Evaluation of 2D Gel Electrophoresis Reproducibility 
2D gel electrophoresis is an extremely powerful tool for the analysis of complex 
protein mixtures. The utility of this technique lies in its enormous resolving power, which 
allows for the separation of approximately 2,000 proteins in a single electrophoretic run. 
This technique is powerful for detecting small changes in the levels or properties of 
proteins in response to changes in cellular conditions. However, several factors can 
influence the quantification feature of 2D gel electrophoresis, such as solubilization of 
proteins, rehydration condition of IPG strips, staining, and how PDQuest is used to analyze 
gel images. The reproducibility of 2D gels can be improved by keeping the practical 
parameters constant or running all samples at the same time. Even so, there is still another 
question about the quantification property of this technique. Does the OD value really 
reflect the real amount of protein in mixtures? The hypothesis of the quantification by 2D 
gel electrophoresis is that the same percentage of protein in the sample should have the 
same normalized optical density (OD) on the 2D gel using PDQuest software. 
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Table 2-2-6. Summary of the additional down-regulated proteins following treatment of 
SH-SY5Y cells with 50 µM CPF for 16 h compared with control samples 
Protein Accession #(Sprot) 
Molecular 
mass (KDa) 
Spot 
# 
Score Cov(%) 
Chapterone proteins 
Stress-induced-phosphoprotein 1 P31948 63 26, 27 146 26 
Enzymes 
Ubiquitin carboxyl-terminal hydrolase 
isozyme L1 P09936 25 28 59 30 
Cytoskeletal Protein 
Stathmin P16949 17 29 120 53 
Lamin B2 Q03252 63 30 68 7 
Other Proteins 
Elongation factor 1-beta P24534 25 31 58 13 
GTP-binding protein GEM P55040 34 32 90 16 
Rho GDP-dissociation inhibitor 1 P52565 23 33 104 50 
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Table 2-2-7. Summary of the additional up-regulated proteins following treatment of 
SH-SY5Y cells with 50 µM CPF for 16 h compared with control samples. 
Protein 
Accession 
#(Sprot) 
Molecular 
mass (KDa) 
Spot 
# 
Score Cov(%) 
Enzymes 
ATP synthase chain, mitochondrial 
precursor P06576 57 31 77 18 
Carbonic anhydrase-related protein 10 Q9NS85 38 32 53 10 
Cytoskeletal Proteins 
Stathmin 3 (SCG10-like protein) Q9NZ72 21 34 68 17 
Other Proteins 
RAS-related protein Rab-25 P57735 23 33 58 14 
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The reproducibility of 2D gel electrophoresis was investigated using four proteins 
as standards in this chapter. Two sets of experiments were performed. Results showed that 
the experimental data were consistent with the expected data (Table 2-2-2 and 2-2-3), 
which indicated that 2D-PAGE was a reliable technique for protein quantification.  
Evaluation of Protein Identification with Combination of 2DE and MALDI  
Protein identifications were also investigated using proteins, BSA, Ova, CA and 
STI, as standards in this chapter.  In the validation experiments, 0.1 µg of each protein was 
used to do small format 2D gel experiments and three replicate experiments were 
performed.  Proteins were identified by comparing the experimental MALDI mass spectra 
of the tryptic digests with those from ‘in silico digestion’.  Results clearly demonstrated the 
identies of proteins with significant match. The highest MOWSE scores (n=3) for BSA 
Ova, CA and STI were 1280, 1050, 980 and 550, respectively.   
Proteome Analysis of SH-SY5Y Cells Exposed to 50 µM CPF for 24h 
Previous studies of the effects of CPF on neuron development have focused on 
specific protein alterations, especially Ca2+/cAMP response element binding protein 
(CREB) and adenylyl cyclase (95, 96) using Western-blot and activity assays. There have 
been no simultaneous, quantitative proteomic studies of changes in protein expression 
from SH-SY5Y cell cultures treated with CPF at low exposure levels. 
This is the first study to investigate proteome analysis of SH-SY5Y cells treated 
with 50 μM CPF for 24 h. A total of 37 unique, altered proteins were identified in three 
parallel experiments. These proteins can be classified as chaperone proteins, cytoskeletal 
proteins, enzymes and other proteins based on their functions. Characterization of proteins 
identified in these experiments showed that they were from diverse pathways, including 
ATP energy production, neuritogenesis, protein synthesis, DNA transcription, cell 
signaling cascades, and antioxidant defense systems.  
 
ATP Energy Production 
ATP synthase was detected as a down-regulated protein in CPF-treated samples. 
This protein plays important roles in the synthesis of ATP from ADP and Pi in the presence 
of a proton gradient across the membrane. The detected ATP synthase is responsible for 
proton transportation into the matrix to form ATP. We also observed that one isoform of 
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enolase 1 (spot 15 in Figure 2-3-3 A) and glyceraldehyde-3-phosphate dehydrogenase 
were down-regulated. Meanwhile, another isoform of enolase 1 (spot 21 in Figure 2-2-3 B) 
was up-regulated in CPF-treated neurons. Enolase is important for the ninth step in 
glycolysis, and glyceraldehydes-3-phosphate dehydrogenase is responsible for the sixth 
step. Because our study quantified different isoforms of the protein on 2D gels, it was a 
challenge to determine the total change of enolase represented by different isoforms. 
Down-regulation of proteins associated with ATP production suggests that ATP levels 
decreased following exposure to CPF at subcytotoxic doses. These results were consistent 
with those of Song et al.(95), who showed that adenylyl cyclase, which catalyzes the 
formation of cyclic AMP from ATP, decreased after exposed to CPF at low levels.  
 
Neuritogenesis  
Actin is the most abundant cytoskeletal protein in the neuronal proteome. The state 
of actin polymerization determines the status of cytoskeleton, neurite (baby axon) and 
growth cone mobility (101), as well as neurite maintenance and extension. Actin 
polymerization can make axons extend within the growth cone, a highly dynamic structure 
at the tip of the axon. In this study, several isoforms of actin (spots marked as 7, 14, 23 in 
Figure 2-2-3 A and Table 2-2-4) were detected as down-regulated proteins induced by CPF. 
Changes in actin reported here indicate changes in actin polymerization, which is very 
important in neuritogenesis and the spiny outgrowths on dendrites. Dendritic spines are 
known to change shape, to the extension of appearing and disappearing entirely.  It has 
long been hypothesized that such changes may be the basis of memory itself (102) (103). 
Actin is thought to mediate these changes in dendritic spine shape (104). Therefore, actin 
changes can eventually lead to long term irreversible learning damage. 
Several detected altered proteins play important roles in the regulation of actin 
polymerization. Rho GDI, which is a small G protein and regulates the reorganization of 
the actin cytoskeleton, was detected as up-regulated in CPF-treated samples. The role of 
Rho GDI in pathways is displayed in Figure 2-2-4. The up-regulation of Rho GDI suggests 
decrease in actin levels and indeed three isoforms of which were detected as 
down-regulated. Cofilin, which is critical in the control of polymerization/ 
depolymerzation of actin, increased in the CPF-treated cultures. Levels of annexin V, 
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which was reported as a γ-actin binding protein and influences actin polymerization in 
neuritogenesis (75), were also increased. The elevation of annexin V observed here may be 
a compensatory response of cells to increase levels of functional protein necessary for the 
maintenance of actin levels. Profilin another actin-binding protein, which regulates actin 
polymerization, was detected as an up-regulated protein in CPF-treated neurons. The 
addition of profilin usually inhibits the assembly of actin filaments, thereby resulting in the 
decrease of actin. Results suggest that the neuritogenesis may be damaged due to decreased 
actin. 
Actin is not the only important protein in neuritogenesis; vimentin and tubulin also 
play important roles. Three main cytoskeletal systems (including microtubules, 
intermediate filaments, and microfilaments composed of tubulin, vimentin and actin) 
regulate the growth of neurites (axons and dentrites) and their subsequent maintenance, 
stability and functionality. These cytoskeletal proteins are important in generating and 
maintaining the morphology of differentiating neurons, motility and leading the pathway 
of growth cones as well as helping to transport cytoplasmic constituentes (105). Although 
these skeletal proteins share some common functions, they also have some unique 
functions as described in the next several paragraphs.  
The expressions of three isoforms of vimentin (Vm) were altered after exposure to 
CPF. Vm at spots 13 and 24 in Figure 2-2-3 A were detected as down-regulated; however, 
Vm at spots 13 and 14 in Figure 2-2-3 B were up-regulated. Vm from the native source has 
several isoforms due to differential phosphorylations (106).  These identified Vm isoforms 
suggested that the cross-linked infrastructure of an axon may be altered by CPF, resulting 
in neuritogenesis alteration. The reason is that vimentin is an intermediate filament species 
which is gradually replaced by neurofilaments during the development of axonal stability 
(23). In addition, vimentin plays an important role in neurite initiation in the neuroblastoma 
and hippocampal neurons in culture (22).  
Tubulins were identified as altered proteins in this study with many different 
isoforms resulting from posttranslational modifications. Three posttranslational 
modifications of α-tubulin are described in the literature (106), and β-tubulin has 
significantly more complicated and undetermined modifications (106). Here, tubulin at 
spots 8, 16, and 21 in Figure 2-2-3 A was detected as down-regulated proteins, but tubulin 
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at spots 19 and 26 in Figure 2-2-3 B was up-regulated. Since all the isoforms of tubulin are 
structural units for microtubules, the different developing trends of tubulin isoforms must 
result in different adverse consequence based on their specific functions in neurons. Thus, 
the changes in tubulin expressions induced by CPF exposure indicated that the 
developmental neuritogenesis would be damaged. 
All the above information suggested that neuritogenesis in neuron cells was 
impaired after treated with 50 µM CPF for 24 h. During brain development, neurite grows 
toward other regions of the nerve system or other organisms such as muscle to form 
connections. Since the proper functioning like memory/learning of the nervous system 
depends on the proper formation of proper connections, any disturbance on the 
neurogenesis could cause dysfunction of neurons.  
Protein Synthesis 
Studies (107) (108) in a variety of species have shown that the consolidation of 
newly acquired memories into stable long-term memories depends on the synthesis of new 
proteins and gene transcription in neurons. One can say that the influence of protein 
synthesis parthway in neurons could cause memory/learning damage. Eukaryotic 
translation initiation factor 3 (eIf) was been detected as an up-regulated protein in 
CPF-treated samples. Translation initiation factors associated with ribosomes are required 
for the initiation phase of protein synthesis. The observation of the increased levels of eIF, 
which is involved in the synthetic pathway of other proteins, suggests a compensatory 
increase by cells exposed to CPF to maintain protein levels. These results are consistent 
with previous studies, which showed that CPF significantly reduced protein synthesis (95). 
Heterogeneous nuclear ribonucleoprotein C, which modulates translation of c-myc mRNA 
(61), was detected as a down-regulated protein in CPF-treated cultures. The decrease of 
this protein suggests the responding decrease of the translation of mRNA, thus the decrease 
of protein synthesis. 
 
DNA Transcription 
Because histones bind DNA to form nucleosomes, histone proteins regulate the 
chromatin structure and function related to transcriptional activity and other nuclear 
functions (109). The posttranslational modifications of the histones are very important for 
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the regulation of transcription and chromatin condensation. The detected histone proteins 
showed a similar pattern as a row of spots, some of which (spots at 18, 19, 20, 22 in Figure 
2-2-3 A) were identified as down-regulated, some of which (spot at 28 in Figure 2-2-3 B) 
were up-regulated in cells treated with 50 µM CPF for 24 h. This phenomenon implies that 
the changed modifications of the histones may result in transcriptional changes, which may 
induce memory damage. As known, long-term memory requires new gene expression or 
gene transcription, which involves the formation of new synaptic connections.  
 
Proteome Analysis of SH-SY5Y Cells Exposed to 50 µM CPF for 16 h 
In the proteome analysis of SH-SY5Y cells from experiments treated with vehicle 
alone (control) or 50 μM CPF for 16 h, 48 unique altered proteins were identified. 
Comparing these identified proteins with those from the samples incubated with CPF for 
24 h, 37 unique proteins were observed to be identical. However, 11 additional unique 
proteins were identified from the samples with incubation time of 16 h. Most of the 
identified common proteins demonstrated the same trend including glyceraldehyde 
3-phosphate dehydrogenase (G-3-PD), which was detected as down-regulated in both 16 h 
and 24 h samples. However, some protein isoforms were detected as down-regulated in this 
work, but up-regulated in a former work, such as Rho GDP-dissociation inhibitor (Rho 
GDI). Proteins identified in these experiments, which play an important role in diverse 
pathways including ATP energy production, DNA synthesis, cell signaling cascades, 
axonogenesis and oxidative stress, showed different response trends with time-dependent 
incubation with CPF. Here, only altered proteins with different trends and the newly 
identified proteins will be discussed. 
One isoform of ATP synthase was detected as an up-regulated protein after 
incubation with CPF for 16 h. However, a down-regulation of the enzyme was observed in 
the sample treated with CPF for 24 h. As described before, ATP synthase regulates the 
synthesis of ATP in mitochondria. Elevation of this protein suggests a compensatory 
response of CPF-treated cells for a short time period (16 h) to try to maintain ATP levels. 
However, after incubation for longer time (24 h), cells responded to this stimulation by 
showing the depletion of ATP synthase, which agrees with that of Braber et al. (112) who 
showed that CPF inhibited Ca-stimulated ATP synthase activity.  
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One isoform of Rho GDI was detected as a down-regulated protein in cells treated 
with CPF for 16 h and another isoform was up-regulated in samples treated for 24 h. This 
protein functions as an inhibitor of the dissociation of GDP from Rho proteins and then 
inhibits their GDP/GTP exchange reaction, which regulates the formation of cAMP from 
ATP. Down-regulated Rho GDI suggests increased cAMP production from ATP, resulting 
in low levels of ATP. This is consistent with the other proteins associated with ATP 
production, such as ATP synthase. The elevation of Rho GDI at 24 h suggests that longer 
incubation provides enough time for SY5Ys to adjust to the low levels of ATP in the 
system. Furthermore, Rho GDI is important in the mediation of cytoskeletal organization. 
GTP-binding protein GEM, another G-protein, was detected as down-regulated protein in 
the cells after incubation for 16 h with CPF. The GEM protein interfaces with the Rho 
pathway and eventually leads to alterations in cellular neurite growth (113). The decrease 
in GEM suggests a compensatory response of cells to increase the levels of actin, which 
was detected as down-regulated in this study.  
Eukaryotic elongation factor 1-beta (elf), which plays a critical role in the 
elongation phase of protein synthesis, was detected as a down-regulated protein in cells 
after incubation with CPF for 16 h. The decrease of this protein suggests a decrease of 
protein synthesis, which is consistent with previous studies that CPF significantly reduces 
protein synthesis (95). 
Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1), a neuronal 
de-ubiquitinating enzyme whose mutation has been linked to an early-onset familial 
Parkinson's disease (PD), was detected as a down-regulated protein. This result is 
consistent with the findings of Choi et al (114), who reported that UCH-L1 was 
down-regulated in idiopathic PD as well as in Alzheimer's disease (AD) brains. The 
down-regulated UCH-L1 suggests a direct link between damage to neurons and 
neurodegenerative diseases. 
Actions of these altered proteins caused by CPF are summarized in Figure 2-2-4. 
These detected proteins play important roles in energy production, protein synthesis, DNA 
transcription, antioxidant defense system, and cell signaling cascades, all of which interact 
with each other through energy transfer or signal transductions. In brief, cells must be 
ready to respond to essential signals in their environment. Signaling molecules are often  
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Figure 2-2-4. Summary for the modes of action of CPF-induced altered proteins in the 
energy production cycle, antioxidant defense systems and cell signaling cascades.  
 
 
 
 
GTP GDP
ATP cAMP
Rho GDI Actin filament
  Glycolysis 
Signal (?) 
Glucose-6-phosphate 
NADP+ NADPH 
Protein kinase
Cellular response
------- 
Neuritogenesis 
Vimentin
Tubulin
Oxidative       
Stress        
Signal (?) ------- 
 174
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2-5. Distribution of the identified proteins including the down- and up-regulated 
proteins according to their functions. 
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1. Cell signal cascade: 7.1%  
2. Antioxidant defense system: 5.3% 
3. Protein systhesis: 3.6% 
4. DNA transcription: 10.7 % 
5. Neuritogenesis: 30.4%  
6. ATP production: 8.9%  
7. Chaperone: 30.4%  
8. other/unknown proteins: 3.6% 
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chemicals such as hormones, cytokines, or CPF in this study. Some signal proteins, such as 
Rho GDI (a G-protein), can receive the signals and further transmit it by regulating 
GDP/GTP exchange and eventually modulating axonogenesis development. The inhibition 
of GDP/GTP exchange reactions catalyzes the formation of cAMP from ATP, which 
further causes changes in all metabolism (e.g. glycogenolysis). The changes in metabolism 
lead to changes in protein synthesis and changes in the antioxidant defense system. 
Furthermore, these signal molecules can trigger changes in DNA transcription and electric 
potential across the plasma membrane. It is evident that all cellular responses are related to 
one other. 
The detected proteins were categorized by their functions, as shown in Figure 2-2-5. 
The largest percentage of detected proteins was neural structural proteins and chaperone 
proteins. This is understandable, as a range of physiological stresses can induce the 
expression of heat shock proteins (115). Furthermore, neuron structural proteins are the 
most abundant proteins and play important roles during neuron development. 
 
CONCLUSIONS 
 
We have successfully investigated the proteome of SY5Y cells treated with 50 μM 
CPF for 24 h and 16 h with the combination of 2D gel electrophoresis with 
MALDI-TOF-MS. Using this approach, we simultaneously, quantitatively identified the 
CPF- induced altered proteins (both up- and down- regulated). A total of 37 common 
unique proteins from 56 spots were identified, out of which 16 proteins from 26 ± 4 spots 
were down-regulated, and 21 proteins from 30 ± 3 spots were up-regulated (mean ± SD of 
three experiments). These identified proteins play important roles in ATP production, 
neuritogenesis, protein synthesis, DNA transcription, signaling cascades and antioxidant 
defense systems. These detected proteins support the hypothesis that alterations in protein 
expressions underlie the impairment of energy production, protein synthesis, and 
neuritogenesis. All these studies show that cells need time to respond to the ‘stimulations’ 
caused by CPF. In order to respond to these stimulations from CPF, the cells have evolved 
a response system that induces cell cycle to allow sufficient time to repair or follow the 
cascades of the damage. 
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It is still unclear how these protein changes were initiated by CPF. We suggest that 
some signal proteins, such as Rho GDI, first receive the signal or insult from the cell 
environment, and further transmit the signal to the whole cell through energy production, 
or protein synthesis pathways. Based on the protein functions, several altered proteins, 
such as ATP synthase, vimentin, and Rho GDI, will be further investigated in the next step 
of experiments using bio-techniques. Mutation studies and metabolic experiments on 
animals, such as mice, will be the future experiments. It is very promising to understand the 
mechanism in biochemical pathways leading to neurodegeration associated with cognitive 
damage after exposure to CPF at subtoxic levels. 
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CHAPTER THREE 
 
CONCLUSIONS 
 
There is an increasing concern about exposure of pregnant women, infants and 
children to chlorpyrifos (CPF), an organophosphate insecticide. This concern is based on 
the in vitro and in vivo studies, which indicate that CPF is a developmental neurotoxin. 
Previous studies suggest that CPF, at concentrations below the threshold for symptoms of 
systemic toxicity, disrupts brain development and damages cognitive function. Studies 
both in vivo and in vitro confirmed that CPF at levels that do not cause cytotoxicity can 
compromise cellular processes in brain development. However, the actual mechanism for 
CPF perturbation in neuron development at the subcellular level remains unclear and 
complicated. This was the first study to systematically investigate CPF neurotoxicity at the 
subcellular level using SH-SY5Y as a model system. We tested the hypothesis that changes 
in protein expression underlie neuronal anomalies associated with CPF exposure. 
We successfully investigated differential protein expression in SY5Y cells treated 
with 50 µM CPF using 2D-PAGE with MALDI-TOF-MS. The time-dependent proteome 
changes of SH-SY5Y cells resulting from CPF exposure were also successfully examined. 
This was based on the comparison of the proteome changes of the neuroblastoma cells 
treated with CPF for 24 h and 16 h. A total of 37 common unique proteins from 56 spots 
were identified as altered proteins. However, 11 additional unique proteins were detected 
as altered proteins in samples treated with CPF for 16h. These identified proteins play 
important roles in ATP production, neuritogenesis, protein synthesis, DNA transcription, 
signaling cascades and antioxidant defense systems. The changes in protein expression 
suggested that the alterations were due to cellular responses to CPF stimulation. It is 
evident that cells need time to respond to the ‘stimulation’ caused from CPF by evolving a 
response system, which induces cell cycle to allow for sufficient time to repair or follow 
the cascades of the damage. 
2D gel electrophoresis has been a core technology of proteome analysis since the 
1980s. The technique offers high-throughput and relatively high reproducibility in 
combination with either MALDI-TOF-MS or LC/MS. 2D gel electrophoresis is an 
extremely powerful tool for the analysis of complex protein mixtures. The utility of this 
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technique lies in its enormous resolving power, which allows for the separation of 
approximately 2,000 proteins in a single electrophoretic run. The technique is powerful for 
detecting small changes in the levels or properties of proteins in response to changes in 
cellular conditions. However, 2D-PAGE is not the only method for proteome analysis. 
Many research groups are beginning to realize that “MudPIT” (Multidimensional Protein 
Identification Technology) is an alternate powerful tool. The rapid development of the 
technique relies on reduced sample preparation and manual labor compared to 2D gel 
electrophoresis. 
Thirty seven common unique proteins were detected as altered proteins in this 
study. Based on their functions, ATP synthase, vimentin, Rho GDI, and eukaryotic 
translation initiation factor (eif) will be chosen for further experiments using 
bio-techniques. The proteins of interest play important roles in ATP production, 
neuritogenesis, signal cascade protein, and protein synthesis, respectively. Once we 
systematically understand the altered proteins of the entire SH-SY5Y cells treated by CPF, 
mutation studies and metabolic experiments on animals, such as mouse, will be followed. 
These investigations can allow us to clearly understand the actual mechanism for CPF 
perturbations in neuron development at the subcellular level.  
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GENERAL CONCLUSION 
 
Some bizarre and puzzling problems, such as altered behaviors of animals in 
mating, parenting, and nesting, have been discovered all over the world since the 1950s. 
Many of the disturbing wildlife reports involved behavioral abnormalities and 
malfunctioning sexual organs, leading to damaged fertility. The loss of young, or the 
sudden disappearance of entire animal populations indicated that wildlives are disturbed. 
Most of these incidents seemed associated somehow to chemical pollution, especially 
man-made pesticides. Through the creation and release of billions of pounds of these 
man-made chemicals over the past half century, we have been instigating large-scale 
changes to the Earth’s atmosphere and even in chemistry of our own bodies. The 
magnitude of the damage is frightening. Most disturbing of all, many of us already carry 
contamination levels that may put us and our children at considerable risk. 
In the most extreme circumstances, chemicals were intentionally used as weapons 
for mass destruction. Associated with military operations, chemical warfare (CW) agents 
are designed with a high ability to kill, injure or incapacitate the enemy (including military 
and civilians). Chemical warfare was revolutionized, during World War II, by the 
discovery by Nazi Germany of nerve agents such as tabun, sarin and soman. Fortunately, 
the CW agents were not extensively applied during that time. The threat of CW became 
foremost during the Cold War. Both the Soviet and Western governments poured 
enormous resources into developing chemical and biological weapons. After the Cold War, 
mass destructions involving CW reagents occurred on several occasions. Implementation 
and use of these CW weapons have often led to tragic memories and terrible costs to human 
lives. About 100,000 Iranian soldiers were victims of Iraqi chemical attacks in 1980. 
Approximately 5000 Iraqi Kurdish civilians were slaughtered in a few hours by chemical 
bombs with multiple chemical agents. Things became worse, when CW agents were used 
as tools by many terrorist organizations. Several events involving the notorious use of CW 
agents in non-combat settings happened for several occasions lately. The most recent one 
was the Tokyo subway attack with sarin in 1995. 
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Defending ourselves from the hazard requires actions on several fronts involving 
scientific researches. As bioanalytical scientists, we have been conducting research driven 
by the need to answer several crucial questions: 
• What are the chemicals exposed to people? 
•  Whar are the exposure levels? 
• How is the human body really responding to these chemicals?  
The ultimate goal of pesticide exposure research should be recovery of victims. However, 
efforts are still required for the early detection of pesticide exposure and knowledge of 
pesticide effects on human before recovery comes to be true. As such, reliable, sensitive 
and accurate clinical diagnostics are critical in saving human lives and increasing public 
health. 
The concern of public health is increasing because of the extensive use of pesticides 
and occasional applications of CW agents in local conflicts or terrorism. Public health 
demands more sensitive and reliable programs for monitoring pesticide exposure. In the 
first part of this dissertation, a methodology was designed to solve the first two crucial 
questions mentioned before. This was achieved based on a full understanding of the 
chemistry, mode of action and toxicity of OPs and CBs, along with careful experimental 
design in mass spectrometry. The new methodology was based on the analysis of inhibited 
BChE by pesticides, particularly based on the detection of modified active site peptides 
generated from trypsin digests of the enzyme. The methodology employed proteomic 
approaches and much more sensitive, selective, accurate mass spectrometry techniques. 
Although the MALDI method was proven as a powerful tool for the analysis of single 
pesticide exposure, the lower ionization efficiency of phosphorylated peptides in MALDI 
and the suppression of the modified peptides in a complex peptide mixture make this 
method limited for the analysis of multiple pesticide exposure. However, LC/MS/MS can 
particularly analyze the precursor ions of interest in the ion trap with the presence of other 
abundant peptides. LC/MS/MS techniques were successfully applied to analyze a mixture 
of the phosphorylated peptides in vitro, and the precursor ions were monitored by a 
common fragment ion.  
Application of the developed LC/MS/MS methodology for measuring pesticide 
exposure in vitro and in serum samples clearly demonstrated the power of MS-based 
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method development in pesticide analysis. Results clearly displayed critical evidence of 
the exposure to OPs and CBs as low as 5 % human BChE inhibition in serum, which the 
traditional Ellman method can not detect. To design a reliable monitoring methodology 
and effect a treatment for victims, it is imperative that research focuses on the identification 
and quantification of exposure to OPs and CBs at early exposure times and at low levels. 
LC/MS/MS techniques can be broadly applied for the other possible pesticide analysis, 
such as CW agents, due to the large varieties of LC/MS parameters. For instance, many 
fragmentation techniques in MS and many types of LC columns can be adjusted to the 
analyte of interest. The technique of packing columns in laboratory makes it more 
attractive by customizing columns with the analyte of interest with numerous types of 
stationary phase available. As such, it is very promising to apply LC/MS-based methods 
for the analysis of other man-made chemicals. Metabolic studies in other body fluids, such 
as urine, coupled LC/MS/MS with the other techniques can further provide an indication of 
pesticide or CW agent exposure.  
The two critical questions, ‘what are the chemicals’ and ‘Whar are the exposure 
levels’, were successfully answered in the first part of this dissertation. To answer the third 
crucial question, a comprehensive research program is needed to determine the effects of 
synthetic chemicals on human health. Probing such questions will require a sophisticated 
integration of epidemiology on human populations, animal studies, and laboratory 
investigations of how these chemicals act at the cellular and molecular level. 
Epidemiological studies are never easy, and particularly difficult in the following instances. 
First, researchers confront the lack of an uncontaminated population for comparison. All 
young persons in our society are more or less exposed to synthetic chemicals. Second of all, 
there is a long time between exposure to these chemicals and the emergence of ill effects. 
Scientists find that the good opportunities for testing human health effects are cell culture, 
tissue culture, and organ culture. The diversities of cultures make it more appealing to 
achieve the different goals of various research subjects, as well as avoiding the long time 
period needed.  
The second part of this dissertation focused on the proteome analysis of SH-SY5Y 
cells, a neuroblastoma cell line, in an effort to obtain a clear understanding of protein 
expression in a CPF-treated sample. The protein expression indicated how the cells 
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respond to essential stimulation resulting from 50 µM chlorpyrifos (CPF), an 
organophosphate pesticide. The concerns of CPF exposure to pregnant women, infants and 
children are increasing due to its developmental neurotoxic effects. The main hypothesis of 
part two of this dissertation was that changes in protein expression underlie neuronal 
anomalies associated with CPF exposure. In this dissertation, we investigated the whole 
proteome alteration induced by CPF at the concentration levels below the threshold for 
symptoms of systemic toxicity using SH-SY5Y cell line as a model system. 
Two-dimensional gel electrophoresis (2DE) was applied with MALDI-TOF-MS to 
analyze differential protein expression. A total of 37 common unique altered proteins were 
identified, which play important roles in energy production, protein synthesis, DNA 
transcription, antioxidant defense system, and cell signaling cascades. The changes in 
protein expression suggest the changes resulting from cell response. Part II of this 
dissertation provided a basic insight for understanding how undifferentiated 
neuroblastoma cells respond to CPF at concentration levels without causing cytotoxicity. 
Some altered proteins, such as ATP synthase, will be further investigated to clearly 
understand how CPF influences neuron development. These closer examinations should 
combine biochemical techniques. A quantitative proteomics method combining 
multi-dimensional chromatographic separation method (MudPIT) and ICAT will probe the 
proteome analysis in a more productive way. 
In order to thoroughly investigate differential protein expression of neuroblastoma 
cells, proteome analysis of different organelles, such as proteins extracted from 
mitochondria, should be examined. A sophisticated integration of epidemiology on human 
populations, animal studies, and laboratory investigations is required to determine the 
effects of pesticide on human health at the cellular and molecular level. Once we 
systematically understand the altered proteins of the entire SH-SY5Y cells treated by CPF, 
mutation studies and metabolic experiments on animals, such as mouse, will follow. These 
investigations can allow us to clearly understand the actual mechanism for CPF 
perturbation in neuron development at the subcellular level. Results from these 
investigations can definitely enable us to find a way to cure or alleviate symptoms of the 
memory damage and learning disability caused from CPF.  
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The world market in pesticides amounted to 5 billion pounds in 1989 and included 
sixteen hundred chemicals. In this dissertation, we successfully analyzed the detection and 
quantification of two types pesticide of exposure (Part I), and we also successfully 
investigated how neuroblastoma cells respond to one kind of OP using a proteomics 
approach and mass spectrometry (Part II). This dissertation reveals a promising future of 
the proteomics approach and mass spectrometry for pesticide analysis, because of high 
sensitivity and high-throughput of this technique. However, this technique does have its 
shortcomings and will not be able to single-handedly tackle and analyze all pesticides. In 
addition, some emergent situations like the 1995 Tokyo Subway Attack, required a quick 
investigation from forensic analysis. How to apply the method in the field is a challenge for 
mass spectrometry specialists. A portable mass spectrometer with high sensitivity should 
be invented in the next few years. In addition, a culmination of several techniques, 
including but not limiting to mass spectrometry, UV, and biosensors, will result in the most 
productivity of pesticide analysis. The next several years should be very exciting as 
researchers apply mass spectrometry techniques and combine this with the other 
techniques for the purpose of answering the three crucial questions about pesticides and the 
other man-made chemicals. 
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